Signal transduction mechanisms and wiring specificity of bce-type antimicrobial peptide sensing and detoxification modules in firmicutes by Fang, Chong
  
 
 
 
Signal Transduction Mechanisms and Wiring 
Specificity of Bce-type Antimicrobial Peptide 
Sensing and Detoxification Modules in Firmicutes  
 
 
 
 
 
Dissertation 
 
Chong Fang  
2015 
  
 
 
Signal Transduction Mechanisms and Wiring 
Specificity of Bce-type Antimicrobial Peptide 
Sensing and Detoxification Modules in Firmicutes   
 
 
 
 
 
Dissertation 
der Fakultät für Biologie  
der Ludwig-Maximilians-Universität München  
 
vorgelegt von 
Chong Fang  
 
München 2015 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Erstgutachter: Prof. Dr. Thorsten Mascher 
Zweitgutachter: PD Dr. Ralf Heermann 
Tag der Einreichung: 29.07.2015 
Tag der mündlichen Prüfung: 22.09.2015 
  
Eidesstattliche Versicherung und Erklärung 
Hiermit versichere ich an Eides statt, dass die vorliegende Dissertation von mir selbständig und ohne 
unerlaubte Hilfe angefertigt wurde. Zudem wurden keine anderen als die angegebenen Quellen 
verwendet. 
Außerdem versichere ich, dass die Dissertation keiner anderen Prüfungskommission vorgelegt wurde 
und ich mich nicht anderweitig einer Doktorprüfung ohne Erfolg unterzogen habe. 
München, 29.07.2015 
                                                       Chong Fang 
 
 
 
 
 
Statutory declaration and statement 
I declare that I have authored this thesis independently, that I have not used other than the declared 
sources/resources. As well I declare that I have not submitted a dissertation without success and not 
passed the oral exam. The present dissertation (neither the entire dissertation nor parts) has not been 
presented to another examination board. 
München, 29.07.2015 
                                                       Chong Fang 
Table of contents 
 
Table of contents  
Abbreviations .......................................................................................................................................... I 
List of publications ................................................................................................................................ II 
Contributions to publications presented in this thesis ..................................................................... III 
Summary .............................................................................................................................................. IV 
Zusammenfassung ............................................................................................................................... VI 
Chapter I ― Introduction ..................................................................................................................... 1 
1.1. The bacterial cell envelope ................................................................................................................ 2 
1.2. Antimicrobial peptides ...................................................................................................................... 5 
1.3. Mechanisms of antimicrobial peptide resistance in Gram-positive bacteria ..................................... 6 
1.4. Regulatory network orchestrating antimicrobial peptide resistance in Bacillus subtilis ................... 7 
1.5. Regulatory network orchestrating antimicrobial peptide resistance in Enterococcus faecalis ....... 10 
1.6. Two-component signal transduction systems .................................................................................. 11 
1.7. Signaling specificity of Bce-type two-component systems in Bacillus subtilis .............................. 13 
1.8. Aims of this thesis ........................................................................................................................... 16 
Chapter II ............................................................................................................................................. 17 
Bacillus subtilis as a Platform for Molecular Characterisation of Regulatory Mechanisms of 
Enterococcus faecalis Resistance against Cell Wall Antibiotics 
Chapter III ............................................................................................................................................ 27 
Identification and Characterization of a Bacitracin Resistance Network in Enterococcus faecalis 
Chapter IV ............................................................................................................................................ 37 
Insulation and Wiring Specificity Determinants of BceR-like Response Regulators and their Target 
Promoters in Bacillus subtilis 
Chapter V .............................................................................................................................................. 67 
Specificity Determinant and Rewiring Signal Transduction of BceRS-like Two-Component Systems in 
Bacillus subtilis 
Chapter VI ― Concluding Discussion................................................................................................ 87 
6.1. Bacillus subtilis as a heterologous host: advantages and considerations ........................................ 88 
6.2. The Bce-type modules are arranged differently within B. subtilis and E. faecalis ......................... 89 
6.3. Specificity determination of Bce-like TCSs in Bacillus subtilis ..................................................... 92 
6.4. Open questions and further research ............................................................................................... 98 
References of Chapter I and Chapter VI ......................................................................................... 100 
Acknowledgments............................................................................................................................... 107 
Curriculum Vitae ............................................................................................................................... 108 
Abbreviations 
I 
 
Abbreviations 
ABC ATP-binding cassette 
AMP antimicrobial peptide 
bp base pair(s) 
CM cytoplasmic membrane 
EMSA electrophoretic mobility shift assay 
HK histidine kinase 
IM-HK intramembrane-sensing histidine kinase 
IPTG isopropyl-β-D-thiogalactopyranoside 
MLS macrolide-lincosamide-streptogramin B 
OD optical density 
OM outer membrane 
PCR polymerase chain reaction 
PG peptidoglycan 
RR response regulator 
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SPR surface plasmon resonance 
TCS two-component system 
X-Gal 5-bromo-4-chloro-3-indoyl-β-D-galactopyranoside 
List of publications 
II 
 
List of publications 
Publications and manuscripts presented in this thesis: 
Chapter II 
Fang C., Stiegeler E, Cook G.M., Mascher T., Gebhard S. (2014) Bacillus subtilis as a Platform for 
Molecular Characterisation of Regulatory Mechanisms of Enterococcus faecalis Resistance against 
Cell Wall Antibiotics. PLoS ONE 9(3): e93169. 
Chapter III 
Gebhard S., Fang C., Shaaly A., Leslie D.J., Weimar M.R., Kalamorz F., Carne A. and Cook G.M. 
(2014) Identification and Characterisation of a Bacitracin Resistance Network in Enterococcus 
faecalis. Antimicrob. Agents Chemother. Vol. 58 no. 3 1425-1433. 
Chapter IV 
Fang C., Staroń A., Grafe M., Heermann R., Jung K., Gebhard S. and Mascher T. Insulation and 
Wiring Specificity Determinants of BceR-like Response Regulators and their Target Promoters in 
Bacillus subtilis. Manuscript. 
Publication not presented in this thesis: 
Dintner S., Heermann R., Fang C., Jung K. and Gebhard S. (2014) A Sensory Complex Consisting of 
an ATP-Binding-Cassette Transporter and a Two-Component Regulatory System Controls Bacitracin 
Resistance in Bacillus subtilis. J. Biol. Chem. doi: 10.1074/jbc.M114.596221. 
 
Contributions to publications 
III 
 
Contributions to publications presented in this thesis  
Chapter II 
Susanne Gebhard, Thorsten Mascher and Gregory M. Cook conceived and designed the experiments. 
Chong Fang and Emanuel Stiegeler performed the experiments. Chong Fang, Emanuel Stiegeler and 
Susanne Gebhard analyzed the data. Susanne Gebhard and Chong Fang wrote the manuscript.     
Chapter III 
David J. Leslie, Marion R. Weimar, and Falk Kalamorz characterized the resistance network in E. 
faecalis; Chong Fang performed all work with B. subtilis; Aishath Shaaly and Alan Carne performed 
the proteomic analysis; Susanne Gebhard and Gregory M. Cook designed the study and coordinated 
experimental work; Susanne Gebhard wrote the manuscript. 
Chapter IV 
Thorsten Mascher and Susanne Gebhard conceived and designed the experiments. Chong Fang, Anna 
Staroń and Martin Grafe performed the in vivo experiments. Chong Fang performed the in vitro BceR 
purification and EMSAs. Ralf Heermann conducted and analyzed the SPR experiments. Ralf 
Heermann and Kirsten Jung gave valuable input for the manuscript. Thorsten Mascher, Ralf 
Heermann and Chong Fang analyzed the data and wrote the manuscript.     
 
 
                 Chong Fang                                                               Prof. Dr. Thorsten Mascher 
 
Summary 
IV 
 
Summary 
The environment of many bacteria often contains antimicrobial peptides (AMPs) that are produced by 
competing microorganisms or the host immune defense systems. Most AMPs target the bacterial cell 
envelope. Among all the mechanisms exploited by bacteria to survive AMP challenge, the most 
efficient and significant way is the use of ABC transporters, which remove AMPs from their sites of 
action. A special type of BceAB-like ABC transporters is widely distributed in Firmicutes bacteria. 
The transporters are unique in their dual role as both mediators of resistance and sensors for the 
underling signal transduction. The ABC transporter binds and thereby senses the AMP, and then 
passes the signal onto the cognate histidine kinase, which harbors only a short extracellular loop and is 
by itself not capable of AMP sensing. Signaling from the histidine kinase to the cognate response 
regulator by phosphotransfer then strongly induces the transcription of the ABC transporter operon, 
thereby mediating AMP resistance. Since the ABC transporter is usually located in direct genomic 
neighborhood to its two-component system, both together form Bce-like AMP detoxification modules, 
which are widely conserved in Firmicutes bacteria. 
In the first part of my thesis, I focused on studying AMP resistance signaling in Enterococcus faecalis. 
The knowledge of AMP resistance-related systems is limited by the challenge of genetic manipulation 
of E. faecalis. Therefore, we exploited Bacillus subtilis as a host for heterologous studies. Two 
previously studied E. faecalis AMP resistance systems were introduced and proved well functional in 
B. subtilis. We confirmed that B. subtilis is a suitable heterologous host for studying the E. faecalis 
cell wall-targeting antibiotic resistance module, with considerations being paid to the genomic 
background and the expression level. Previous studies identified two BceAB-like ABC transporters 
and one BceRS-like two-component system in the genome of E. faecalis, but these ABC-transporters 
are not located near the two-component system operon. Neither the function of nor the relationship 
between them is known. By using the established B. subtilis platform, we functionally characterized a 
bacitracin sensing and detoxification network comprised of these two ABC transporters and the one 
two-component system, and gained a deeper understanding of the Bce-type antibiotic resistance 
module of E. faecalis. 
In the second part of my thesis, I then analyzed the determinants of wiring signaling specificity for 
Bce-like two-component systems of B. subtilis. The genome of B. subtilis encodes three paralogous 
Bce-like systems, which share significant sequence and structural similarity and are therefore 
predicted to have considerable cross-talk. However, previous studies demonstrated that these three 
systems are insulated quite well with only minor cross-regulation between the BceS histidine kinase 
and the PsdR response regulator. We first aimed at understanding the molecular mechanisms evolved 
by B. subtilis to maintain the intrasystem signaling fidelity and intersystem insulation with regards to 
RR-promoter. By performing in vivo chimeric promoter activity assays and in vitro response regulator 
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binding assays, we demonstrated that B. subtilis developed a hierarchical cooperative binding model, 
involving two binding sites and a linker region on the promoter, to maintain the regulatory specificity 
of Bce-like response regulator to their target promoters. Next we aimed at understanding the 
phosphotransfer specificity between Bce-like histidine kinases and their cognate response regulators. 
Towards that aim, we performed in vivo chimeric response regulator assays with either the cognate or 
the non-cognate histidine kinases. We were able to identify a novel specificity determinant ― the α1-
β2-α2 region — within the response regulator receiver domain that is necessary to determine the 
specific signaling with the cognate histidine kinase. 
In summary, this thesis established B. subtilis as a platform for heterologous studying AMP responsive 
signaling systems of E. faecalis, which then provided a deeper understanding of the bacitracin sensing 
and resistance network in this organism. Moreover, it provides new insight into specificity 
determining mechanisms of two Bce-like systems of B. subtilis. 
Zusammenfassung 
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Zusammenfassung  
Der Lebensraum vieler Bakterien enthält antimikrobielle Peptide (AMPs), welche von Konkurrenten 
oder dem Immunsystem des Wirtes produziert weden. Viele AMPs haben die bakterielle Zellhülle als 
Hauptangriffspunkt. Unter allen bakteriellen AMP-Resistenzmechanismen, stellt der effizienteste und 
bedeutendste Mechanismus das Verwenden von ABC-Transporter dar, welche AMPs von ihren 
Wirkorten entfernen. Ein spezieller Typ von BceAB-ähnlichen ABC-Transportern ist weitverbreitet in 
firmicuten Bakterien. Diese Transporter sind einzigartig in ihrer Doppelrolle als sowohl Vermittler 
von Resistenz, als auch Sensoren für die zugrundeliegende Signaltransduktion. Die ABC-Transporter 
binden und erkennen somit die AMPs. Danach geben sie das Signal an die zugehörigen 
Histidinkinasen weiter, welche nur über eine kleine extrazelluäre Domäne verfügen und selbst zur 
AMP-Erkennung nicht in der Lage sind. Die Signalweiterleitung von der Histidinkinase zum 
zugehörigen Antwortregulator mittels der Phosphatgruppenübertragung induziert dann die 
Transkription des ABC-Transporter-Operons stark und vermittelt so die AMP-Resistenz. Da die ABC-
Transporter häufig genomisch in nächster Nähe zu ihren Zweikomponentensystemen liegen,  bilden 
sie zusammen ein Bce-artiges Entgiftungsmodul gegen Peptidantibiotika, welches weitgehend 
konserviert in firmicuten Bakterien vorliegt. 
Im ersten Teil meiner Arbeit lag das Hauptaugenmerk auf der Erforschung des Signalwegs der AMP-
Resistenz in Enterococcus faecalis. Das Wissen hierüber ist in E. faecalis aufgrund der in dieser 
Bakterienart schwierigen Genmanipulation gering. Deshalb wollten wir Bacillus subtilis als Wirt für 
heterologe Studien etablieren. Zwei vormals untersuchte Resistenzsysteme von E. faecalis gegen 
Peptidantibiotika wurden in B. subtilis eingebracht und funktionierten dort einwandfrei. Wir konnten 
somit bestätigen, dass B. subtilis ein geeigneter heterologer Wirt zur Untersuchung von 
Resistenzmodulen aus E. faecalis ist. Frühere Studien identifizierten zwei BceAB-ähnliche ABC-
Transporter und ein BceRS-artiges Zweikomponentensystem im Genom von E. faecalis. Die ABC-
Transporter befanden sich aber genomisch nicht in der Nähe des Zweikomponentensystems und weder 
über ihre Funktion noch eine mögliche Interaktion zwischen ihnen war Näheres bekannt. Durch das 
Verwenden der etablierten B. subtilis-Plattform konnten wir die Funktionsweise eines 
Bacitracinerkennungs- und Entgiftungsnetzwerkes beschreiben, welches aus den oben erwähnten zwei 
ABC-Transportern und dem Zweikomponentensystem bestand. Somit konnten wir ein besseres 
Verständnis des Bce-ähnlichen Rsistenzmoduls gegen Antibiotika in E. faecalis erlangen. 
Im zweiten Teil meiner Arbeit analysierte ich die Determinanten, welche für die Signalspezifizität von 
Bce-ähnlichen Zweikomponentensystemen in B. subtilis verantwortlich sind. Das Genom von B. 
subtilis codiert drei paraloge Bce-ähnliche Systeme, welche eine signifikante Ähnlichkeit in der 
Sequenz und Struktur besitzen, weshalb ihnen ein hohes Maß an Crosstalk vorhergesagt wurde. 
Frühere Studien konnten hingegen zeigen, dass diese drei Systeme ziemlich gut voneinander isoliert 
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sind und es nur zu einer geringen Kreuzregulation zwischen der BceS Histidinkinase und dem PsdR 
Antwortregulator kommt. Unser erstes Ziel war es, die molekularen Mechanismen zu verstehen, 
welche die systeminterne Signalspezifizität und die Isolierung zwischen den Systemen 
aufrechterhalten. Mittels in vivo Aktivitätsanalysen chimärer Promotoren und in vitro Bindungsstudien 
von Antwortregulatoren konnten wir zeigen, dass B. subtilis hierfür ein fein abgestimmtes 
hierarchisches und kooperatives Bindungsmodell entwickelte. Dieses beinhaltet zwei Bindestellen und 
eine Linker-Region auf dem Promotor und sorgt dafür, dass die Regulationsspezifität von Bce-
ähnlichen Antwortregulatoren zu ihren Zielpromotoren erhalten bleibt. Als nächstes untersuchte ich 
die Spezifität der Phosphatgruppenübertragung zwischen der Bce-ähnlichen Histidinkinase und ihrem 
Antwortregulator. Um dieses Ziel zu erreichen, führten wir in vivo Bindungsstudien chimärer 
Antwortregulatoren mit entweder der zugehörigen oder nicht zugehörigen Histidinkinase durch. Wir 
konnten damit eine neue Spezifizitätsdeterminante ― die α1-β2-α2-Region ― auf der 
Empfängerdomäne des Antwortregulators identifizieren, welche für die Signalspezifizität mit der 
zugehörigen Histidinkinase verantwortlich ist. 
Zusammenfassend etablierte diese Arbeit B. subtilis als eine Plattform für heterologe Studien von 
Signaltransduktionssystemen aus E. faecalis, welche auf Antibiotika reagieren. Diese heterologe 
Plattform ermöglichte uns ein tieferes Verständnis des Netzwerks, welches Bacitracin erkennt und die 
Resistenz ermöglicht. Zusätzlich erlangten wir neue Erkenntnisse über spezifitätsbestimmende 
Mechanismen zweier Bce-artiger Systeme in B. subtilis.  
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1. Introduction  
Survival in the competitive bacterial habitat demands both production of and defense against 
numerous antimicrobial peptides (AMPs). The bacterial cell envelope is the first and principal line to 
confront and protect the cell from antibiotics. It is therefore the target of a wide array of antibiotics. To 
cope with myriad AMPs and improve the chances of survival in harsh living environments, bacteria, 
like Bacillus subtilis and Enterococcus faecalis, have evolved a variety of direct and indirect 
resistance mechanisms. 
1.1. The bacterial cell envelope — the first defense system  
The cell envelope is an essential and complex structure of the bacterial cell with sophisticated layers. 
It is crucial for maintaining cell integrity, cell shape, surface properties, solute permeability, and self-
defense. It keeps the bacterial cell as a separate individual while also enabling bacterial 
communication (Braun et al., 2014). The Gram-negative bacterial cell envelope has three layers 
including the outer membrane, the peptidoglycan cell wall and the cytoplasmic membrane (Fig. 1.1). 
The outer membrane plays an important role in separating the cell from toxic molecules and 
stabilizing the cytoplasmic membrane. Compared to the Gram-negative bacteria, the Gram-positive 
cell envelope has only two functional layers: the peptidoglycan cell wall and the cytoplasmic 
membrane (Fig. 1.1). For Gram-positive bacteria, lacking the protective outer membrane necessitates a 
peptidoglycan cell wall thicker and more complex than Gram-negative bacteria to tolerate the harsh 
environmental challenges and support the cell membrane (Silhavy et al., 2010).  
1.1.1. The composition of the Gram-positive bacterial cell wall 
The cell wall of Gram-positive bacteria varies among different species, but can be described in general 
as a three dimensional net-like structure comprised of many peptidoglycan layers, teichoic acids (TAs) 
and surface proteins (Silhavy et al., 2010) (Fig. 1.1).  
The peptidoglycan of Gram-positive bacteria is around 30-100 nm thick with up to 40 layers 
consisting of glycan chains cross-linked by cell wall peptides, while the Gram-negative bacterial 
peptidoglycan has only one to a few layers (Bertsche et al., 2014). Every glycan strand is made up of 
repeating N-acetylglucosamine-(β1-4)-N-acetylmuramic acid (GlcNAc-MurNAc) disaccharide units. 
The penta-peptide moiety with a common sequence L-Ala-D-Glu-DAA (dibasic amino acid)-D-Ala-D-
Ala is linked to the lactic acid of N-acetylmuramic acid via an amide bond with the first amino acid (L-
alanine). DAA is the dibasic amino acid that differs between bacteria. Most Gram-negative species, as 
well as some Gram-positives such as Bacilli and Mycobacteria, use mDAP (meso-diaminopimelate), 
while most Gram-positives use L-Lys (Scheffers & Pinho, 2005, Bertsche et al., 2014, Wheeler et al., 
2014). The glycan strands and the peptide stems together form the peptidoglycan chains, which are 
connected by cross-bridges (Vollmer et al., 2008). The length of the peptidoglycan chains and the 
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cross-links vary among Gram-positive bacteria. Staphylococcus aureus has short peptidoglycan 
strands but a high degree of cross-links, whereas B. subtilis has longer strands but a lower degree of 
cross-links (Vollmer, 2008, Vollmer & Seligman, 2010, De Pedro & Cava, 2015). The three 
dimensional mesh-like peptidoglycan plays an important role in the tolerance of turgor and in 
maintaining the shape and viability of the cell (Desmarais et al., 2013). 
 
 
 
 
 
 
 
Figure 1.1. Structure and composition of the Gram-positive (left) and Gram-negative (right) cell envelopes. 
CAP, covalently attached protein; IMP, integral membrane protein; OMP, outer membrane protein; LP, 
lipoprotein; LPS, lipopolysaccharide; LTA, lipoteichoic acid; WTA, wall teichoic acid (Silhavy et al., 2010). 
Another important and widespread constituent of the Gram-positive bacterial cell wall is TA. It can be 
tethered either to the cell wall by phosphodiester bond to the C6 hydroxyl of MurNAc (wall teichoic 
acids, WTA) or to the glycolipids that are embedded in the outer layer of the cytoplasmic membrane 
(lipoteichoic acids, LTA) (Perego et al., 1995, Silhavy et al., 2010). The structure and composition of 
WTA and LTA vary among different Gram-positive bacteria, but the common feature is that they are 
phosphate-rich polymers comprised of a continuum of anionic charge. This feature can significantly 
affect the synthesis and degradation of the cell wall, cation homeostasis, the antimicrobial resistance, 
and the interaction of bacterial cells with various surfaces (Hughes et al., 1973, Neuhaus & Baddiley, 
2003, Bhavsar et al., 2004, Brown et al., 2013).  
Surface proteins are attached to the peptidoglycan, TAs or the cytoplasmic membrane by non-covalent 
interactions or covalent bonds. They are responsible for peptidoglycan synthesis and turnover during 
cell growth and division, recognition and interaction with their host for Gram-positive pathogens and 
nutrient utilization (Navarre & Schneewind, 1999, Ton-That et al., 2004, Scott & Barnett, 2006). 
1.1.2. The biosynthesis of the Gram-positive bacterial cell wall 
The bacterial cell wall has a dynamic structure and undergoes a constant remodeling process: it is 
synthesized, modified and hydrolyzed to allow cell growth, cell division, and AMP resistance. The 
synthesis process can be generally divided into three stages that occur respectively in cytoplasm, 
Chapter I - Introduction 
4 
 
membrane and extracellular cell wall compartment, including peptidoglycan assembly, TAs and 
proteins attachment involved with a variety of enzymes and substrates (Shockman & Barren, 1983, 
Scheffers & Pinho, 2005, Johnson et al., 2013) (Fig. 1.2).  
 
 
 
 
 
 
 
 
 
Figure 1.2. Cell wall biosynthesis of the Gram-positive bacteria and its inhibition by antibiotics. Important 
steps in cell wall biosynthesis are schematically depicted together with their cellular locations. GlcNAc, N-
acetyl-glucosamine; MurNAc, N-acetyl-muramic acid. Amino acids are symbolized by small grey circles. 
Undecaprenyl is showed as waved lines. Some cell wall antibiotics relevant for this thesis are given and placed 
next to the steps they inhibit. Antibiotics in green sequester the substrate of the given step; those in blue inhibit 
the corresponding enzymatic function. See text for details on their actions. This figure was originally based in 
parts on (Jordan et al., 2008), with modifications. 
In the cytoplasm, peptidoglycan synthesis starts with the conversion of fructose-6-phosphate into 
UDP-GlcNAc by sequential reactions involving different enzymes. UDP-GlcNAc can be converted 
into UDP-MurNAc penta-peptide, which is further transferred to a membrane undecaprenyl phosphate 
lipid carrier to form lipid I. At the next step, GlcNAc is linked to MurNAc from lipid I via β1-4 
glycoside bond to generate lipid II. Amino acids involved in peptide cross-bridges are also linked to 
the DAA of the penta-peptide. Translocation of lipid II to the exterior face of the membrane is 
followed by polymerization and cross-linking catalyzed by penicillin-binding proteins (PBPs). These 
two functions of PBPs are executed by different domains: transglycosylase domain and transpeptidase 
domain (Ton-That et al., 2004, Bugg et al., 2011, Typas et al., 2012, Johnson et al., 2013). PBPs work 
cooperatively with autolysins as well as WTA and LTA synthesis enzymes for cell wall growth. In 
most bacteria, the insertion of new cell wall material for cell elongation is guided by actin-like protein 
MreB and for cell division is organized by tubulin-like protein FtsZ (Shockman & Barren, 1983, Jones 
et al., 2001, Carballido-López & Errington, 2003, Scheffers & Pinho, 2005, Kawai et al., 2009, Domí
nguez-Cuevas et al., 2013). After adding the peptidoglycan precursor into the cell wall, the membrane 
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lipid carrier remains in the pyrophosphate form and will further be dephosphorylated and flipped back 
to the cytoplasmic side of the membrane for recycling. The steps of the cell wall biosynthesis linked to 
the cytoplasmic membrane via undecaprenyl are referred to as the “Lipid II cycle”. The cell wall 
synthesis process, especially the lipid II cycle, is the target of numerous AMPs. 
1.2.  Antimicrobial peptides — the inhibitors of bacterial cell wall synthesis 
AMPs are secondary metabolites produced for self-defense by a variety of organisms like bacteria, 
fungi, plants, insects, and animals. They are small (usually 6 to 100 amino acids) and usually 
positively charged amphipathic molecules with different lengths, sequences, secondary structures, and 
antimicrobial spectrum (Berdy, 2005, Nakatsuji & Gallo, 2012, Bahar & Ren, 2013). They can be 
separated into four groups based on the secondary structure they mainly harbor: β-strands, α-helices, 
loop structures, and extended structures (Davies & Webb, 1998, Lee et al., 2015). AMPs can be 
synthesized either nonribosomally or ribosomally. Nonribosomally synthesized AMPs like bacitracin, 
gramicidin, and glycopeptides are drastically modified and mainly produced by bacteria. They are 
synthesized according to the multiple-carrier thiotemplate mechanism by a series of very large and 
multifunctional peptide synthetases in an ordered fashion. Ribosomally synthesized AMPs can be 
produced by a wide range of organisms as major defense molecules against microorganisms (Stein et 
al., 1996, Hancock & Chapple, 1999, Papagianni, 2003). Lantibiotics, a large family of AMPs, are 
ribosomally synthesized and post-translationally modified with unusual amino acids such as 
lanthionine and methyllanthionine (McAuliffe et al., 2001, Chatterjee et al., 2005). One of the most 
famous members is Nisin, a type A lantibiotic containing five lanthionine rings and three dehydrated 
amino acids produced by Lactococcus lactis during stationary growth phase (Hsu et al., 2004).  
The modes of action AMPs exert against bacteria include inhibition of the cell wall synthesis, 
membrane dysfunction by channels/pores formation, and repression of intracellular functions like 
DNA, RNA or proteins synthesis (Yeaman & Yount, 2003). Cell wall targeting AMPs implement their 
functions either by disrupting the activity of enzymes involved in cell wall synthesis or isolating 
substrates/precursors of corresponding enzymes (Jordan et al., 2008).  
Examples of AMPs acting on bacterial cell wall are wide-ranging (Fig. 1.2). Fosfomycin and D-
cycloserine can target and hinder the cytoplasmic steps of the bacterial cell wall synthesis (Nikolaidis 
et al., 2014). Most lantibiotics can target the lipid II and impede the cell wall synthesis (Breukink & de 
Kruijff, 2006). Nisin has antimicrobial function against a wide range of Gram-positive bacteria and the 
outgrowth of spores of Bacilli and Clostridia (Héchard & Sahl, 2002, de Arauz et al., 2009). It can 
bind to lipid II and use it as an anchor molecule to further insert itself into the lipid bilayers. Thus it 
presents a dual mode of antimicrobial activity causing inhibition of the cell wall biosynthesis and pore 
formation on the membrane, which ultimately result in cell lysis (Nagao et al., 2006). Mersacidin, a 
type B lantibiotic with a more globular structure, can complex lipid II and prevent the cell wall 
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synthesis (Stein, 2005, Willey & van Der Donk, 2007). Lipid II is also the target of glycopeptides like 
teicoplanin and vancomycin. They can inhibit polymerization and cross-linking by binding to the D-
Ala-D-Ala dipeptide terminus of the lipid II and block the cell wall synthesis, which eventually leads 
to cell death (Marshall et al., 1998, Silver, 2003). Bacitracin, a branched cyclic nonribosomally 
synthesized dodecylpeptide AMP mainly produced by Bacillus licheniformis and some strains of B. 
subtilis, binds tightly to the undecaprenyl pyrophosphate and prevents its dephosphorylation and 
recycling (Bernlohr & Novelli, 1963, Katz & Fisher, 1987, Azevedo et al., 1993, Konz et al., 1997).  
1.3. Mechanisms of antimicrobial peptide resistance in Gram-positive bacteria 
To survive in a competitive environment, bacteria have developed different strategies either via 
spontaneous mutations or acquisition of additional genes to acquire AMP resistance. Some bacteria 
can form biofilm to confer resistance (Otto, 2006). Resistance can also be achieved by synthesizing 
proteases to degrade the AMPs (Sun et al., 2009). Resistance against cell wall acting AMPs can also 
be mediated by reducing the access of the drugs to the cell envelope by changing the cell’s surface 
charge — possible in both Gram-positive and Gram-negative bacteria. In Gram-positive bacteria, the 
negative charge of the cell surface can be reduced by incorporating D-Ala to the highly negatively 
charged TAs. This is accomplished by gene products of the dlt operon. Bacteria are more sensitive to 
cationic AMPs if this operon is inactivated (Neuhaus & Baddiley, 2003, McBride & Sonenshein, 2011, 
Reichmann et al., 2013). The reduced negative charge of TAs was postulated to diminish the 
electrostatic attraction between the AMPs and the cell envelope (Peschel & Sahl, 2006). However, an 
alternative model was proposed: the D-alanylation of TAs modifies the electrostatic interaction 
between TAs themselves thereby making the cell envelope more compact and less permeable for 
AMPs to reach their cell wall targets (Saar-Dover et al., 2012, Revilla-Guarinos et al., 2014).                    
Specific resistance against AMPs includes modifying their cell wall targets. In enterococci, resistance 
against vancomycin is conferred by altering the binding target D-Ala-D-Ala on the C-terminal of lipid 
II into D-Ala-D-Lac or D-Ala-D-Ser (Bugg et al., 1991). This switch leads to a reduced number of 
hydrogen bonds from five to four between AMPs and their target — lipid II, which decreases the 
binding affinity by 1000-fold (Bugg et al., 1991, Kahne et al., 2005). Two types of vancomycin 
resistance were found in E. faecalis and will be described in detail in Section 1.5 (Walsh et al., 1996).  
The most efficient mechanism against AMPs is mediated by the ATP-binding cassette (ABC) 
transporters. These transporters usually contain one or two permease domains with variable number of 
transmembrane (TM) helices, and each permease domain is associated with an ATPase (Gebhard, 
2012). ATP hydrolysis provides energy for resistance against AMPs. Three different types of ABC 
transporters, the LanFEG-type, the BceAB-type, and the BcrAB-type, have been found widespread in 
Firmicutes bacteria for AMP resistance (Gebhard, 2012). The BcrAB-type and the LanFEG-type 
transporters are mainly responsible for sensing and resistance against self-produced AMPs and most of 
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them have a very narrow substrate range. Some of them were found to be associated with AMP 
biosynthesis genes. For example, the ABC transporter BcrAB together with the undecaprenyl 
pyrophosphate phosphatase BcrC are encoded in the bacitracin biosynthesis locus and confer self-
resistance in B. licheniformis (Podlesek et al., 1995); the NisFEG system in L. lactis is responsible for 
mediating resistance to the self-produced nisin (Stein et al., 2003).  
The BceAB-type transporters are hardly ever associated with AMP biosynthetic genes. The range of 
resistance is quite broad including lantibiotics, cyclic AMPs like bacitracin, glycopeptides, and 
peptides from the innate immune systems of higher organisms like defensins and cathelicidins 
(summarized in (Gebhard & Mascher, 2011)). The permeases of these transporters have 10 TM helices 
and a large extracellular loop between helices 7 and 8. TM helices 2 to 4 and TM helices 8 to 10 form 
two FtsX-domains (Dintner et al., 2011, Dintner et al., 2014). Furthermore, this kind of transporters 
are not only responsible for AMP resistance but also indispensable for AMP perception (Rietkötter et 
al., 2008, Staroń et al., 2011). However, the molecular mechanisms of substrate detection, signaling 
and resistance are not fully understood (more details see Section 1.7). 
1.4. Regulatory network orchestrating antimicrobial peptide resistance in Bacillus 
subtilis 
B. subtilis is the best-characterized member of the Gram-positive bacteria and can be isolated from 
diverse environments, e.g., soil, water source, and plant root surfaces. It is a rod-shaped bacterium that 
can form highly resistant dormant endospores in response to nutrient limitation (Earl et al., 2008, van 
Dijl & Hecker, 2013). The genome of B. subtilis contains around 4.2×10
6
 bp with 4,100 protein-
coding genes, and about 4-5% of the genome is devoted to antibiotics production (Kunst et al., 1997). 
Antibiotics such as subtilosin, surfactin, bacilysin, lantibiotics including subtilin, ericin and mersacidin 
have been reported to be synthesized ribosomally or nonribosomally by a wide array of B. subtilis 
strains to inhibit competitors in the same environment (Stein, 2005). In addition to the ability of AMP 
production, AMP resistance is also crucial and orchestrated by a complex regulatory network, which is 
shown in Figure 1.3A. One of the specific and most efficient defense mechanisms is the Bce-type 
ABC transporter that are mainly found in Firmicutes bacteria (Dintner et al., 2011). As mentioned 
above, the Bce-type ABC transporter is responsible for both AMP perception and resistance. The 
expression of the ABC transporter operon is regulated by a Bce-type two-component system (TCS), 
which is comprised of a membrane-anchored histidine kinase (HK) and a cytoplasmic response 
regulator (RR) (Joseph et al., 2002) (details of TCSs will be introduced in Section 1.6). The sensor 
domain of the Bce-type HK harbors a short extracellular loop (<10 amino acids for most) between the 
two transmembrane helices and is not able to detect the AMP (Mascher, 2006, Mascher, 2014). The 
ABC transporter and TCS are genetically and functionally linked, and together they form the Bce-type 
AMP sensing and detoxification module (Dintner et al., 2011). The signal transduction circuit starts 
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when the ABC transporter detects the AMP and passes the signal to the TCS to activate the HK. The 
phosphotransfer from the HK to the RR will in turn trigger the upregulation of the ABC transporter 
operon for AMP resistance. The TCS operon is under the control of a constitutive promoter, while the 
ABC transporter operon is expressed under the control of an AMP inducible, RR-dependent promoter 
(Ohki et al., 2003, Staroń et al., 2011). The genome of B. subtilis encodes three such systems to cope 
with the challenges from different kinds of AMPs (Joseph et al., 2002) (Fig. 1.3A blue systems). The 
BceRS-BceAB system can sense and confer resistance against bacitracin, actagardine and mersacidin. 
It has also been reported to respond to a fungal defensing plectasin (Staroń et al., 2011). The PsdRS-
PsdAB system shares the same inducer actagardine with the Bce system but cannot confer resistance 
against it. Other antibiotics that can be detected and detoxified by the Psd system are nisin, 
enduracidin, gallidermin and subtilin (Staroń et al., 2011). The only known inducer for the YxdJK-
YxdLM-YxeA system is a human neutrophil peptide, LL-37 (Pietiäinen et al., 2005). This system is 
assumed to be involved in resistance against an unknown group of antibiotics. The gene locus harbors 
an extra yxeA gene encoding a long peptide that is conserved in many Gram-positive bacteria. It might 
be an immune protein participating in the proposed AMP resistance by interacting with and 
neutralizing the antibiotic (Joseph et al., 2004).  
B. subtilis also developed other response systems to counteract cell envelope damage caused by AMPs. 
The LiaRS TCS, which is widespread in most Firmicutes bacteria, is a damage-sensing signal 
transduction system (Wolf et al., 2012) (Fig. 1.3A red system). It can strongly respond to a wide range 
of cell wall antibiotics, such as bacitracin, nisin, ramoplanin, and vancomycin (Mascher et al., 2004, 
Pietiäinen et al., 2005, Hachmann et al., 2009). In the presence of a stimulus, the phosphorylated LiaR 
can strongly induce the expression of the liaIH-liaGFSR operons. While in the absence of stimulus, 
the transcription of the liaIH operon is switched off and the liaGFSR operon is under the control of a 
weak constitutive promoter, PliaG (Jordan et al., 2006). The LiaRS TCS has a strong inhibitor, LiaF, 
and deletion of liaF led to a constitutive active system in the absence of cell envelope stress (Jordan et 
al., 2006). However, the functions of most gene products of the lia operon are not clearly known. The 
LiaG is a putative membrane anchored hypothetical protein with unknown function. The LiaH is a 
member of phage shock protein family, and it is homologous to the Escherichia coli phage shock 
protein PspA, which suggests that the Lia system harbors a PspA-like response to maintain the 
membrane integrity (Model et al., 1997, Darwin, 2005, Wolf et al., 2010). The LiaH is anchored to the 
membrane by the small membrane protein LiaI (Domínguez-Escobar et al., 2014). 
Another important signal transduction system that can regulate AMP resistance involves the 
extracytoplasmic function (ECF) σ factors. They are small proteins containing only two of the four 
conserved regions of the primary σ factor. Additionally, they are usually co-transcribed with 
corresponding anti-σ factors (Heimann, 2002). The anti-σ factor often harbors an extracytoplasmic 
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sensor domain that can sense the stimuli and an intracellular inhibitory domain that can regulate the 
activity of its σ factor. The genome of B. subtilis encodes at least three ECF σ factors related to cell 
wall-targeting AMP resistance (reviewed in (Jordan et al., 2008). The best understood one is the σW. A 
variety of cell wall active antibiotics, such as vancomycin, cephalosporin, and LL-37, can trigger the 
anti-σ factor RsiW releasing the σW,  which then regulates around 60 genes for AMP resistance 
(Helmann, 2006) (Fig. 1.3A green system).  Additionally, σM and σX also play important role in cell 
wall active antibiotics resistance by regulating gene operons such as undecaprenyl pyrophosphate 
phosphatase (Cao & Helmann, 2002, Jordan et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. The regulatory networks orchestrating AMP resistance in B. subtilis (A) and E. faecalis (B). 
The Bce-type AMP sensing and detoxification models are colored in blue and the Lia systems are colored in red 
in both B. subtilis and E. faecalis. The σW and its anti-σ factor RsiW in B. subtilis are colored in green. The one-
component system BcrR and the two-component system VanRS in E. faecalis are colored in brown and pink, 
respectively. The known signal transduction is shown by solid arrow, while the unknown signal transduction is 
shown by dotted arrow. CM, cytoplasmic membrane. This figure was originally based in parts on (Jordan et al., 
2008), with modifications. 
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1.5. Regulatory network orchestrating antimicrobial peptide resistance in 
Enterococcus faecalis 
E. faecalis, another low-GC Gram-positive bacterium, is a core member of the normal intestinal 
microflora in humans and animals. It is mostly a harmless commensal, but opportunistically 
pathogenic and can cause life-threatening infections especially in hospital settings. E. faecalis strain 
V583, the first vancomycin resistant clinical isolate reported in the U.S., contains four DNA molecules: 
the main chromosome (the size is 3.2×10
6
 bp, the G+C content is 37.5%) with a total of 3337 
predicted protein-encoding open reading frames and three circular plasmids (Paulsen et al., 2003). In 
addition to vancomycin, E. faecalis V583 can also resist to several antibiotics, such as bacitracin and 
teicoplanin, which leads to the difficulty of clinical treatment (Sahm et al., 1989, McBride et al., 2007). 
A deeper understanding of the AMP resistance network in E. faecalis will therefore provide useful 
information for clinical research. 
E. faecalis has high-level of bacitracin resistance, which is mediated by an ABC transporter BcrAB 
(Manson et al., 2004). The bcrAB genes together with bcrD form the bcrABD operon. BcrD is 
suggested to be able to increase the amount of undercaprenyl phosphate as an undercaprenyl 
pyrophosphate phosphatase for bacitracin resistance. The expression of the bcrABD operon is 
regulated by a constitutively transcribed one-component system, BcrR (Gauntlett et al., 2008) (Fig. 
1.3B brown system). BcrR, a membrane-bound transcriptional regulator, can perceive bacitracin 
directly and bind to PbcrA to induce the expression of the bcrABD operon for bacitracin resistance 
(Gebhard et al., 2009).  
Two BceAB-like ABC transporters: EF2050-EF2049 and EF2752-2751, and one BceRS-like TCS 
EF0926-EF0927 were found in the genome of E. faecalis by comparative genomic analysis (Dintner et 
al., 2011) (Fig. 1.3B blue system). However, neither of the ABC transporter operons was located 
adjacent to the operon of the BceRS-like TCS. The functions of these two ABC transporters have not 
been described so far. The functional analysis of these two ABC transporters and one TCS is described 
in Chapter III. 
A LiaR highly conserved ortholog in E. faecalis, RR03, was demonstrated to be up-regulated in 
response to bacitracin and the RR03 mutant in E. faecalis showed increased bacitracin sensitivity 
(Hancock & Perego, 2004). A RR03 ortholog from S. aureus, VraR, was demonstrated to play an 
important role in cell wall-targeting antibiotics, which suggests a similar function of RR03 from E. 
faecalis (Kuroda et al., 2003) (Fig. 1.3B red system). 
Two major types of inducible glycopeptide resistance have been identified in E. faecalis, which were 
demonstrated to be regulated by two TCSs — the VanRS (in VanA type E. faecalis) and the VanRBSB 
(in VanB type E. faecalis) (Arthur et al., 1997, Arthur & Quintiliani, 2001) (Fig. 1.3B pink system). 
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The VanA type strain has high level of resistance against both vancomycin and teicoplanin, which are 
also the inducers. The resistance is mediated by products of vanHAXYZ operon, of which the 
expression is regulated by VanRS TCS, by altering the binding target (D-Ala-D-Ala) on lipid II of 
glycopeptide into D-Ala-D-Lac or D-Ala-D-Ser. VanH is a D-lactate dehydrogenase and can reduce 
pyruvate to D-lactate. VanA, an ATP-dependent D-Ala-D-Lac ligase, is able to add D-lactate to D-Ala 
and form D-Ala-D-Lac. The remaining D-Ala-D-Ala is then hydrolyzed by VanX (a D-Ala-D-Ala 
dipeptidase) (Arthur et al., 1992, Marshall & Wright, 1998). The VanB type strain confers resistance 
against vancomycin and teicoplanin, but it is only capable of vancomycin perception. The functions of 
products of the vanYBWHBBXB operon are similar to the VanA type (Evers & Courvalin, 1996). 
1.6. Two-component signal transduction systems 
TCSs play an important role in regulating the resistance against cell wall targeting AMPs. A typical 
TCS consists of a membrane-anchored HK that detects the signal input and a cytoplasmic RR that 
mediates corresponding cellular output. Signal transduction between these two proteins is 
accomplished by transferring a phosphoryl group from the HK to the cognate RR. TCSs are widely 
distributed in bacteria, archaea, some lower eukaryotes, and plants. The absence of TCS in mammals 
makes it a potential and promising target for antibiotic development (Wuichet et al., 2010).  
1.6.1. Histidine kinases (HKs) 
HKs are the first protein in the TCS signal transduction pathways. They receive the input stimulus and 
subsequently transfer the signal to the RRs. Most HKs harbor a diverse sensing (input) domain and a 
highly conserved kinase core (Stock et al., 2000).  
There are three types of input domains for HKs. The periplasmic (or extracellular)-sensing (the largest 
group) domain contains an extracellular sensory region framed by at least two transmembrane helices. 
The membrane-spanning sensing domain usually harbors 2 to 20 transmembrane regions responsible 
for signal perception. The cytoplasmic sensing domain, either in membrane anchored HK or soluble 
HK, senses the input inside the cytoplasm (Mascher et al., 2006). The E. coli HK PhoQ of the PhoQP 
TCS, which is responsible for bacterial virulence and cationic antimicrobial peptide resistance, 
possesses a sensing domain comprised of two membrane-spanning antiparallel helices and a 
periplasmic sensor region (Lemmin et al., 2013). The periplasmic region adopts a mixed α/β-fold 
containing a central five-stranded anti-parallel β-sheet flanked by α-helices and additional loops on 
each side for direct signal detection (Cheung et al., 2008).  
The cytoplasmic kinase core is connected to the input domain via a linker region that contains a 
number of amino acids (Fabret et al., 1999). The linker region such as the HAMP or the PAS domain 
are critical for signal transduction (Stock et al., 2000). The cytoplasmic kinase core consists of a 
dimerization and histidine phosphotransfer (DHp) domain and a catalytic and ATP binding (CA)-
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domain (Krell et al., 2010) (Fig. 1.4). The DHp domain with a long α-hairpin structure is responsible 
for dimerization (Marina et al., 2005). HK catalyzes autophosphorylation on the conserved histidine 
residue (located on the first α-helix) in the presence of ATP by the CA domain (West & Stock, 2001). 
The phosphoryl group is subsequently transferred to the RR for mediation cellular response.  
1.6.2. Response regulators (RRs) 
Most RRs contain two domains: a conserved N-terminal receiver (regulatory) domain and a diverse C-
terminal output (effector) domain (Stock et al., 2000). A flexible linker joins the two domains together 
(Fig. 1.4). The receiver domain has a modular secondary structure with alternating β-strands and α-
helices adopting a topology with a central five-stranded paralleled β-sheet surrounded by two α-helices 
on one side and three on the other (Fig. 1.5) (Bourret, 2010). The highly conserved aspartate residue, 
which is responsible for receiving the phosphoryl group from the histidine kinase, is located at the end 
of the β3 strand (Lukat et al., 1991, Appleby & Bourret, 1998).  
Bacterial RRs have a great variety of output domains to elicit the specific cellular response according 
to the input obtained by the HK. They can be assigned into five groups by their functions: DNA-
binding, RNA-binding, ligand-binding, protein-binding, and enzyme (Galperin, 2010). A majority of 
RR receiver domains are connected to a DNA-binding output domain and have the function of gene-
transcriptional regulation. The OmpR subfamily is the largest RR group possessing a winged helix-
turn-helix (wHTH) DNA binding output domain (Galperin, 2006). The secondary structure of the 
OmpR output domain is β1-β2-β3-β4-α1-β5-α2-α3-β6-β7. The α2-loop-α3 builds up the helix-turn-
helix motif and the loop connecting β6 and β7 is referred as a wing. OmpR can bind to the region 
upstream of the -35 element on promoters of two porin genes: ompF and ompC, and regulate the 
transcription by interacting with the α subunit of RNA polymerase to adjust to changes in osmolarity 
in E. coli (Slauch et al., 1988, Forst et al., 1989, Slauch et al., 1991).  
 
 
 
 
Figure 1.4. Schematic overview of the two-component signal transduction paradigm and the domain 
structure of each component. HK, histidine kinase. RR, response regulator. The name of each domain is given 
below the corresponding domain structure. The signal transduction between HK and RR is represented as 
transferring a phosphoryl group from the histidine residue (H) on the HK DHp domain to the aspartate residue 
(D) on the RR receiver domain.  
1.6.3. Phosphotransfer between histidine kinase and response regulator 
Three phosphotransfer reactions and two phosphoprotein intermediates are involved in the basic two-
component signal transduction pathways. In the first step, the HK executes autophosphorylation of the 
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histidine residue by the CA domain in the presence of ATP, creating phosphoramidate. In the second 
step, the RR catalyzes the transfer of the phosphoryl group from phospho-His (HK) to Asp (RR), 
resulting in a high-energy acyl phosphate. In the final step, the RR can also catalyze 
dephosphorylation of phospho-Asp (RR) by transferring the phosphoryl group to a water molecule. A 
divalent metal ion (usually Mg
2+
 in vivo) is required for every step (Stock et al., 2000). The 
phosphotransfer between the HK and the RR is mediated by protein-protein interaction via the 
cytoplasmic domain of the HK and the receiver domain of the RR (Casino et al., 2010). 
Phosphorylation-mediated conformational change of the RR, especially the α4-β5-α5 face on the 
receiver domain, passes the signal from the receiver domain to the output domain for further 
regulation (Hoch & Silhavy, 1995, Gao et al., 2007, Bourret, 2010, Gao & Stock, 2010). 
1.7. Signaling specificity of Bce-type two-component systems in Bacillus subtilis 
Harboring numerous highly related TCSs in one genome, such as the three homologous Bce-like TCSs 
in B. subtilis, increases the possibility of cross-talk, which can be deleterious. Direct-coupling analysis, 
which is based on the co-evolution of inter-protein contact residues, previously predicted a 
considerable potential for cross-talk among these three systems (Szurmant & Hoch, 2010, Procaccini 
et al., 2011). Instead, a previous in vivo study showed that these systems are generally well insulated 
from each other: Only some minor degree of cross-regulation was observed between BceS and PsdR 
in the presence of high concentrations of bacitracin (Rietkötter et al., 2008) (Fig. 1.3A). This raises the 
questions: How do bacteria simultaneously coordinate the activity of so many highly related signaling 
systems to maintain the signal transduction specificity and prevent unwanted cross-talk? How does the 
HK discriminate its cognate RR from the non-cognate ones in the pool of homologous RRs? How is 
the RR able to discriminate the cognate promoter region from non-cognate ones? 
1.7.1. Signaling specificity between the histidine kinase and the response regulator 
Myriad mechanisms have been employed by bacterial cell to maintain the intrasystem signal 
transduction fidelity and intersystem insulation. Specificity can be achieved by different cellular 
localizations as well as by differentiation of temporal expression of different systems (Ubersax & 
Ferrell Jr, 2007). At the phosphotransfer level, three mechanisms are applied to maintain the 
specificity of TCS. Most HKs are bifunctional, that is, they exhibit both kinase and phosphatase 
activities, and can thereby tightly control the activity of the cognate RR by preventing unspecific 
phosphorylation through noncognate HKs or small phosphodonors (Boll & Hendrixson, 2011). The 
competition between the cognate RR and noncognate ones can also avoid cross-talk (Laub & Goulian, 
2007). The molecular recognition between cognate partners, which is the most important mechanism, 
enables the HK and the RR of one system to interact specifically in order to avoid accidental 
interactions with components from other systems (Podgornaia & Laub, 2013). 
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Specificity of TCSs is dictated primarily at the level of molecular recognition, requiring proper paring 
of amino acids located on the interaction surface of both HK and RR. These amino acids have co-
evolved, which means the change in a residue of one protein over the course of evolution will cause 
the compensatory change of another residue on the partner protein to maintain a functional interaction 
between these two proteins (Szurmant & Hoch, 2010). The co-crystal structure of HK853-RR468 from 
Thermotoga maritima provides a clear view of the HK/RR interaction surfaces and implies the 
possible positions of those amino acids (Fig. 1.5). The interaction surfaces involving in forming the 
HK853-RR468 pair are: (1) the α1 helix and the β5-α5 loop of the RR468 receiver domain with the 
two α helices of the HK853 DHp domain; (2) the β3-α3 loop of the RR468 with the ATP lid and the 
β4-α4 loop of the HK853 CA domain; and (3) the RR468 β4-α4 loop with the DHp-CA interdomain 
linker of HK853 (Casino et al., 2009). The importance of these amino acids in TCS specificity has 
been proved by experiments. For instance, three amino acids on the α1-helix of the HK EnvZ DHp 
domain were demonstrated to play a significant role in specificity determination between EnvZ/OmpR 
TCS in E. coli (Bourret, 2010).  
Figure 1.5. The co-crystal structure of  
the HK853C-RR468 complex. C, 
cytoplasmic domain of the HK853. The 
structure of the complex is viewed from 
the cell membrane along the two-fold 
axis (indicated with a black ellipse) with 
the cell membrane and the cell interior at 
the top and bottom, respectively. α 
helices of the left and right HK853C 
protomer is colored in blue and and cyan, 
respectively. The two RR468 molecules 
are shown in gold and light yellow, 
respectively. β strands are colored red in 
all cases. The side chains of the 
phosphoacceptor H260 (pink) and D53 
(green) residues, and the bound sulfate 
(black) and ADPβN (red) molecules are 
illustrated in stick representation. In one 
protomer of each HK853C and RR468, 
secondary structure elements and 
relevant loops have been labeled. Three 
interaction surfaces in this complex are 
labeled with yellow stars pointed by red 
arrows. The numbers of contacts are in 
consistence with in the text. This figure 
is based on (Casino et al., 2009), with 
modifications. 
Signal transduction fidelity is equally important for the three high homologous Bce-type TCSs in B. 
subtilis for proper antibiotic resistance. These three systems share significant sequence and structural 
similarity. The HK BceS is 30% and 29% identical to PsdS and YxdK respectively, while the RR 
BceR is 40% and 35% identical to PsdR and YxdJ (Joseph et al., 2002). Instead of high level of cross-
talk, only a minor level of cross-phosphorylation between BceS and PsdR has been demonstrated in 
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vivo at high concentrations of bacitracin (Rietkötter et al., 2008). However, the residues on BceRS and 
PsdRS TCSs that dictate intrasystem specificity and minimize intersystem cross-talk remain unclear. 
The nature and localization of these amino acids still needs to be unraveled. A first insight into this 
question is provided by the data described in Chapter V. 
1.7.2. Specificity on the response regulator transcriptional regulation level  
In bacteria, transcription initiation starts with promoter recognition by the σ subunit of holo RNA 
polymerase on the -35 promoter element followed by discerning and unwinding of the DNA double 
helix at the -10 promoter element (Lee et al., 2012). For promoters lacking a -35 element or deviating 
significantly from the consensus sequence at the appropriate position, the σ subunit can still be 
recruited to the promoter by interaction with activators like RRs binding to the upstream region 
(Jarmer et al., 2001, Paget & Helmann, 2003).  
Specific interaction between a regulator and its target is important for bacteria to trigger the desired 
response to the right stimulus, which is primarily determined via molecular recognition between amino 
acids of the output domain and nucleotides within the RR binding site. The output domain structure of 
OmpR indicates that the α3 helix (recognition helix on the output domain) is responsible for specific 
interaction with the DNA major groove, and the β6-β7 loop (wing on the output domain) is 
responsible for specific interaction with the DNA minor groove (Martínez-Hackert & Stock, 1997).  
In B. subtilis, the transcription of the Bce-type ABC transporter genes is upregulated by binding of the 
Bce-like RRs to the promoter. BceR and PsdR belong to the OmpR subfamily (Fabret et al., 1999) 
with a winged helix-turn-helix output domain. The known binding sites on PbceA and PpsdA have eleven 
out of fourteen identical base pairs. This indicates a considerable potential of cross-regulation at the 
RR/promoter level between these two systems. In vivo, however, the regulation is highly specific 
between BceR/PbceA and PsdR/PpsdA. This raises the question of how Bce-like RRs specifically regulate 
the transcription of the cognate ABC transporters. A clear understanding of the specificity 
determinants on bceA and psdA promoters that determine exclusive binding of BceR and PsdR, 
respectively, is currently lacking. This question is addressed comprehensively in Chapter IV. 
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1.8. Aims of this thesis  
This thesis aimed to investigate the cell wall-targeting AMP sensing and resistance modules in two 
Firmicutes bacteria: E. faecalis and B. subtilis. We aimed at gaining a deeper understanding on the 
signal transduction mechanisms and the determinants of wiring specificity of the underling TCSs-
dependent regulation. 
Chapter II 
The technical challenges of molecular genetic studies in E. faecalis hinder a deeper understanding of 
the molecular mechanism in antibiotic detection, signal transduction, and gene regulation. The 
genetically highly tractable Gram-positive model organism B. subtilis on the other hand might be a 
suitable candidate as a heterologous host. In this chapter, two fundamentally different regulators of E. 
faecalis, the bacitracin sensor BcrR and the vancomycin-sensing two component system VanSB-
VanRB, were introduced into B. subtilis and their functions were monitored using target promoters 
fused to reporter genes (lacZ and luxABCDE). We explored and validated B. subtilis as a platform for 
studying the regulatory mechanisms of cell wall antibiotic resistance of E. faecalis.  
Chapter III 
In this chapter, the established B. subtilis platform was subsequently used for an in-depth heterologous 
functional analysis of two Bce-type ABC transporters and one Bce-type TCS of E. faecalis. Combined 
with studies in the native host, we analyzed the bacitracin sensing and resistance network of E. 
faecalis. 
Chapter IV 
Both the output domains of BceR and PsdR as well as their known binding sites are highly 
homologous in B. subtilis. The aim of this chapter was to gain a full comprehension of the mechanism 
that dictates specific binding of RR to its cognate promoter (BceR-PbceA, PsdR-PpsdA). In vivo 
experiments were used to first dissect the promoter and later identify the specificity dictating elements. 
In vitro assays were then performed to further corroborate the specificity determining mechanism. 
Chapter V 
Due to the high sequence and structure similarity of BceRS and PsdRS TCSs in B. subtilis, the 
question of what determines signal transduction specificity between a HK and its cognate RR was 
raised. In this chapter, different regions on the receiver domain were exchanged between BceR and 
PsdR to rewire the signal transduction in vivo and thereby identify the specificity determinants for 
Bce-type TCSs. 
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Abstract
To combat antibiotic resistance of Enterococcus faecalis, a better understanding of the molecular mechanisms, particularly of
antibiotic detection, signal transduction and gene regulation is needed. Because molecular studies in this bacterium can be
challenging, we aimed at exploiting the genetically highly tractable Gram-positive model organism Bacillus subtilis as a
heterologous host. Two fundamentally different regulators of E. faecalis resistance against cell wall antibiotics, the bacitracin
sensor BcrR and the vancomycin-sensing two-component system VanSB-VanRB, were produced in B. subtilis and their
functions were monitored using target promoters fused to reporter genes (lacZ and luxABCDE). The bacitracin resistance
system BcrR-BcrAB of E. faecalis was fully functional in B. subtilis, both regarding regulation of bcrAB expression and
resistance mediated by the transporter BcrAB. Removal of intrinsic bacitracin resistance of B. subtilis increased the sensitivity
of the system. The lacZ and luxABCDE reporters were found to both offer sensitive detection of promoter induction on solid
media, which is useful for screening of large mutant libraries. The VanSB-VanRB system displayed a gradual dose-response
behaviour to vancomycin, but only when produced at low levels in the cell. Taken together, our data show that B. subtilis is
a well-suited host for the molecular characterization of regulatory systems controlling resistance against cell wall active
compounds in E. faecalis. Importantly, B. subtilis facilitates the careful adjustment of expression levels and genetic
background required for full functionality of the introduced regulators.
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Introduction
Enterococcus faecalis is one of the most common causes of
nosocomial infections. Increasing incidences of infections with
antibiotic resistant strains, particularly with vancomycin resistant
enterococci (VREs), therefore pose a major health risk [1,2].
Vancomycin is a glycopeptide antibiotic that targets the lipid II
cycle of cell wall biosynthesis by binding to the terminal D-alanyl-
D-alanine (D-Ala-D-Ala) moiety of peptidoglycan precursors on
the surface of the cell, thus inhibiting their incorporation into the
cell wall [3]. Many other antimicrobial substances also target the
lipid II cycle [4], including bacteriocins and mammalian defensins
[5,6], both of which will likely be encountered by E. faecalis in its
natural gut habitat. Furthermore, many enterococcal isolates were
found to be highly resistant against bacitracin [7,8], yet another
inhibitor of cell wall biosynthesis [9].
The molecular mechanisms leading to resistance are often well
known. In the case of vancomycin, high-level resistance is for
example ensured by target alteration through replacement of the
terminal D-Ala-D-Ala by D-Ala-D-lactate. In VanA-type strains,
this is accomplished through the action of the VanHAX system,
while in VanB-type strains the VanHBBXB proteins mediate
resistance [10,11]. High-level bacitracin resistance of E. faecalis is
conferred by the ATP-binding cassette (ABC) transporter BcrAB,
which presumably removes the antibiotic from its site of action (i.e.
the cytoplasmic membrane) [7]. The precise mechanism of
bacitracin resistance by ABC-transporters is not yet fully
understood [12].
The expression of most resistance genes is induced in the
presence of the respective antibiotic. For example, the van operons
are induced in the presence of vancomycin by the two-component
systems VanS-VanR or VanSB-VanRB for VanA- and VanB-type
resistance, respectively [11,13]. Bacitracin-dependent induction of
bcrAB is mediated by the one-component transmembrane regula-
tor BcrR [7,14]. While the regulators and target promoters, as well
as the conditions leading to induction are known, we lack in-depth
understanding of the molecular mechanisms of regulation. For
example, while both VanS and VanSB respond to vancomycin,
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their sensory domains differ considerably in size with 37 amino
acids for VanS and 103 residues for VanSB, and share only low
sequence similarity [15]. It is therefore difficult to envisage the
same sensing mechanism for both proteins. It is similarly unclear
how BcrR detects bacitracin, because the protein lacks any
obvious extracellular domains but is nevertheless able to directly
interact with its substrate [14,16]. Additionally, it is not known
how a membrane-bound transcriptional regulator like BcrR
activates transcription from its target promoter. While a direct
interaction with RNA-polymerase has been proposed [16],
experimental evidence is lacking to date.
Sensory perception of antimicrobial substances by bacteria is a
first and essential step in antibiotic resistance, and a thorough
understanding of the mechanisms involved would provide an
important basis for the development of new drugs to combat
resistance. However, in many genera, e.g. the enterococci,
investigations are hampered by the difficulty to manipulate these
bacteria genetically. Although more and more genetic tools are
becoming available for enterococci, poor transformability of many
strains, including clinical isolates, still impedes studies involving,
for example, high-throughput or detailed mutagenic approaches.
To circumvent these problems, heterologous hosts have been
chosen, often using E. coli [17], or electro-transformable laboratory
strains of E. faecalis [7,14]. The latter provide improved
transformability, but no additional genetic tools, while the former
host does not appear well suited to study resistance against cell wall
active compounds, due to the major differences between the
Gram-positive and Gram-negative cell envelope. Alternatively,
Bacillus subtilis has been used successfully for the functional
expression of the VanS-VanR two-component system of E. faecalis,
as well as of the VanB-type resistance proteins [1,18]. Like E. coli,
B. subtilis is easy to manipulate and a large number of genetic tools
are available. The G+C contents of B. subtilis (43.5%) and of E.
faecalis (37.5%) are comparable, which is of great advantage for
heterologous gene expression. Furthermore, the transcription
machinery in both organisms is sufficiently similar to facilitate
the interaction of heterologous transcriptional regulators with the
native machinery, as has been shown in vitro for activation of B.
subtilis RNA polymerase by E. faecalis BcrR [16]. Importantly for
the present application, the intrinsic resistance mechanisms of B.
subtilis against cell wall antibiotics are well understood [19,20],
allowing directed deletion of genes to create a clean genetic
background.
In the present study, we have used two well-understood
examples from E. faecalis to develop and validate B. subtilis as a
platform for studying the regulatory mechanisms leading to
resistance against cell wall-active antibiotics. To test the feasibility
of our approach and determine the optimal genetic background of
the host, we chose the one-component regulator BcrR and could
show full functionality with highly similar behaviour to its native
context. This set-up was then applied to the VanSB-VanRB two-
component system. A previous attempt at heterologous expression
of this system in B. subtilis had resulted in a constitutively active
behaviour [18]. Optimization of expression levels and growth
conditions now resulted in vancomycin-dependent induction of the
target promoter, further supporting the suitability of B. subtilis as
host organism.
Materials and Methods
Bacterial strains and growth conditions
All strains used in this study are listed in Table 1. E. coli
DH5aand XL1-blue were used for cloning. E. coli and B. subtilis
were grown routinely in Luria-Bertani (LB) medium at 37uC with
agitation (200 rpm). B. subtilis was transformed by natural
competence as previously described [21]. Selective media
contained ampicillin (100 mg ml21 for E. coli), chloramphenicol
(5 mg ml21 for B. subtilis), kanamycin (10 mg ml21 for B. subtilis),
erythromycin 1 mg ml21 with lincomycin 25 mg ml21 (for
macrolide-lincosamide-streptogramin B (mls) resistance in B.
subtilis) or spectinomycin (100 mg ml21 for B. subtilis). Bacitracin
was supplied as the Zn2+-salt. Unless otherwise stated, media for
strains carrying pXT-derived constructs contained 0.2% (w/v)
xylose for target gene expression. Solid media contained 1.5% (w/
v) agar. Growth was measured as optical density at 600 nm
wavelength (OD600).
Construction of plasmids and genetic techniques
All primer sequences used for this study are listed in Table 2; all
plasmid constructs are listed in Table 1.
Transcriptional promoter fusions of PbcrA to lacZ or bacterial
luciferase (luxABCDE) were constructed in vectors pAC6 [22] or
pAH328 [23] by the sites of EcoRI/BamHI and EcoRI/SpeI,
respectively, obtaining plasmids pES601and pNTlux101, respec-
tively. The transcriptional promoter fusion of PvanYB to bacterial
luciferase was cloned into the EcoRI and SpeI sites of vector
pAH328 creating plasmid pCF133. The exact regions contained
in the constructs are given in Table 1.
For heterologous, xylose-inducible expression of bcrR or bcrR-
bcrAB in B. subtilis (pES701 and pES702) the respective DNA
fragments were amplified from the plasmid pAMbcr1 [7] and
cloned in the vector pXT [24] using the BamHI and EcoRI
restriction sites, placing the genes under the control of the vector’s
xylA-promoter. Plasmid pCF132 was constructed by inserting
vanRBSB from E. faecalis V583 into the BamHI and HindIII sites of
vector pXT for heterologous, xylose-inducible expression in B.
subtilis.
Constructs for unmarked gene deletions in B. subtilis were
cloned into the vector pMAD [25]. For each operon to be deleted,
800–1000 bp fragments located immediately before the start
codon of the first gene (‘‘up’’ fragment) and after the stop codon of
the last gene (‘‘down’’ fragment) were amplified. The primers were
designed to create a 17–20 bp overlap between the PCR-products
(Table 2), facilitating fusion of the fragments by PCR overlap
extension and subsequent cloning into pMAD. Gene deletions
were performed as previously described [25].
All constructs were checked for PCR-fidelity by sequencing, and
all created strains were verified by PCR using appropriate primers.
Antimicrobial susceptibility assays
All cultures were grown in Mueller-Hinton (MH) medium for
antibiotic susceptibility assays [26]. Minimal inhibitory concen-
tration (MIC) of bacitracin and vancomycin were determined by
broth-dilution assays. Freshly grown overnight cultures of B. subtilis
in MH medium were used as inoculum at a dilution of 1:500. After
24 h incubation in the presence of two-fold serial dilutions of the
antibiotic the MIC was scored as the lowest concentration where
no growth was observed.
b-Galactosidase assays
Cells were inoculated from fresh overnight cultures and grown
in LB medium at 37uC with aeration until they reached an OD600
between 0.4 and 0.5. The cultures were split into 2 mL aliquots
and challenged with different concentrations of bacitracin with
one aliquot left untreated. After incubation for an additional
30 min at 37uC with aeration, the cultures were harvested and the
cell pellets were frozen at 220uC. b-galactosidase activities were
determined as described, with normalization to cell density [27].
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Luciferase assays
Luciferase activities of B. subtilis strains were assayed using a
Synergy 2 multi-mode microplate reader from BioTek controlled
by the software Gen5. LB medium was inoculated 1:500 from
overnight cultures, and each strain was grown in 100 ml volumes
in a 96-well plate. Cultures were incubated at 37uC with shaking
(intensity: medium), and the OD600 was monitored every 10 min.
At an OD600 of 0.02 (4–5 doublings since inoculation; corre-
sponding to OD600 = 0.1 in cuvettes of 1 cm light-path length),
either bacitracin was added to final concentrations of 0.03, 0.1,
0.3, 1 mg ml21, or vancomycin to final concentrations of 0.01,
0.025, 0.05, 0.25 mg ml21; in all cases one well was left untreated.
Cultures were further incubated for 2 h, and the OD600 and
luminescence (endpoint-reads; 1 s integration time; sensitivity:
200) were monitored every 5 min. OD600 values were corrected
using wells containing 100 ml LB medium as blanks. Raw
luminescence output (relative luminescence units, RLU) was
normalized to cell density by dividing each data-point by its
corresponding corrected OD600 value (RLU/OD).
Table 1. Plasmids and strains used in this study.
Name Descriptiona Source
Vectors
pAC6 Vector for transcriptional promoter fusions to lacZ in B. subtilis, integrates in amyE; cmr [22]
pAH328 Vector for transcriptional promoter fusions to luxABCDE in B. subtilis; integrates in sacA; cmr [23]
pMAD Vector for construction of unmarked deletions in B. subtilis, temperature sensitive replicon; mlsr [25]
pXT Vector for xylose-inducible gene expression in B. subtilis; integrates in thrC; spcr [24]
Plasmids
pAMbcr1 E. coli-E. faecalis shuttle vector containing a 4.7 kb EcoRI-fragment encompassing the bcrR-bcrABD locus
of E. faecalis AR01/DGVS
[7]
pCF102 pMAD containing the joined ‘‘up’’ and ‘‘down’’ fragments for unmarked deletion of bceRS-bceAB This study
pCF104 pMAD containing the joined ‘‘up’’ and ‘‘down’’ fragments for unmarked deletion of psdRS-psdAB This study
pCF119 pMAD containing the joined ‘‘up’’ and ‘‘down’’ fragments for unmarked deletion of yxdJK-yxdLM-yxeA This study
pCF132 pXT containing the vanRBSB operon of E. faecalis V583 This study
pCF133 pAH328 containing PvanYB of E. faecalis V583 from -215 to +65 relative to the vanYB start codon This study
pES601 pAC6 containing PbcrA of E. faecalis AR01/DGVS from -219 to +170 relative to the bcrA start codon This study
pES701 pXT containing bcrR of E. faecalis AR01/DGVS This study
pES702 pXT containing the bcrR-bcrAB region of E. faecalis AR01/DGVS This study
pNTlux101 pAH328 containing PbcrA of E. faecalis AR01/DGVS from -219 to +170 relative to the bcrA start codon This study
E. coli
DH5a supE44 DlacU169(Q80lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 [39]
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F9::Tn10
proAB lacIq D(lacZ)M15]
Stratagene
E. faecalis
AR01/DGVS Plasmid-cured clinical isolate; bacr [7]
V583 Sequenced clinical strain containing plasmids pTEF1, pTEF2, pTEF3; vanr [40]
B. subtilis
W168 Wild-type, trpC2 Laboratory stock
SGB34 W168 thrC::pES702 This study
SGB35 TMB035 thrC::pES702 This study
SGB36 TMB035 thrC::pES702 amyE::pES601; kanr, spcr, cmr This study
SGB40 W168 thrC::pES701 amyE::pES601; spcr, cmr This study
SGB42 W168 thrC::pES702 amyE::pES601; spcr, cmr This study
SGB43 TMB035 thrC::pES701 amyE::pES601; kanr, spcr, cmr This study
SGB273 TMB1518 sacA::pNTlux101; cmr This study
SGB274 TMB1518 thrC::pES701 sacA::pNTlux101; spcr, cmr This study
TMB035 W168 bceAB::kan; kanr This study
TMB1518 W168 with unmarked deletions of the bceRS-bceAB, psdRS-psdAB, yxdJK-yxdLM-yxeA loci This study
TMB1560 TMB1518 sacA::pCF133; cmr This study
TMB1562 TMB1518 thrC::pCF132 sacA::pCF133; spcr, cmr This study
aBac, bacitracin; cm, chloramphenicol; fs, fusidic acid; kan, kanamycin; mls, macrolide-lincosamide-streptogramin B group antibiotics; rif, rifampin; spc, spectinomycin;
van, vancomycin; r, resistant.
doi:10.1371/journal.pone.0093169.t001
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Results and Discussion
Functional transfer of the BcrR-BcrAB bacitracin
resistance system to B. subtilis
In E. faecalis, expression of the genes bcrAB that encode the
bacitracin resistance transporter BcrAB is controlled solely by the
one-component regulator BcrR [14]. This regulator is encoded by
a gene directly upstream of the transporter operon, but as an
independent transcriptional unit [7]. To test if BcrR could be
functionally produced in B. subtilis, we introduced a transcriptional
fusion of its target promoter, PbcrA, to lacZ (pES601), together with
an expression construct of bcrR controlled by a xylose-inducible
promoter (pES701), into the wild-type strain. Addition of
increasing concentrations of bacitracin led to a strong upregulation
(approximately 80-fold) of promoter activities with a threshold
concentration for induction of 0.3 mg ml21 (Fig. 1A). No promoter
activities above background (ca. 1 Miller Unit (MU)) could be
detected in a strain lacking BcrR (data not shown), demonstrating
that the observed induction was indeed due to BcrR activity. It was
shown previously that the sensitivity of BcrR is increased in a
strain of E. faecalis lacking BcrAB, and this was attributed to
competition between the transporter and BcrR in bacitracin
binding [14]. While B. subtilis itself does not contain a BcrAB-like
transporter, it nevertheless possesses a transport system for
bacitracin resistance, BceAB, belonging to a different family of
transporters [28]. To test if this unrelated transporter could also
influence the sensitivity of BcrR, we next introduced the
expression and reporter constructs into a strain carrying a
bceAB::kan deletion (TMB035). Here, the threshold for induction
was ten-fold lower at 0.03 mg ml21 bacitracin, with 0.1 mg ml21
leading to full induction. Furthermore, the maximal amplitude of
induction was significantly increased (p = 0.006) to more than 200-
fold (Fig. 1B). Therefore, the BceAB transporter of B. subtilis
appeared to decrease the availability of bacitracin for detection by
BcrR, similar to the effect of BcrAB in E. faecalis.
We next introduced a construct containing bcrR under control of
the xylose-inducible promoter followed by bcrAB under BcrR-
dependent control of its native promoter (pES702) into TMB035
(bceAB::kan). In this strain, the induction behaviour was compa-
rable to that of wild-type B. subtilis carrying BcrR alone (Fig. 1C).
Introduction of the same construct into the wild-type background
produced a strain harbouring both transporters, BceAB and
BcrAB. While the induction threshold was not significantly altered
compared to strains possessing only one transporter, the amplitude
of induction was lowered to approximately 50-fold (Fig. 1D).
These data clearly show that both BceAB and BcrAB are able to
compete with BcrR for bacitracin binding and closely reflect the
behaviour of the system in E. faecalis. As stated above, this
competition is most likely due to removal of bacitracin by the
transporters.
The decreased sensitivity of PbcrA induction in strains harbouring
the construct of bcrR together with bcrAB, with the latter being
controlled by its native promoter (Fig. 1C and D), further implied
that bcrAB was expressed in a BcrR-dependent manner in B.
subtilis. We therefore wanted to test if this construct was also able to
impart bacitracin resistance to the B. subtilis host. The minimal
inhibitory concentration (MIC) of bacitracin was strongly reduced
from 128 mg ml21 in the wild-type to 2–4 mg ml21 in the bceAB-
deleted strain TMB035 (Table 3), consistent with earlier reports
[20,29]. Introduction of the bcrR-bcrAB construct increased the
Table 2. Primers used in this study.
Primer name Sequence (59-39)a Use
TM1569 AGTGGATCCTAGGAACGTTTTTACCAAC bcrAB rev
TM1798 TTAAGGATCCGAAAAACCCGTTGATGGACG bcrR fwd
TM1800 TTAAGAATTCTTTTATTTCATTCCCATCTGC bcrR rev
TM1801 TTAAGAATTCTTTTGCTGTTAATCGGCAAG PbcrA-lacZ fwd
TM1802 TTAAGGATCCCAAGCTGCAACATCATTTTC PbcrA-lacZ rev
TM2450 AAATTGGATCCGGAAACTACAGACTGTTATG vanRB fwd
TM2451 AAATTAAGCTTTATACCTGTCGGTCAAAATC vanSB rev
TM2550 AATTTGAATTCTTTGTTCTGGCTGGATTTAC PvanYB fwd
TM2551 AATTTACTAGTTCCCCAGATTGTTTCATATG PvanYB rev
TM2813 TTAAACTAGTCAAGCTGCAACATCATTTTC PbcrA-lux rev
TM2347 AATTTGGATCCAGTTTAATATCAACGGCCTG yxdJK-yxdLM-yxeA deletion up fwd
TM2348 AGGTAATTCTGCAATAGTCC yxdJK-yxdLM-yxeA deletion up rev
TM2349 ctattgcagaattacctGGAAGAAGTCAAGTTTGAAG yxdJK-yxdLM-yxeA deletion down fwd
TM2350 AATTTGGATCCTTCTGCTTCCGAAAAAACAG yxdJK-yxdLM-yxeA deletion down rev
TM2351 AATTTGGATCCGAGGAAGCAAAAGGAAATC bceRS-bceAB deletion up fwd
TM2352 CTTGATTTCATGAAACAGCG bceRS-bceAB deletion up rev
TM2355 ctgtttcatgaaatcaagATGGTGTTATATACTGCGC bceRS-bceAB deletion down fwd
TM2356 AATTCCATGGACGAATCCAGTTATCATAGC bceRS-bceAB deletion down rev
TM2357 AATTTGGATCCCTACGATCTAAATGGTTTCC psdRS-psdAB deletion up fwd
TM2358 ATTTTTGAAGATGACCGCCC psdRS-psdAB deletion up rev
TM2361 cggtcatcttcaaaaatGTCATATTTATAAGCGTGCTG psdRS-psdAB deletion down fwd
TM2362 AATTCCATGGAGAGATTGAAGCATTCATCG psdRS-psdAB deletion down rev
aRestriction sites are underlined; overlaps to other primers for PCR fusions are shown by lower case letters.
doi:10.1371/journal.pone.0093169.t002
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resistance of the bceAB-deleted strain to 32 mg ml21 (Table 3). This
degree of protection conferred to B. subtilis (i.e. 8- to 16-fold
increase in MIC) is the same as that conferred to E. faecalis itself,
where BcrAB raises the MIC from 32 mg ml21 to .256 mg ml21
[7]. The difference in final resistance reached is due to the
differing degrees of intrinsic bacitracin resistance between the two
hosts. Additional expression of the E. faecalis transporter in wild-
type B. subtilis could not further increase its resistance (Table 3). In
fact we have to date been unable to raise the MIC of the wild-type
strain, even with overproduction of its native BceAB transporter
(own unpublished observation), suggesting that the level of
resistance is not limited by transport capacity.
Taken together, our results demonstrate full functionality of the
E. faecalis Bcr-system in B. subtilis, both regarding gene regulation
and bacitracin resistance. Importantly, however, the native
resistance determinants of the B. subtilis host were shown to
interfere with the sensitivity and amplitude of promoter induction
and masked the resistance imparted by the introduced system.
This observation is addressed in the following section.
Development of a sensitive recipient strain
When employing a heterologous host for functional studies of
resistance and associated regulatory systems, it is of vital
importance to consider any potential interference from intrinsic
resistance determinants. One advantage of using B. subtilis as the
heterologous host is that its resistance determinants against cell
wall antibiotics are very well known. Several proteins were shown
to contribute to broad-spectrum protection from charged antimi-
crobial peptides, for example by modification of teichoic acids in
the cell envelope [30], but most of these mechanisms are not drug-
specific. In contrast, antimicrobial peptide transporters such as the
BceAB system described above, are thought to function by
removal of the antibiotic from its site of action [12,20,31–33], and
are thus likely to interfere with heterologously introduced
Figure 1. BcrR-dependent induction of PbcrA by bacitracin in B. subtilis. The PbcrA-lacZ reporter construct pES601 was introduced into different
strains of B. subtilis producing either BcrR or BcrR and BcrAB. The relevant genes for bacitracin transporters in each strain are given at the top right of
each graph. (A) SGB40; wild-type (WT) B. subtilis with BcrR. (B) SGB43; bceAB::kan mutant with BcrR. (C) SGB36; bceAB::kan mutant with BcrR and BcrAB.
(D) SGB42; wild-type B. subtilis with BcrR and BcrAB. Cultures growing exponentially in the presence of 0.2% (w/v) xylose were challenged with
different concentrations of bacitracin as indicated for 30 min, and b-galactosidase activities, expressed in Miller Units (MU), were determined. Results
are shown as the mean plus standard deviation of three to four biological replicates.
doi:10.1371/journal.pone.0093169.g001
Table 3. Antibiotic susceptibility of B. subtilis strains.
Strain Relevant resistance proteins Bacitracin MICa (mg ml21) Vancomycin MICa (mg ml21)
W168 BceAB+ 128 0.25
TMB035 BceAB2 2–4 0.25
TMB1518 BceAB2 4 0.25
SGB34 BceAB+, BcrR-BcrAB+ 128 0.25
SGB35 BceAB2, BcrR-BcrAB+ 32 0.25
aMinimal inhibitory concentrations (MIC) determined from three biological replicates; where a range of concentrations is given, results varied between replicates.
doi:10.1371/journal.pone.0093169.t003
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resistance determinants. B. subtilis possesses three paralogous
systems of differing substrate specificities: BceAB mediates
resistance against bacitracin, mersacidin, actagardine and plecta-
sin [20,31]; PsdAB confers resistance against a broad-range of lipid
II-binding lantibiotics such as nisin or gallidermin [31]; for
YxdLM no role in resistance has been identified to date, but it’s
expression is induced in response to the human cathelicidin LL-37
[34]. All three transporters are encoded together with an operon
for a two-component regulatory system, BceRS, PsdRS and
YxdJK, respectively, which controls expression of its correspond-
ing transporter operon [28,31,35].
To obtain a recipient strain that is well suited for the study of
resistance mechanisms against cell wall antibiotics from E. faecalis
and potentially also other genetically intractable Gram-positive
bacteria, we therefore created unmarked deletions of all three
entire genetic loci, bceRS-bceAB, psdRS-psdAB and yxdJK-yxdLM-
yxeA. yxeA is a small gene of unknown function that may form a
transcriptional unit with yxdLM and was therefore included in the
deletion. To test for the absence of interference, we then
introduced the bcrR expression construct pES701 used above into
the triple deletion strain, TMB1518. While our study was in
progress, the Losick-laboratory developed a new reporter system
for B. subtilis, based on the bacterial luciferase operon luxABCDE,
which allows time-resolved, semi-automated analyses of transcrip-
tional promoter fusions [23,36]. To test the applicability of this
reporter for our purposes, we inserted the BcrR target promoter
PbcrA upstream of the lux operon and introduced this construct into
the triple deletion strain harbouring BcrR. At high expression
levels of BcrR due to induction by xylose, addition of bacitracin to
growing cultures of this strain resulted in a rapid response, with a
more than ten-fold increase of promoter activity within 5 min after
addition of 1 mg ml21 bacitracin (Fig. 2A). Only background
luminescence (ca. 103 relative luminescence units (RLU) per OD)
was observed in the absence of bacitracin or in a strain lacking
BcrR (Fig. 2A and data not shown). Analysis of promoter activities
30 min post-induction showed a similar dose-response behaviour
(Fig. 2B) compared to the corresponding lacZ reporter strain
shown above (Fig. 1B). While the threshold concentration for
induction appeared slightly increased for the PbcrA-lux construct,
possibly due to the different growth conditions in 96-well plates
compared to test-tubes, the maximal amplitude of induction was
approximately doubled to over 500-fold, which can most likely be
attributed to the very low background luminescence obtained with
luciferase assays. Therefore both the lacZ and lux reporters are
equally suitable to determine dose-response behaviours of regula-
tory systems, while the lux reporter offers higher sensitivity and
additionally allows time-resolved analyses for dynamic studies.
To test if the cellular protein levels of a one-component
regulator like BcrR affected the promoter induction behaviour, the
same experiments were also carried out in the absence of xylose,
relying on the basal activities of the PxylA-promoter for bcrR
expression (Fig. 2C and D). Under these conditions, the maximal
promoter activities were reduced approximately eight-fold
(p = 0.0003). Considering that the difference in PxylA activity in
the presence and absence of xylose is ten-fold under the conditions
used here [36], this difference in BcrR-activity is likely directly due
to a reduced copy number of BcrR in the cell. However, the dose-
response behaviour was again similar to previous results, with a
threshold concentration for induction in the range of 0.03 to
0.1 mg ml21 bacitracin. Thus the overall function of BcrR was
robust to changes in expression, with differences in protein levels
merely affecting the amplitude of induction but not the response to
the stimulus.
Qualitative activity assays on solid media for screening
applications
To elucidate the molecular mechanisms of stimulus perception
and signal transduction in regulatory systems, random or site-
directed mutagenesis is often used. Particularly in the case of
random mutagenesis approaches, but also for (synthetic) DNA-
libraries, assays performed on solid media greatly facilitate
screening of large numbers of clones. To evaluate the lacZ and
lux reporters for such applications, the derived BcrR/PbcrA reporter
strains were streaked onto agar plates in the absence or presence of
bacitracin. Strains harbouring the PbcrA-lacZ fusions showed a blue
colouration on XGal-containing agar plates in the presence of
inducing concentrations of bacitracin, but remained white in its
absence (Fig. 3A and B). As observed before in the quantitative
assays, presence of the transporters BceAB or BcrAB diminished
the intensity of colouration (Fig. 3B, sectors 1 and 2). In the strain
possessing both transporters, bacitracin concentrations of at least
10 mg ml21 were required to produce blue colonies (data not
shown), consistent with the low promoter activities reported above
for this strain. The reporter strain harbouring BcrR and the PbcrA-
lux construct showed strong luminescence when grown on agar
plates containing 0.3 mg ml21 bacitracin, and no detectable
luminescence in its absence (Fig. 3C and D).
Both reporter constructs are therefore suitable for screening
libraries of clones for promoter induction and are applicable for
high-throughput approaches. In principle, screens for loss-of-
function as well as gain-of-function mutations can be performed,
depending on experimental design. This set-up offers a great
advantage over studies performed directly in E. faecalis, where it is
much more difficult to obtain large numbers of transformants than
in the naturally competent B. subtilis. Importantly, the output of
both promoters is sufficiently sensitive to allow assays to be
performed at sub-lethal concentrations of the antibiotic, at least in
the case of the Bcr-system. The feasibility of this approach was
recently demonstrated in a study that identified essential residues
in the B. subtilis bacitracin resistance transporter BceAB [29], and
the same strategy should be applicable to the heterologous set-up
described here.
Functional transfer of the VanSB-VanRB two-component
system to B. subtilis
Following successful transfer of the Bcr-system of E. faecalis to B.
subtilis, we next wanted to test if our set-up could be applied to
other regulatory systems. The two-component system VanS-VanR
regulating VanA-type vancomycin resistance had previously been
shown to be functional in B. subtilis [1]. However, heterologous
expression of vanRBvanSB encoding the regulatory system for
VanB-type resistance had resulted in constitutive expression of the
target promoter, PvanYB, and the authors could show that this was
due to constitutive activity of the sensor kinase VanSB under the
conditions chosen [18]. To test if vancomycin-dependent modu-
lation of VanSB activity could be obtained by optimization of
conditions, we introduced an expression construct of the
vanRBvanSB operon under control of the xylose-inducible promoter
PxylA into TMB1518. The activity of the two-component system
was monitored as activation of a PvanYB-luxABCDE transcriptional
fusion. In the absence of xylose, only low levels of the two-
component systems will be produced in the cell, due to basal
promoter activity of PxylA. Under these conditions, addition of
increasing concentrations of vancomycin to growing cultures of the
reporter strain led to a gradual up-regulation of promoter activity
(Fig. 4A). Importantly, and in contrast to previous data, only
background activity was observed in the absence of vancomycin
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(Fig. 4A, open circles). The threshold concentration for induction
was 0.01 mg ml21, and a maximum induction of ca. 500-fold was
observed in the presence of 0.05–0.25 mg ml21 vancomycin. The
MIC of B. subtilis for vancomycin was determined as 0.25 mg ml21
for both the wild-type and TMB1518 (Table 3), and therefore
higher concentrations were not tested. In the previous study,
promoter activities were analysed only in the presence of xylose to
ensure high expression levels of the two-component system [18],
which may have led to the high basal activities observed. We
therefore next repeated the induction experiments, but in the
presence of 0.2% xylose, and indeed found ten-fold increased
promoter activities in the absence of vancomycin (Fig. 4B).
Vancomycin-dependent induction was still observed, but only to a
maximum of ten-fold over the uninduced control, due to the
higher basal activity.
Together with previously published reports [1,18], our data
show that the regulators of vancomycin resistance in E. faecalis can
be functionally produced in B. subtilis, although the expression
levels have to be adjusted for optimal signal-to-background ratios.
The full functionality of the VanRS two-component systems, both
of VanA-type resistance described previously [1] and VanB-type
resistance shown here, validates the biological relevance of the
heterologous set-up and paves the way for detailed mechanistic
investigations into the respective modes of vancomycin detection.
The high degree of competence of B. subtilis, for example, allows
high-throughput screening of random mutants, synthetic DNA
libraries, or chimeric protein fusions, which may lead to discovery
of ligand binding sites and thus to elucidation of sensory
mechanisms. Promising results can then be validated in a more
targeted fashion in E. faecalis.
Additionally, Bisicchia and colleagues had reported that
vancomycin resistance could be imparted on B. subtilis by
expression of the VanB-type resistance operon vanYBWHBBXB,
further extending the applicability of this host organism.
Conclusions
In summary we here show that B. subtilis is well suited to the use
as a host for functional production of regulatory systems that
control resistance against cell wall active compounds in E. faecalis.
Our data also show that care has to be taken regarding the genetic
background of the host strain and that appropriate expression
levels of the regulator genes have to be experimentally determined.
Due to the availability of a range of inducible and constitutive
promoters, for which strength and dynamic behaviour are very
well characterized [36], B. subtilis offers a vast potential for
optimization of expression levels, again supporting its suitability as
a versatile heterologous host. Full functionality of any newly
introduced system should of course be validated by comparison of
its behaviour between B. subtilis and the native host before detailed
mechanistic investigations are commenced.
To minimize interference from intrinsic resistance determinants
against antimicrobial peptides, we have constructed a B. subtilis
strain devoid of the most efficient systems. This strain should
provide a clean genetic background for the study of a broad range
of resistance mechanisms against cell wall active substances,
particularly regarding their regulation. In addition to one-
component regulation of bacitracin resistance and two-component
regulation of vancomycin resistance implemented here, we have
successfully applied this set-up to the functional reconstitution of a
more complex regulatory and resistance network [37]. It should be
Figure 2. Time-resolved induction of PbcrA by bacitracin in an unmarked, sensitive B. subtilis recipient strain. SGB274, carrying
unmarked deletion of bceRS-bceAB, psdRS-psdAB, yxdJK-yxdLM-yxeA and harbouring the PbcrA-lux reporter construct pNTlux101 and bcrR expression
construct was grown in the presence of 0.2% (w/v) xylose (panels A and B), or in the absence of xylose (panels C and D). In early exponential phase
(t = 0 min), bacitracin was added to final concentrations of 0 (open circles) 0.03 mg ml21 (open squares), 0.1 mg ml21 (grey circles), 0.3 mg ml21 (solid
circles) or 1 mg ml21 (solid squares), and luminescence normalized to optical density (RLU/OD) was monitored. (A, C) Time-course of promoter
induction over 60 min after bacitracin-challenge. (B, D) Dose-response at 30 min post-induction; the time point is labelled with the arrow in the
panels above. Results are shown as the mean and standard deviation of three biological replicates.
doi:10.1371/journal.pone.0093169.g002
B. subtilis as Host for E. faecalis Systems
PLOS ONE | www.plosone.org 7 March 2014 | Volume 9 | Issue 3 | e93169
noted that the response of B. subtilis to antibiotics in general is
among the best understood of all bacteria investigated to date [38].
This plethora of available data therefore constitutes an ideal basis
for construction of new sensitive recipient strains adapted to the
study of resistance and regulatory systems also for other classes of
antimicrobials.
Further, we showed that the two reporters, lacZ and luxABCDE,
can both be used for qualitative (high-throughput) screening
approaches, for example of mutant libraries, as well as for the
quantitative characterization of regulators. Complementation
studies with random or directed mutations can thus be initiated
in the genetically accessible, highly competent host B. subtilis, and
promising results then validated directly in E. faealis. Construction
of the desired heterologous strains will be further aided by a
recently established and fully validated tool-box of vectors,
promoters, reporters and epitope-tags for engineering of B. subtilis
[36]. We therefore envisage that the system developed here will aid
investigations into the molecular mechanisms of sensory percep-
tion of antimicrobials and subsequent signal transduction, the first
essential step of antibiotic resistance. Furthermore, this set-up
should also be applicable to the study of unrelated resistance
systems or even regulatory cascades of diverse functions from other
genetically intractable Gram-positive bacteria.
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Resistance of Enterococcus faecalis against antimicrobial peptides, both of host origin and produced by other bacteria of the gut
microflora, is likely to be an important factor in the bacterium’s success as an intestinal commensal. The aim of this study was to
identify proteins with a role in resistance against the model antimicrobial peptide bacitracin. Proteome analysis of bacitracin-
treated and untreated cells showed that bacitracin stress induced the expression of cell wall-biosynthetic proteins and caused
metabolic rearrangements. Among the proteins with increased production, an ATP-binding cassette (ABC) transporter with
similarity to known peptide antibiotic resistance systems was identified and shown to mediate resistance against bacitracin. Ex-
pression of the transporter was dependent on a two-component regulatory system and a second ABC transporter, which were
identified by genome analysis. Both resistance and the regulatory pathway could be functionally transferred to Bacillus subtilis,
proving the function and sufficiency of these components for bacitracin resistance. Our data therefore show that the two ABC
transporters and the two-component system form a resistance network against antimicrobial peptides in E. faecalis, where one
transporter acts as the sensor that activates the TCS to induce production of the second transporter, which mediates the actual
resistance.
Enterococcus faecalis is a member of the normal gut microflorain animals and humans. While it is mostly a harmless com-
mensal, opportunistic infections, particularly of immunocom-
promised hospital patients, are amajor health concern. Due to the
rise of vancomycin-resistant strains (VREs), treatment of such
infections is becoming increasingly difficult, and a better under-
standing of the resistance of E. faecalis against cell wall-targeting
antibiotics is urgently needed. In addition to vancomycin resis-
tance, enterococci display a high intrinsic resistance against other
inhibitors of cell wall biosynthesis, including cephalosporins and
bacitracin (1–3). Bacitracin is not used clinically for the treatment
of enterococcal infections, yet resistance against this and other
peptide antibiotics is nevertheless biologically relevant in the hu-
man intestinal environment. For example, gut bacteria are ex-
posed to defensins that are part of the innate immune defense in
the gastrointestinal tract (4). Additionally, other members of the
microflora, especially lactic acid bacteria, produce a range of bac-
teriocins as a means of interspecies competition (5). Thus, resis-
tance of E. faecalis against peptide antibiotics is likely to be impor-
tant for the success of the bacterium in the human host, which in
turn affects the risk of opportunistic infections.
In other Gram-positive bacteria, several resistance mecha-
nisms that combat the action of cell wall-active peptides have been
identified. One strategy can be alterations in the cell’s surface
charge, for example, by alanylation of teichoic acids catalyzed by
the DltABCD system (6, 7). Accordingly, in a recent study, the dlt
operon of E. faecalis was shown to be upregulated in response to
bacitracin and vancomycin (8). Alternatively, upregulation of the
enzyme inhibited by the antibiotic, e.g., in the case of bacitracin,
undecaprenyl-pyrophosphate phosphatases, can confer resis-
tance, as has been shown for Bacillus subtilis and E. faecalis (2, 9).
A third resistance mechanism is the expression of specific ATP-
binding cassette (ABC) transporters. One type of such transport-
ers possesses permeases with six transmembrane helices and is
exemplified by the bacitracin transporter BcrAB, which is used for
self-immunity by bacitracin-producing strains of Bacillus licheni-
formis (10) but has also been shown to confer acquired high-level
bacitracin resistance toE. faecalis (3). Anunrelated group of trans-
porters, characterized by permeases with 10 transmembrane heli-
ces and a large extracellular domain, are involved in resistance
against a range of antimicrobial peptides. The best-understood
example is BceAB of B. subtilis, which confers resistance against
bacitracin, mersacidin, and actagardine (11, 12). These transport-
ers form the Peptide-7-Exporter family in the Transport Classifi-
cation Database and are collectively referred to as BceAB-type
systems (13, 14). They are usually found in the genetic neighbor-
hood of a two-component regulatory system (TCS; BceRS type)
that controls expression of the transporter operon (15, 16). Im-
portantly, these transporters not only mediate resistance but play
an additional role as sensors, because the TCSs alone are unable to
detect their substrate peptides (11, 17). Together, transporters and
TCSs form peptide antibiotic resistance modules and are found
widely distributed among low-GC Gram-positive organisms
(13, 16). A comparative genomics analysis identified two BceAB-
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type transporters in the genome of E. faecalis (16), but no func-
tional data are available on these systems, nor has a TCS been
identified as the corresponding regulator.
In accordance with the need for a better understanding of the
response of E. faecalis to antibiotics that inhibit cell wall synthesis,
a recent transcriptomic study identified a large number of genes
that were upregulated after exposure to ampicillin, cephalothin,
vancomycin, and bacitracin (8). Of these compounds, bacitracin
elicited the broadest response, affecting genes with functions in
cell wall maintenance, metabolism, and transport processes. Here
we report on a proteomic analysis of the bacitracin response of E.
faecalis. Among the differentially produced proteins, we again
identified those involved in cell wall maintenance and energy me-
tabolism as important factors. Additionally, one BceAB-type
transporter was found at higher levels following bacitracin expo-
sure, and subsequent investigations revealed the existence of a
regulatory and resistance network comprised of two such trans-
porters and one TCS.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains and plas-
mids used in this study are listed in Table S1 in the supplemental material.
E. coli MC1061 was used for cloning with vector pTCVlac; strains DH5
and XL1-Blue were used for all other cloning. E. coli and B. subtilis were
grown routinely in Luria-Bertani (LB) medium at 37°C with agitation
(200 rpm). Enterococcus faecalis was grown routinely in brain heart infu-
sion (BHI) at 37°C without agitation. E. faecalis was transformed by elec-
troporation as previously described (18). B. subtilis was transformed by
natural competence as previously described (19). Selective media con-
tained ampicillin (100gml1), chloramphenicol (10gml1 for E. coli;
15 g ml1 for E. faecalis; 5 g ml1 for B. subtilis), kanamycin (50 g
ml1 for E. coli; 1,000 g ml1 for E. faecalis), 1 g ml1 erythromycin
with 25gml1 lincomycin (formacrolide-lincosamide-streptograminB
[MLS] resistance), or spectinomycin (150 g ml1 for E. faecalis; 100 g
ml1 for B. subtilis). Bacitracin was supplied as the Zn2 salt. Solid media
contained 1.5% (wt/vol) agar. Growth was measured as optical density at
600 nm (OD600).
Proteomic analysis. For proteomic analyses, exponentially growing
cultures (OD600 0.4) ofE. faecalisV583 inBHImediumwere exposed to
64 g ml1 bacitracin for 1 h. The cytoplasmic protein fraction was ex-
tracted and analyzed by isoelectric focusing, followed by second-dimen-
sion (2D) SDS-PAGE. Differentially produced proteins were identified by
mass spectrometry. Detailed experimental and analytical procedures are
described in the supplemental text.
Construction of plasmids and genetic techniques. All primer se-
quences used for cloning or transcriptional start site mapping are listed in
Table S2 in the supplemental material.
Transcriptional promoter fusions to lacZ in E. faecalis were con-
structed in the vector pTCV-lac (20). All fragments were cloned via the
EcoRI andBamHI sites of the vector. The exact regions amplified aswell as
the primers used are given in Tables S1 and S2 in the supplemental mate-
rial. For complementation of the strain of E. faecaliswith a deletion of the
transporter operon EF2050-2049, the entire operon, including its native
promoter region, was cloned into the EcoRI and BamHI sites of vector
pAT28 (21). Transcriptional promoter fusions in B. subtilis of EF2752
(PEF2752) or EF2050 (PEF2050) to the bacterial luciferase genes (luxAB-
CDE) were cloned into the EcoRI and SpeI sites of the vector pAH328
(22), creating plasmids pCF135 and pCF134. The exact regions contained
in the construct are given in Table S1 in the supplemental material.
Plasmids for heterologous, xylose-inducible expression of EF2752-
2751 or EF2050-2049 in B. subtilis (pCF129 and pCF130) were con-
structed in the vector pXT using the BamHI and EcoRI restriction sites,
placing the genes under the control of the vector’s xylA promoter (23).
The construct for the heterologous expression of EF0926-0927 in B.
subtilis was cloned according to the BioBrick standard (24). To facilitate
constitutive expression in B. subtilis, a BioBrick of the bceRS operon pro-
moter, PbceR, of B. subtilis was amplified and cloned into the EcoRI and
SpeI sites of vector pSB1A3, creating pCF144. A BioBrick of EF0926-0927
containing an optimal Shine-Dalgarno sequence for B. subtilis was simi-
larly cloned into pSB1A3 via EcoRI and SpeI, creating plasmid pCF143.
Assembly of both BioBricks in vector pBS2E (25) created plasmid
pCF145, where expression of EF0926-0927 is controlled by PbceR.
Constructs for unmarked gene deletions in E. faecalis were cloned in
the vector pLT06 (26). For each gene or operon to be deleted, 700- to
1,000-bp fragments located immediately before the start codon of the first
gene (“up” fragment) and after the stop codon of the last gene (“down”
fragment) were amplified. The primers were designed to create a 17- to
20-bp overlap between the PCR products (see Table S2 in the supplemen-
talmaterial), facilitating fusion of the fragments by PCRoverlap extension
(27) and subsequent cloning into pLT06. Gene deletions were performed
as previously described (26).
All constructs were checked for PCR fidelity by sequencing, and all
created strains were verified by PCR using appropriate primers.
To determine the transcriptional start sites of the EF2050-2049 and
EF2752-2751 operons, total RNAwas isolated from E. faecalis JH2-2 using
a RNeasy minikit and QIAshredder columns (Qiagen) according to the
manufacturer’s instructions. DNA was removed with a TURBO DNA-
free kit (Ambion). Transcriptional start sites were determined by 5= rapid
amplification of cDNA ends (5= RACE) as described previously (28). The
sets of nested primers used are listed in Table S2 in the supplemental
material.
Antimicrobial susceptibility assays. For antibiotic susceptibility as-
says, all cultures were grown in Mueller-Hinton (MH) medium. MICs of
bacitracin were determined by broth dilution assays. Freshly grown colo-
nies of E. faecalis were suspended in sterile saline to 0.5 McFarland stan-
dard turbidity and diluted 1:1,000 into MH medium containing serial
2-fold dilutions of bacitracin. For B. subtilis, freshly grown overnight cul-
tures in MH broth were used as inoculum at a dilution of 1:500. After 24
h of incubation, theMICwas scored as the lowest concentration where no
growth was observed. MICs obtained from broth dilution assays were
subsequently confirmed using bacitracin Etest strips (bioMérieux) ac-
cording to the manufacturer’s instructions.
Additionally, bacitracin susceptibility of B. subtilis was determined by
growth inhibition of exponentially growing cultures in LB. Strains were
inoculated 1:500 fromovernight cultures and grown in 100-l volumes in
a 96-well plate. Cultures were incubated at 37°C with shaking (medium
intensity) in a Synergy2 multimode microplate reader from BioTek con-
trolled by the softwareGen5, andOD600wasmonitored every 5min. At an
OD600 of 0.02 (4 to 5 doublings since inoculation; corresponding to an
OD600 of 0.1 in cuvettes with a 1-cm light path length), bacitracin was
added to a final concentration of 2, 4, 8 or 16 g ml1 with one well left
untreated, and growth was monitored for another 2.5 h.
-Galactosidase assays. Qualitative assays for induction of LacZ re-
porter constructs in E. faecalis were performed by the disk diffusion
method. A suspension of cells from freshly grown colonies at 0.5 Mc-
Farland standard turbidity was spread onto MH agar containing appro-
priate antibiotics for selection and 5-bromo-4-chloro-3-indolyl--D-
galactopyranoside (X-Gal) (100g ml1) using cotton swabs. Filter discs
containing 5 l antibiotic test solution (100 mg ml1) were placed onto
the plates. After overnight incubation, plates were scored for formation of
a blue ring around the filter discs.
For quantitative assays, exponentially growing cells in BHI me-
dium were exposed to different concentrations of bacitracin for 1 h as
previously described (2). -Galactosidase activities were assayed in
permeabilized cells as described previously and were expressed in
Miller units (MU) (29, 30).
Luciferase assays. Luciferase activities of B. subtilis strains containing
pCF135 and pCF134 were assayed using the microplate reader described
above. LB medium was inoculated 1:500 from overnight cultures, and
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each strain was grown in 100-l volumes in a 96-well plate. Cultures were
incubated at 37°C with shaking (medium intensity), and the OD600 was
monitored every 10 min. At an OD600 of 0.02 (see above), bacitracin was
added to a final concentration of 1, 3, or 10 g ml1, with one well left
untreated. Cultures were further incubated for 2 h, and the OD600 and
luminescence (endpoint reads; 1-s integration time; sensitivity, 200) were
monitored every 5 min. OD600 values were corrected using wells contain-
ing 100 l LB medium as blanks. Raw luminescence output (relative
luminescence units [RLU]) was normalized to cell density by dividing
each data point by its corresponding corrected OD600 value (RLU/OD).
RESULTS
Proteome analysis of the bacitracin stress response of E. faeca-
lis. To investigate the response of E. faecalis to bacitracin, we an-
alyzed the proteome of strain V583, whose genome has been fully
sequenced, after 1 h exposure to 64 g ml1 bacitracin, which
corresponded to the strain’s MIC, compared to an untreated con-
trol. A detailed description of the findings is presented in the sup-
plemental text. The 2D gels and detailed analyses of protein spots
are available in Fig. S1 and in Tables S3 and S4, respectively, in the
supplemental material. In brief, as expected, a number of proteins
involved in cell wall metabolism were found in increased quanti-
ties after bacitracin stress. Additionally, several enzymes for en-
ergy metabolism or fatty acid synthesis were differentially ex-
pressed, indicating metabolic rearrangements in response to
bacitracin. Further proteins with increased production after bac-
itracin exposure likely indicated a general response to stress. The
twomost strongly upregulated proteins are homologous to a pro-
tein of unknown function, YvlB of B. subtilis, and to cobyric acid
synthase. Their roles in the response to bacitracin are not clear.
The third strongest effect was observed with EF2050. This protein
is the ATPase component of a BceAB-like ABC transporter
(EF2050-2049), a group of proteins that to date have been identi-
fied only in the context of resistance against peptide antibiotics
(13, 16). As mentioned above, operons for two such transporters
were previously identified in the genome of E. faecalis by a com-
parative genomics study, namely, EF2050-2049 and EF2752-2751
(16). Although our proteomic study identified only the former
transporter, both loci were found to be upregulated in response to
bacitracin by transcriptome analysis (8). We therefore decided to
investigate these two transporters in more detail, regarding both
their role in bacitracin resistance and their regulation.
Identification of orthologous genes in E. faecalis JH2-2. Be-
cause strain V583 is a vancomycin-resistant clinical isolate, we
chose the laboratory strain JH2-2 for all further studies. For this,
we first needed to identify the genes corresponding to EF2050-
2049 and EF2752-2751 from strain V583. Using PCR primers de-
signed according to the V583 genome sequence, we readily ob-
tained amplicons of the correct size from strain JH2-2. DNA
sequencing confirmed that all four genes possessed the same se-
quence in both strains. For simplicity and consistency with the
existing literature, we maintained the strain V583 nomenclature
for all genes from strain JH2-2 throughout this study.
As described in the introduction, BceAB-type transporters are
usually regulated by a BceRS-like TCS encoded in the genomic
neighborhood of the transporter. However, neither of the two
transporters investigated here possessed such a regulatory system.
Because the sensor kinases of these TCSs have a characteristic
domain architecture of two transmembrane helices with a very
short intervening extracellular linker (ca. 3 to 10 amino acids) and
no additional cytoplasmic domains besides the catalytic domains
for autophosphorylation, candidate TCSs can be identified via
genome analyses (16). Indeed, the genome of E. faecalis V583 en-
codes a single BceRS-like TCS, EF0926-0927, and identical genes
were identified by PCR and sequencing in strain JH2-2. Schemat-
ics of all three loci are shown in Fig. 1.
The transporter EF2050-2049, which was identified as bacitra-
cin induced in our proteome analysis, is amember of phylogenetic
group VII of BceAB-type transporters, which also includes the
YxdLMsystemofB. subtilis (16). The second transporter, EF2752-
2751, could not be assigned to any group. However, its branch of
the phylogenetic tree includes four other transporters, one fromE.
faecium and three from Lactobacillus species (16), showing that
the occurrence of close homologues is not restricted to E. faecalis.
Interestingly, one of these transporters was recently shown to be
involved in nisin resistance of Lactobacillus casei (31).
Both transporters are induced by bacitracin.To confirmbac-
itracin-induced expression of the transporter operon EF2050-
2049, and to test if EF2752-2751 was also inducible under these
conditions, we first constructed transcriptional fusions of the pro-
moter regions PEF2050 and PEF2752 to a lacZ reporter gene. The
transcriptional start sites of both operons were determined by 5=
RACE, and putative 10 and 35 promoter elements could be
identified within a suitable distance upstream of the1 position
(Fig. 1A). Additionally, sequence analysis of the regions upstream
of the35 element revealed the presence of inverted repeats with
FIG 1 Schematic of operon structures and promoter regions in the resistance
circuit. (A) Operons for the ABC transporters. In each, the first gene encodes
the ATPase and the second gene the permease; the bent arrow indicates the
promoter. The nucleotide sequences of the promoter regions are given below
the respective schematics. The proposed response regulator binding site is
highlighted in gray, the10 and35 elements are boxed, the transcriptional
start site (1) determined by 5=RACE is shown as an underlined capital letter,
and the translational start is shown in italicized capitals. Vertical lines show the
beginning of fragments used to construct transcriptional reporter fusions, and
the numbers of the derived constructs are given. (B) Operon for the two-
component system. The first gene encodes the response regulator, and the
second gene encodes the sensor kinase; the promoter region is indicated by a
bent arrow. No putative regulator binding site was identified in the promoter,
and therefore no sequence is shown.
Bacitracin Resistance Network of E. faecalis
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similarity to the binding consensus of BceR-like regulators (16)
(Fig. 1A). The transcriptional fusions were therefore designed to
contain all of these motifs (fragments 56 for PEF2050 and 59 for
PEF2752 [Fig. 1A]).
Initial assays were performed by disc diffusion on agar plates
inoculated with a lawn of the reporter strains. Consistent with the
proteome analysis, blue circles indicating promoter induction
were observed around filter discs containing bacitracin (data not
shown). Because BceAB-like transporters normally recognize sev-
eral different substrates (12, 13, 17), we also tested several other
cell wall-active antibiotics. Nisin, gallidermin, vancomycin, teico-
planin, and penicillin G did not elicit a response, but the lantibi-
otic mersacidin was able to induce both promoters (data not
shown). These results were confirmed by quantitative -galacto-
sidase assays in liquid cultures and showed that maximum induc-
tion of both promoters was obtained at 20 to 50gml1 mersaci-
din or 4 g ml1 bacitracin but not with any of the other
antibiotics tested (Fig. 2A and data not shown). Because mersaci-
din is not commercially available and bacitracin elicited the more
sensitive response, all subsequent assays were performed using
bacitracin as an inducer. Following 1 h exposure of exponentially
growing cultures to 4 g ml1 bacitracin, PEF2050-lacZ was in-
duced approximately 5-fold from23Miller units (MU) to 112MU
(Fig. 2A, left). PEF2752-lacZwas also induced by bacitracin, but the
overall activities were low (2 to 4 MU) and induction was only
2-fold (Fig. 2B, right), explaining why this transporter had not
been identified in the proteome analysis.
Next, we constructed a series of truncated promoter fusions
lacking part of (fragment 57) or the entire (fragments 58 and 60)
proposed regulator binding sites (Fig. 1A). All strains carrying the
derived promoter-lacZ fusions displayed activities near the detec-
tion limit (ca. 1 MU) and no induction by bacitracin (Fig. 2A),
showing that these sequences were required for expression and
thus indeed presented likely binding sites for a BceR-like regula-
tor.
Both transporters and the TCS are required for full bacitra-
cin resistance of E. faecalis. To investigate the role of the two
transporters in bacitracin resistance, we created unmarked dele-
tions of the entire coding region of each transporter. Additionally,
the gene for the sensor kinase, EF0927, was deleted. Despite re-
peated attempts, no deletion of the regulator gene EF0926 could
be achieved. All three deletion strains displayed reduced bacitra-
cin resistance compared to the wild-type strain JH2-2, albeit to
different extents (Table 1). The strongest effect with a 2- to 4-fold-
increased sensitivity was observed for EF2050-2049, while dele-
tion of EF2752-2751 and of EF0927 resulted in changes of only up
to 2-fold in theMIC. The veryminor effect of the EF0927 deletion
strain can possibly be explained by deletion of the sensor kinase
alone with the regulator still present, as discussed in more detail
below. Interestingly, deletion of both transporters simultaneously
did not further reduce the MIC compared to deletion of EF2050-
2049 alone. The lack of an additive effect might suggest that both
transporters participate in the same pathway, rather than acting
independently of each other. Importantly, none of the deletion
FIG 2 Induction of the transporter operons by bacitracin. Promoter regions of the transporter operons EF2050-2049 (left) and EF2752-2751 (right) were fused
to lacZ, and resulting strains of E. faecalis JH2-2 were assayed for -galactosidase activity, expressed in Miller units (MU), after 1 h exposure of exponentially
growing cultures to 0gml1 (white bars) or 4gml1 (gray bars) bacitracin. (A) Successive truncations from the 5= end of the promoter region. Bars are labeled
by the number of each construct, as shown in Fig. 1. Constructs 56 and 59 contain the full promoter region. (B) Full-length constructs of the promoter fusions
from panel A assayed in the wild-type (WT; same data as in panel A) and mutant backgrounds. The genes deleted in each strain are indicated by the locus tags
below the bars. Results are means plus standard deviations for three to four biological replicates. The significance of induction was calculated for each strain by
one-tailed, pairwise t test analysis and is indicated by one (P 0.05), two (P 0.005), or three (P 0.001) asterisks. ns, not significant.
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strains displayed a growth defect compared to the wild-type strain
(Table 1), showing that the differences in MIC were specifically
due to loss of resistance determinants and not to altered growth
kinetics. Complementation of the EF2050-2049 deletion mutant
by supplying the transporter operon in trans (strain DLEf16) re-
stored bacitracin resistance (Table 1). The higher MIC compared
to the wild-type strain is most likely due to the increase in copy
number by the plasmid-based complementation strategy and sup-
ports the role of EF2050-2049 in bacitracin resistance ofE. faecalis.
Transporters and TCS form a regulatory network. BceAB-
type transporters are often required for their own regulation by
acting as the actual sensors of antimicrobial peptides that some-
how communicate with the TCS to trigger activation of the signal-
ing cascade (11, 17). In such cases, expression of the transporter
operon is abolished in strains carrying transporter deletions (11,
12, 32). In some bacteria, exemplified by Staphylococcus aureus,
two separate transporters exist, where one acts as the sensor, while
the second is responsible for resistance (17, 32). We therefore
wanted to investigate the role of the two enterococcal transporters
in regulation of their own promoters. Additionally, the TCS
EF0926-0927 had so far only been implicated in regulation of the
transporters based on sequence predictions, which had to be val-
idated experimentally.
Deletion of the sensor kinase EF0927 drastically reduced the
expression levels of PEF2050-lacZ to less than 20% of wild-type
activities (Fig. 2B, left). Interestingly, a significant induction by
bacitracin could still be observed, whichwas again likely due to the
presence of the response regulator as described below. Expression
of PEF2752-lacZ was also reduced by deletion of the sensor kinase,
but due to the overall low activities of this reporter, the differences
were less pronounced. Nevertheless, the significant induction by
bacitracin observed in the wild type was lost in the EF0927 dele-
tion strain (Fig. 2B, right). These data show that the TCS EF0926-
0927 indeed acts as the regulator for both transporter operons.
Deletion of the transporter EF2050-2049 had no effect on ex-
pression of either transporter (Fig. 2B), indicating that this trans-
porter’s role was restricted to mediating resistance. In contrast,
deletion of EF2752-2751 severely reduced the activities of both
lacZ fusions, and bacitracin-dependent induction was lost (Fig.
2B). Thus, the second transporter represents the antibiotic sensor
of the resistance network.
In B. subtilis, expression of BceRS, the TCS regulating bceAB
expression, is not induced by bacitracin (33). However, the ho-
mologous system BraRS from S. aureus (referred to as NsaRS in
reference 34) was shown to be upregulated in response to nisin,
one of its substrate peptides (34). To test if EF0926-0927 was in-
ducible by bacitracin, we constructed a transcriptional fusion of
the promoter PEF0926 to lacZ and introduced it into E. faecalis
JH2-2 and derived deletion strains. Exposure of exponentially
growing cells to bacitracin resulted in a strong upregulation of
promoter activities from 1 to 16 MU (Fig. 3). Interestingly, dele-
tion of neither theTCSnor the two transporters affected promoter
activities or bacitracin-dependent induction (Fig. 3), showing that
regulation of the TCS is mediated by an as-yet-unidentified addi-
tional regulator and not due to autoregulation. Importantly, this
regulation by a factor external to the resistance networkmay offer
an explanation for the mild phenotypes of the EF0927 deletion
strain compared to the transportermutants: in the	EF0927 back-
ground, expression of the response regulator gene EF0926 is still
upregulated in the presence of bacitracin. Because in the absence
of their cognate sensor kinase many response regulators can be
efficiently phosphorylated and thus activated by small-molecule
phospho-donors such as acetyl-phosphate (35, 36), this increased
production of EF0926 may indirectly lead to an induction of its
target promoters by bacitracin.
EF2050-2049 canmediate bacitracin resistance in B. subtilis.
Because of the mild effects of the gene deletions generated in E.
faecalis, we next attempted to transfer parts of the identified resis-
tance network to B. subtilis to confirm the individual roles of the
components in bacitracin resistance. As a chassis, we employed a
strain of B. subtilisW168 carrying unmarked deletions of all three
endogenous Bce-like modules (bceRS-bceAB, psdRS-psdAB, and
yxdJK-yxdLM-yxeA). This strain, TMB1518, has been developed
and validated as an appropriate platform to investigate resistance
mechanisms against inhibitors of cell wall synthesis and the asso-
ciated regulatory pathways from E. faecalis in a genetically highly
accessible set-up (a detailed description will be published else-
where). Expression of the EF2050-2049 operon under the control
of a xylose-inducible promoter increased the MIC for bacitracin
FIG 3 Induction of the two-component system operon by bacitracin. The
promoter region of the two-component system operon EF0926-0927 was
fused to lacZ and introduced intowild-type E. faecalis JH2-2 (WT) andmutant
backgrounds. The resulting strains were assayed for -galactosidase activity,
expressed in Miller units (MU), after 1 h exposure of exponentially growing
cultures to 0 g ml1 (white bars) or 4 g ml1 (gray bars) bacitracin. The
genes deleted in each strain are indicated by locus tags below the bars. Results
are means plus standard deviations for three biological replicates. The signifi-
cance of induction and strain differences was calculated across the entire data
set by two-way analysis of variance (ANOVA). Significant effects of bacitracin
compared to uninduced cells are indicated by three asterisks (P 0.001); the
different mutant backgrounds caused significant differences between strains
(P 0.018; not depicted in the graph).
TABLE 1 Bacitracin sensitivity of E. faecalis strains
Strain or genotype
MIC (g ml1)
Growth rate
(h1)bBroth dilutiona Etest
JH2-2 32 32 1.06
 0.067
	EF0927 16–32 24 1.2
 0.377
	EF2050-2049 8–16 8 1.11
 0.135
	EF2752-2751 16 16 1.14
 0.146
	EF2050-2049 	EF2752-2751 8 8 1.08
 0.033
DLEf16 64 64 ND
a Results are from three independent broth dilution experiments; where a range of
concentrations is given, results varied between replicates.
b Results are means
 standard errors from three to six independent experiments. ND,
not determined.
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of TMB1518 from 2 g ml1 to 4 to 8 g ml1 (from 1 to 1.5 g
ml1 to 3 g ml1 when determined by Etest assays), while ex-
pression of EF2752-2751 was unable to confer any resistance. As
observed before for E. faecalis, the differences in MIC were again
small. We therefore chose a different approach, assaying for
growth inhibition of exponentially growing cultures that were
challenged with increasing antibiotic concentrations, which can
provide a more sensitive assay for cell wall-active antibiotics. B.
subtilis strain TMB1518 as well as its derivative carrying the
EF2752-2751 expression construct were unaffected by 2 g ml1
bacitracin, while 4 g ml1 or 8 g ml1 increasingly inhibited
growth (Fig. 4A and C). In contrast, the strain harboring the ex-
pression construct for EF2050-2049 was not affected by concen-
trations up to 4gml1 and showed only slight growth inhibition
at 8g ml1 (Fig. 4B). Exposure to 16g ml1 caused cell lysis in
all strains tested (Fig. 4). These data confirm that EF2050-2049 is
indeed directly capable of mediating bacitracin resistance, not
only in E. faecalis but also in the heterologous host B. subtilis.
EF2752-2751, on the other hand, is not directly responsible for
bacitracin resistance.
EF2752-2751 and the TCS are sufficient for promoter induc-
tion in B. subtilis. Following the successful transfer of bacitracin
resistance to B. subtilis, we next wanted to test if the regulatory
pathway could also be reconstituted in the heterologous host. To
this end, both target promoters, PEF2050 and PEF2752, were fused to
the bacterial luciferase operon luxABCDE as a reporter (22) and
introduced into TMB1518. Both constructs resulted in basal lucif-
erase activities that were not affected by addition of bacitracin
(Fig. 5, leftmost panels). Thus, no endogenous B. subtilis system
was able to induce either of the promoters. Next, the TCS operon
EF0926-0927 was introduced into the reporter strains, controlled
by the promoter of the homologous bceRS operon of B. subtilis to
ensure appropriate expression levels. The presence of the TCS
alone did not alter the activities of the transporter promoters, and
bacitracin-dependent induction was still not observed (Fig. 5, left
center panels), confirming that the TCS alone is unable to respond
to the peptide, as has been shown for other BceRS-like systems
(11, 12, 32). Additional introduction of the expression construct
for EF2050-2049 also did not change the promoter activities (Fig.
5, right center panels), showing that the encoded transporter has
no sensory function. In contrast, simultaneous presence of the
TCS and the transporter EF2752-2751 increased the basal activi-
ties of the PEF2050-lux reporter, and addition of bacitracin resulted
in a further 2-fold induction (Fig. 5, top rightmost panel). Expres-
sion of PEF2752-luxwas not altered in the same genetic background
(Fig. 5, bottom rightmost panel), consistent with the minor in-
duction observed for this promoter in E. faecalis. These results
clearly show that together, the transporter EF2752-2751 and the
TCS EF0926-0927 constitute the sensory and regulatory compo-
nent of the resistance network and that the second transporter
operon, EF2050-2049, is their main target.
DISCUSSION
Our proteomic analysis of bacitracin-exposed E. faecalis showed
that the bacterium responds to the antibiotic with a specific reac-
tion to the bacitracin-induced cell wall damage, as well as with a
more general response to stress or growth inhibition. Overall, our
data are largely consistent with the findings of a recent transcrip-
tome analysis of E. faecalis treated with different inhibitors of cell
wall synthesis, including bacitracin and vancomycin (8). A de-
tailed comparison of our study and the previous one is presented
in the supplemental text. Together, these two data sets provide a
useful overview of the response of E. faecalis to inhibitors of cell
wall synthesis such as bacitracin.
Among the differentially expressed genes identified from both
studies was a putative ABC transporter, EF2050-2049, which is a
homologue of the bacitracin resistance transporter BceAB of B.
subtilis (11, 33). A second such transporter, EF2752-2751, had been
previously identified in E. faecalis by a comparative genomics anal-
ysis of BceAB-type transporters in Firmicutes bacteria (16).While
this second transporter was not found in our proteomic analysis,
its ATP-binding cassette domain-encoding gene, EF2752, was
slightly induced by bacitracin during the transcriptome study (8).
Additionally, we could identify a TCS of E. faecalis with similarity
to BceRS of B. subtilis, which regulates expression of BceAB (33).
Again, the encoding genes EF0926-0927 had been reported as bac-
itracin inducible and were also found to be induced by the cell
wall-active antibiotics cephalothin and vancomycin (8). Our sub-
sequent characterization of these three gene loci in E. faecalis as
well as heterologously in B. subtilis showed that they act together
and form a resistance network against bacitracin. A schematic of
the derived model is shown in Fig. 6.
The primary sensor of the network is the transporter EF2752-
2751, which communicates the presence of bacitracin to the sen-
FIG 4 Transfer of bacitracin resistance to B. subtilis. Strain TMB1518 (A) and derived strains carrying expression constructs of the transporter operon
EF2050-2049 (B) or EF2752-2751 (C) were grown to exponential phase and challenged with bacitracin, and growth was monitored as optical density (OD600).
The time point of bacitracin addition is indicated by the arrow; concentrations are given in panel A. Representative results of two or three independent
experiments are shown. Experimentswere carried out in a 100-l culture volume in 96-well plates; thus,ODvalues cannot be directly compared tomeasurements
made in cuvettes with a 1-cm light path length.
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sor kinase EF0927. Activation of the sensor kinase and phospho-
transfer to the response regulator EF0926 then leads to activation
of the main target promoter, PEF2050, and increased production of
the transporter EF2050-2049. This transporter then removes the
bacitracin from its site of action, thus ensuring resistance. Simul-
taneously, expression of the sensory transporter is slightly induced
by the TCS, while expression of the TCS operon is induced by an
as-yet-unidentified regulator that is not directly part of the resis-
tance network. Upregulation of a BceRS-like TCS has so far been
reported only for the BraRS ( NsaRS) system of S. aureus (34)
and may lead to an increased sensitivity or stronger induction of
the resistance transporter. Future studies will be directed at iden-
tification of the regulator for the TCS. Because the transcriptome
study showed the TCS to be inducible by three of four tested
inhibitors of cell wall biosynthesis (8), it appears likely that this
regulation is part of the cell envelope stress response of E. faecalis.
A number of candidate regulatory systems have been identified by
comparative genomics and provide a good starting point for sub-
sequent investigations (37).
Several BceRS-BceAB-type resistancemodules have been char-
acterized in detail and were always shown to be involved in pep-
tide antibiotic resistance (13, 17). Importantly, the TCSs always
rely on one of the transporters for stimulus perception and are
unable to induce their target genes in the absence of their trans-
porter (11, 12, 31, 32, 38). In most cases the transporter and TCS
are encoded in adjacent operons (15, 16), but in S. aureus and
Lactobacillus casei, some TCSs were shown to regulate the expres-
sion of a second transporter encoded elsewhere on the chromo-
some (31, 32). The situation in E. faecalis as identified in the pres-
ent study is even more complex, with not only the target
transporter but also the sensory transporter being encoded in a
different locus from the TCS. To our knowledge, this is the first
report where a regulatory interaction between a BceAB-like trans-
porter and BceRS-like TCS was shown for two systems not en-
coded together. Our findings further emphasize the widespread
occurrence of these resistance modules and show that the regula-
tory paradigm is conserved even if genomic arrangement is not.
As mentioned in the introduction, E. faecalis is likely exposed
to a range of antimicrobial peptides in the gastrointestinal tract of
humans and animals, which can be of host origin or produced by
other bacteria of the gut microflora. This raises a question regard-
ing the physiological substrate of the resistance network described
here. Most Bce-like modules analyzed so far are not specific for a
single substrate but instead recognize a range of often structurally
diverse peptides (17). In S. aureus, the human beta-defensin hBD3
and cathelicidin LL-37 have been identified as substrates of the
ApsRS-VraFGmodule (39), showing that the function of Bce-like
modules is not restricted to bacterially derived antimicrobial pep-
tides. Our initial screening experiments identified the lantibiotic
mersacidin as a second inducer of both enterococcal transporters,
and it is possible or even likely that other substrates exist. Partic-
ularly for a gut bacterium like E. faecalis, it will be interesting to
FIG 5 Functional reconstitution of the regulatory circuit in B. subtilis. Promoter regions of the transporter operons EF2050-2049 (top graphs) and EF2752-2751
(bottom graphs) were fused to luxABCDE and introduced into B. subtilis TMB1518. Additionally, the two-component system and transporter operons were
introduced under the control of a constitutive (PbceR) or xylose-inducible (Pxyl) promoter. The expression constructs present in each strain are illustrated above
the graphs, using the same shading as in Fig. 1. Exponentially growing cultures were exposed to different concentrations of bacitracin, given in the top leftmost
graph, and luminescence normalized to optical density (RLU/OD) was monitored over 60 min. Results are means plus standard deviations for two or three
biological replicates.
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test if any human antimicrobial peptides can induce expression of
the transporters identified here and if the resistance network im-
parts a selective advantage to the bacterium in the intestinal envi-
ronment.
ACKNOWLEDGMENTS
We thank Lynn Hancock for supplying vector pLT06 and Richard Losick
for vector pAH328. We are also grateful to Tanja Schneider for her gen-
erous gift of purified mersacidin and gallidermin. Furthermore, we thank
the Centre for Protein Research, Department of Biochemistry, University
of Otago, for assistance with mass spectrometry.
Work in the laboratory of S.G. was supported by grants of the Deut-
sche Forschungsgemeinschaft (GE2164/3-1) and the Fonds der Chemi-
schen Industrie. Research in the laboratory of G.M.C. was supported by
the Health Research Council New Zealand and Marsden Fund, Royal
Society of New Zealand. C.F. was supported by a Ph.D. scholarship from
the China Scholarship Council. A.S. was supported by a Maldivian Na-
tional Ph.D. scholarship.
D.J.L., M.R.W., and F.K. characterized the resistance network in E.
faecalis; C.F. performed all work with B. subtilis; A.S. and A.C. performed
the proteomic analysis; S.G. and G.M.C. designed the study and coordi-
nated experimental work; S.G. wrote the manuscript.
REFERENCES
1. Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vanco-
mycin resistance. Nat. Rev. Microbiol. 10:266–278. http://dx.doi.org/10
.1038/nrmicro2761.
2. Shaaly A, Kalamorz F, Gebhard S, Cook GM. 2013. Undecaprenyl
pyrophosphate phosphatase confers low-level resistance to bacitracin in
Enterococcus faecalis. J. Antimicrob. Chemother. 68:1583–1593. http://dx
.doi.org/10.1093/jac/dkt048.
3. Manson JM, Keis S, Smith JMB, Cook GM. 2004. Acquired bacitracin
resistance in Enterococcus faecalis is mediated by an ABC transporter and a
novel regulatory protein, BcrR. Antimicrob. Agents Chemother. 48:3743–
3748. http://dx.doi.org/10.1128/AAC.48.10.3743-3748.2004.
4. Bevins CL, Martin-Porter E, Ganz T. 1999. Defensins and innate host
defence of the gastrointestinal tract. Gut 45:911–915. http://dx.doi.org/10
.1136/gut.45.6.911.
5. Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate im-
munity for food. Nat. Rev. Microbiol. 3:777–788. http://dx.doi.org/10
.1038/nrmicro1273.
6. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. 1999.
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity
to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem.
274:8405–8410. http://dx.doi.org/10.1074/jbc.274.13.8405.
7. McBride SM, Sonenshein AL. 2011. The dlt operon confers resistance to
cationic antimicrobial peptides in Clostridium difficile. Microbiology 157:
1457–1465. http://dx.doi.org/10.1099/mic.0.045997-0.
8. Abranches J, Tijerina P, Avilés-Reyes A, Gaca AO, Kajfasz JK, Lemos
JA. 2013. The cell wall-targeting antibiotic stimulon of Enterococcus faeca-
lis. PLoS One 8:e64875. http://dx.doi.org/10.1371/journal.pone.0064875.
9. Cao M, Helmann JD. 2002. Regulation of the Bacillus subtilis bcrC bacitracin
resistance gene by two extracytoplasmic function sigma factors. J. Bacteriol. 184:
6123–6129. http://dx.doi.org/10.1128/JB.184.22.6123-6129.2002.
10. Podlesek Z, Herzog B, Comino A. 1997. Amplification of bacitracin
transporter genes in the bacitracin producing Bacillus licheniformis.
FEMS Microbiol. Lett. 157:201–205. http://dx.doi.org/10.1111/j.1574
-6968.1997.tb12774.x.
11. Rietkötter E, Hoyer D,Mascher T. 2008. Bacitracin sensing in Bacillus subtilis.
Mol. Microbiol. 68:768–785. http://dx.doi.org/10.1111/j.1365-2958.2008
.06194.x.
12. Staron´ A, Finkeisen DE, Mascher T. 2011. Peptide antibiotic sensing and
detoxification modules of Bacillus subtilis. Antimicrob. Agents Che-
mother. 55:515–525. http://dx.doi.org/10.1128/AAC.00352-10.
13. Gebhard S. 2012. ABC transporters of antimicrobial peptides in Firmic-
utes bacteria—phylogeny, function and regulation. Mol. Microbiol. 86:
1295–1317. http://dx.doi.org/10.1111/mmi.12078.
14. Saier MH, Yen MR, Noto K, Tamang DG, Elkan C. 2009. The Trans-
porter Classification Database: recent advances. Nucleic Acids Res. 37:
D274–8. http://dx.doi.org/10.1093/nar/gkn862.
15. Joseph P, Fichant G, Quentin Y, Denizot F. 2002. Regulatory relation-
ship of two-component andABC transport systems and clustering of their
genes in the Bacillus/Clostridium group, suggest a functional link between
them. J.Mol.Microbiol. Biotechnol. 4:503–513. http://www.horizonpress
.com/backlist/jmmb/v/v4/58.pdf.
FIG 6 Model of the bacitracin resistance network in E. faecalis. Schematic illustrations of the involved genes and proteins are shown and the sequences of
regulator binding sites are given. Bacitracin is detected by EF2752-2751, indicated by the curved downward arrow. Communication between the transporter and
two-component system is shown by a double arrow, and phospho-transfer as well as target promoter activation is shown by single arrows. Increased expression
of operons is shown by dashed arrows. The differences in the strengths of induction are reflected by thickness of lines. Bacitracin resistance mediated by
EF2050-2049 is indicated by the curved upward arrow. Bacitracin-dependent induction of the two-component system operon by an unknown mechanism is
shown as a dashed arrow with a question mark. ATP, ATPase; Perm, permease; R, response regulator; S, sensor kinase; Bac., bacitracin.
Gebhard et al.
1432 aac.asm.org Antimicrobial Agents and Chemotherapy
 o
n
 N
ovem
ber 2, 2014 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
16. Dintner S, Staron´ A, Berchtold E, Petri T, Mascher T, Gebhard S. 2011.
Coevolution of ABC transporters and two-component regulatory systems
as resistance modules against antimicrobial peptides in Firmicutes bacte-
ria. J. Bacteriol. 193:3851–3862. http://dx.doi.org/10.1128/JB.05175-11.
17. Gebhard S, Mascher T. 2011. Antimicrobial peptide sensing and detox-
ification modules: unravelling the regulatory circuitry of Staphylococcus
aureus. Mol. Microbiol. 81:581–587. http://dx.doi.org/10.1111/j.1365
-2958.2011.07747.x.
18. Shepard BD, Gilmore MS. 1995. Electroporation and efficient transfor-
mation of Enterococcus faecalis grown in high concentrations of glycine.
Methods Mol. Biol. 47:217–226.
19. Harwood CR, Cutting SM. 1990. Molecular biological methods for
Bacillus. John Wiley & Sons, Chichester, United Kingdom.
20. Poyart C, Trieu-Cuot P. 1997. A broad-host-range mobilizable shuttle
vector for the construction of transcriptional fusions to beta-galactosidase
in gram-positive bacteria. FEMS Microbiol. Lett. 156:193–198. http://dx
.doi.org/10.1016/S0378-1097(97)00423-0.
21. Trieu-Cuot P, Carlier C, Poyart-Salmeron C, Courvalin P. 1990. A pair
of mobilizable shuttle vectors conferring resistance to spectinomycin for
molecular cloning in Escherichia coli and in gram-positive bacteria. Nu-
cleic Acids Res. 18:4296. http://dx.doi.org/10.1093/nar/18.14.4296.
22. Schmalisch M, Maiques E, Nikolov L, Camp AH, Chevreux B, Muffler
A, Rodriguez S, Perkins J, Losick R. 2010. Small genes under sporulation
control in the Bacillus subtilis genome. J. Bacteriol. 192:5402–5412. http:
//dx.doi.org/10.1128/JB.00534-10.
23. Derré I, Rapoport G, Msadek T. 2000. The CtsR regulator of stress
response is active as a dimer and specifically degraded in vivo at 37 degrees
C. Mol. Microbiol. 38:335–347. http://dx.doi.org/10.1046/j.1365-2958
.2000.02124.x.
24. Knight T. Idempotent vector design for standard assembly of BioBricks.
MIT Artificial Intelligence Laboratory, MIT Synthetic Biology Working
Group, Massachusetts Institute of Technology, Cambridge, MA.
25. Radeck J, Kraft K, Bartels J, Cikovic T, Dürr F, Emenegger J, Kelterborn
S, Sauer C, Fritz G, Gebhard S, Mascher T. 2013. The Bacillus BioBrick
box: generation and evaluation of essential genetic building blocks for
standardized work with Bacillus subtilis. J. Biol. Eng. 7:29. http://dx.doi
.org/10.1186/1754-1611-7-29.
26. Thurlow LR, Thomas VC, Hancock LE. 2009. Capsular polysaccharide
production in Enterococcus faecalis and contribution of CpsF to capsule
serospecificity. J. Bacteriol. 191:6203–6210. http://dx.doi.org/10.1128/JB
.00592-09.
27. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed
mutagenesis by overlap extension using the polymerase chain reaction.
Gene 77:51–59. http://dx.doi.org/10.1016/0378-1119(89)90358-2.
28. Gauntlett JC, Gebhard S, Keis S, Manson JM, Pos KM, Cook GM. 2008.
Molecular analysis of BcrR, a membrane-bound bacitracin sensor and
DNA-binding protein from Enterococcus faecalis. J. Biol. Chem. 283:8591–
8600. http://dx.doi.org/10.1074/jbc.M709503200.
29. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY.
30. Gebhard S, Tran SL, Cook GM. 2006. The Phn system of Mycobacterium
smegmatis: a second high-affinity ABC-transporter for phosphate. Micro-
biology 152:3453–3465. http://dx.doi.org/10.1099/mic.0.29201-0.
31. Revilla-Guarinos A, Gebhard S, Alcántara C, Staron´ A, Mascher T,
Zúñiga M. 2013. Characterization of a regulatory network of peptide
antibiotic detoxification modules in Lactobacillus casei BL23. Appl. Envi-
ron.Microbiol. 79:3160–3170. http://dx.doi.org/10.1128/AEM.00178-13.
32. Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T. 2011. Bacitracin
and nisin resistance in Staphylococcus aureus: a novel pathway involving
the BraS/BraR two-component system (SA2417/SA2418) and both the
BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 81:602–
622. http://dx.doi.org/10.1111/j.1365-2958.2011.07735.x.
33. Ohki R,Giyanto, TatenoK,MasuyamaW,Moriya S, Kobayashi K,Ogasawara
N.2003.TheBceRS two-component regulatory system induces expressionof the
bacitracin transporter, BceAB, in Bacillus subtilis. Mol. Microbiol. 49:1135–
1144. http://dx.doi.org/10.1046/j.1365-2958.2003.03653.x.
34. Kolar SL, Nagarajan V, Oszmiana A, Rivera FE, Miller HK, Davenport
JE, Riordan JT, Potempa J, Barber DS, Koziel J, Elasri MO, Shaw LN.
2011. NsaRS is a cell-envelope-stress-sensing two-component system of
Staphylococcus aureus. Microbiology 157:2206–2219. http://dx.doi.org/10
.1099/mic.0.049692-0.
35. Chamnongpol S, Groisman EA. 2000. Acetyl phosphate-dependent ac-
tivation of a mutant PhoP response regulator that functions indepen-
dently of its cognate sensor kinase. J.Mol. Biol. 300:291–305. http://dx.doi
.org/10.1006/jmbi.2000.3848.
36. Schrecke K, Jordan S, Mascher T. 2013. Stoichiometry and perturbation
studies of the LiaFSR system of Bacillus subtilis. Mol. Microbiol. 87:769–
788. http://dx.doi.org/10.1111/mmi.12130.
37. Jordan S, Hutchings MI, Mascher T. 2008. Cell envelope stress response
in Gram-positive bacteria. FEMS Microbiol. Rev. 32:107–146. http://dx
.doi.org/10.1111/j.1574-6976.2007.00091.x.
38. Falord M, Karimova G, Hiron A, Msadek T. 2012. GraXSR proteins
interact with the VraFG ABC transporter to form a five-component sys-
tem required for cationic antimicrobial peptide sensing and resistance in
Staphylococcus aureus. Antimicrob. Agents Chemother. 56:1047–1058.
http://dx.doi.org/10.1128/AAC.05054-11.
39. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 2007. The antimi-
crobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol.
66:1136–1147. http://dx.doi.org/10.1111/j.1365-2958.2007.05986.x.
Bacitracin Resistance Network of E. faecalis
March 2014 Volume 58 Number 3 aac.asm.org 1433
 o
n
 N
ovem
ber 2, 2014 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
37 
 
 
 
 
 
 
 
 
Chapter IV 
Insulation and Wiring Specificity Determinants of BceR-like 
Response Regulators and their Target Promoters  
in Bacillus subtilis 
Chong Fang, Anna Staroń, Martin Grafe, Ralf Heermann, Kirsten Jung, Susanne Gebhard and 
Thorsten Mascher  
Manuscript 
Chapter IV - Wiring specificity of Bce-like systems 
38 
 
Insulation and Wiring Specificity Determinants of BceR-like Response 
Regulators and their Target Promoters in Bacillus subtilis 
Summary 
BceRS and PsdRS are paralogous two-component systems in Bacillus subtilis. In response to the 
extracellular presence of bacitracin and nisin, respectively, the two response regulators (RRs) bind 
their target promoters, PbceA and PpsdA, resulting in a strong up-regulation of target gene expression and 
ultimately antibiotic resistance. Despite high sequence similarity between BceR and PsdR and their 
known binding sites within PbceA and PpsdA, no cross-regulation has been observed between them. We 
therefore investigated the specificity determinants of PbceA and PpsdA that ensure the insulation of these 
two paralogous pathways at the RR/promoter interface. In vivo and in vitro analyses demonstrate that 
the regulatory regions within these two promoters contain three important elements: in addition to the 
known (main) binding site, we identified a linker region and a secondary binding site to be crucial for 
functionality. The high affinity main binding site enables a tight but rather non-specific binding of 
BceR-like RRs to their target promoters. This initial (primary) binding then allows a highly specific 
interaction with the low affinity secondary binding site. This second binding event is further 
modulated by the linker region to determine binding specificity and thereby ensure the regulatory 
insulation between closely related Bce-like systems.   
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Introduction 
Antimicrobial peptides (AMPs) are majorly produced by Gram-positive microbes to suppress the 
growth of competitors in their habitat environment (Berdy, 2005). The main target of AMPs is the 
bacterial cell envelope, especially different substrates of the lipid II cycle. By binding to their target 
molecules, AMPs inhibit cell wall biosynthesis and cause cell death (Silver, 2003, Breukink & de 
Kruijff, 2006, Jordan et al., 2008).  
In Firmicutes bacteria, sensing of and resistance against AMPs is usually mediated by highly 
conserved Bce-like detoxification modules containing an ATP-binding cassette (ABC) transporter and 
a two-component system (TCS) (Coumes-Florens et al., 2011, Dintner et al., 2011). The genome of 
Bacillus subtilis encodes three such systems: BceRS-BceAB, PsdRS-PsdAB and YxdJK-YxdLM-
YxeA, of which the last is poorly understood (Joseph et al., 2002, Coumes-Florens et al., 2011, 
Gebhard & Mascher, 2011). BceRS-BceAB system is the best understood system and responds to 
AMPs such as bacitracin, actagardine and mersacidin (Bernard et al., 2003, Staroń et al., 2011). It 
consists of two separate operons: the bceRS operon encodes the TCS comprised of a membrane 
anchored histidine kinase (HK), BceS, and a cytoplasmic response regulator (RR), BceR, under the 
control of a constitutive promoter. The bceAB operon encodes the ABC transporter under the control 
of an inducible BceR dependent promoter, PbceA. In the absence of AMPs, both operons are expressed 
at a very low level. In the presence of AMPs such as bacitracin, the ABC transporter BceAB senses 
this stimulus and passes the signal on to the HK BceS (Joseph et al., 2002, Ohki et al., 2003, Gebhard, 
2012, Dintner et al., 2014). Upon autophosphorylation, BceS then triggers the signal transduction to 
its cognate RR BceR by phosphoryl group transfer. Further, the phosphorylated BceR will then bind to 
PbceA and strongly induce bceAB transcription, ultimately results in increased BceAB production, 
thereby conferring AMP resistance (Mascher et al., 2003, Ohki et al., 2003, Bernard et al., 2007) (Fig. 
4.1 black system, BceAB not shown). The main inducers of the Psd system are lipid II-binding 
lantibiotics such as nisin, actagardine, gallidermin and subtilin. In turn, the Psd system confers 
resistance against nisin, actagardine and subtilin (Staroń et al., 2011). The signal transduction pathway 
within Psd system (Fig. 4.1 grey system, PsdAB not shown) is similar to that described for the Bce 
system (Gebhard & Mascher, 2011). Despite significant sequence similarity between BceRS-BceAB 
and PsdRS-PsdAB, the signal transduction of both systems is generally well insulated from each other. 
Only some degree of cross-phosphorylation between BceS and PsdR at high concentrations of 
bacitracin was observed in a previous study (Rietkötter et al., 2008) (Fig. 4.1 dotted arrow). 
RRs usually contain an N-terminal receiver domain and a C-terminal output domain. The receiver 
domain represents the interaction interface to the corresponding HK and catalyzes the phosphorylation 
reaction at an invariant Asp residue (Bourret, 2010). The nature of the output domains can be 
considerably diverse and range from DNA binding, RNA binding to protein binding or enzymatic 
activity (Galperin, 2006, Gao & Stock, 2009). In B. subtilis, the Bce-like RRs belong to OmpR/PhoB 
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subfamily with a winged helix-turn-helix DNA-binding output domain that regulates the transcription 
of target genes by binding to their corresponding promoter regions via a specific recognition motif 
(Martínez-Hackert & Stock, 1997, Fabret et al., 1999, Galperin, 2010). 
 
Figure 4.1. Model of signal transduction 
pathways of two Bce-like systems after 
induction with corresponding AMPs in Bacillus 
subtilis. Bce and Psd two component systems 
including their major antibiotics as signal input are 
coloured with black and grey, respectively. 
Schematic illustration of proteins and promoters 
together with their names are given. For the reason 
of simplicity, signal detectors — ABC transporters 
of both systems are not shown in the model. Solid 
arrows indicate the signal transduction pathway 
within one system, while cross-regulation between 
BceS and PsdR is pointed out by dotted arrow. On 
each promoter, MBS representing for the main 
binding site and SBS representing for the 
secondary binding of Bce-like RRs are filled with 
white on bceA promoter and slashes on psdA 
promoter. CM, cell membrane. 
 
In bacteria, transcription initiation starts with promoter recognition by σ subunit of the RNA 
polymerase holo enzyme at the -35 promoter element, followed by discerning and unwinding the DNA 
double helix at the -10 promoter element (Lee et al., 2012).  In B. subtilis, a -10 promoter element with 
a perfect TATAAT sequence for σA could be identified in PbceA. It is located 6 bp upstream of the 
transcription initiation site, which is 32 bp upstream of the bceA start codon. However, a conserved -
35 element was not found (Ohki et al., 2003). An identical σA-dependent -10 element was also found 
in PpsdA, again lacking a clear -35 element at the appropriate position (Staroń et al., 2011) (Fig. 4.2A). 
For promoters lacking a -35 element or deviating significantly from the consensus sequence at the 
appropriate position, σ subunit can still be recruited to these promoters by interaction with activators 
like RRs binding on the upstream region (Jarmer et al., 2001, Paget & Helmann, 2003). In B. subtilis, 
an inverted BceR main binding site on PbceA as well as PsdR main binding site on PpsdA were mapped 
upstream of the -10 promoter elements (Fig. 4.2A), which implies a cooperation between BceR-like 
RRs and the RNA polymerase holo enzyme (Ohki et al., 2003, de Been et al., 2008, Staroń et al., 
2011).  
BceR and PsdR share 40% sequence identity and the corresponding main binding sites on PbceA and 
PpsdA contain eleven identical nucleotides out of fourteen (Joseph et al., 2002). Because of these 
similarities, a high potential for cross-talk was predicted between these two systems by scoring 
function of direct-coupling analysis (Procaccini et al., 2011). However, no cross-regulation was 
detected on the transcriptional level between BceR-PpsdA and PsdR-PbceA (Rietkötter et al., 2008). Such 
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a regulatory insulation, that is, prevention of nonspecific regulatory cross-talk is of course desired and 
can arise at different molecular levels in vivo (Huynh & Stewart, 2011). The most prominent 
mechanism for conferring such signaling specificity depends on the molecular recognition between the 
two interaction partners (Podgornaia & Laub, 2013).  
Here we report new insights into the molecular mechanisms that ensure insulation and transcriptional 
regulation specificity between two Bce-like systems in B. subtilis, Bce and Psd at the level of 
RR/promoter interaction. Using both in vivo and in vitro approaches, we found out that in addition to 
the previously identified main binding site, a secondary RR-binding site exists in both PbceA and PpsdA. 
We demonstrated that the main binding site, the secondary binding site as well as the linker region in 
between them all contribute to determine RR-specific transcription initiation. 
Results 
Identification of the minimal bceA and psdA promoter motif 
PbceA and PpsdA are the target promoters for BceR and PsdR, respectively (Staroń et al., 2011). When B. 
subtilis is treated with bacitracin, BceR is activated by corresponding HK BceS and binds to a specific 
region of PbceA, resulting in a strong transcriptional upregulation of the operon encoding the ABC 
transporter for resistance (Mascher et al., 2003) (Fig. 4.1). Previous work has already mapped an 
inverted repeat sequence with 4 nt spacing in the PbceA region 
(AAGCgTGTGACgaaaatGTCACAtGCTT) from -111 to -84 upstream of the bceA start codon for 
BceR binding (Ohki et al., 2003). For PpsdA, a highly homologous PsdR binding site 
(ATGTGACAgcatTGTAAGAT) could be identified from -99 to -80 upstream of the psdA start codon 
(Staroń et al., 2011). In agreement with these studies, a putative binding site was identified among 
most bceA-like promoters in Firmicutes bacteria, with an overall consensus sequence TNACA-N4-
TGTAA for BceR-like RRs (Dintner et al., 2011). First, we wanted to verify that these two known 
conserved binding motifs are indeed indispensable for the RR-dependent bceA and psdA promoter 
activity and subsequently identify the minimal regulatory elements for both promoter regions. 
Towards that goal, progressively truncated bceA promoters starting with 5’-position ranging from -111 
to -103 and ending at +82 relative to the ATG start codon of bceA were cloned into pAC6, thereby 
generating transcriptional lacZ reporter fusions (Table 4.2), which were integrated at the amyE locus 
in B. subtilis wild-type (WT) 168 (Table 4.1). Progressively truncated psdA promoter fragments 
starting with 5’-positions ranging from -110 to -95 all ending at position +30 relative to the ATG start 
codon of psdA were constructed in a similar fashion (Fig. 4.2A). The promoter activity of the resulting 
reporter strains was determined by quantitative β-galactosidase assay as described in experimental 
procedure in the presence of bacitracin (Bce system) or nisin (Psd system) (Staroń et al., 2011).  
Truncated bceA promoters from -111 until -106 showed almost WT promoter (using a promoter 
fragment starting at position -122 as a positive control) activity after bacitracin induction (black bars) 
compared to corresponding non-induced samples (white bars) (Fig. 4.2B). Truncations starting at 
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position -105 and position -104 displayed a decreased promoter activity, while a further truncation of 
one additional nucleotide (starting at position -103) led to a complete loss of promoter activity after 
bacitracin induction (Fig. 4.2B). 
 
Figure 4.2. Functional analysis of bceA and psdA promoters of B. subtilis. (A) DNA sequence alignment of 
the bceA promoter and the psdA promoter. Different motifs are framed and annotated underneath the DNA 
sequence. Special positions on each promoter according to the start codon of corresponding regulated gene are 
marked with arrows. Half binding sites of Bce-like RRs on each promoter are emphasized in bold style. 
Activities of (B) truncated constructions of the bceA promoter (from -122: +82 to -103: +82) and (C) truncated 
constructions of the psdA promoter (from -126: +30 to -95: +30) according to the start codon of regulated genes. 
Activities of (D) PbceA mutants and (E) PpsdA mutants with MBS
R
 (main binding site random mutation), L
R
 (linker 
random mutation) and SBS
R
 (secondary binding site random mutation) are compared with the corresponding WT 
promoters. All promoter constructions were fused to lacZ and introduced into amyE locus of B. subtilis 168. 
Cultures growing exponentially in LB were challenged with Zn
2+
-bacitracin 30 µg ml
-1
 (black bars) or nisin 2 µg 
ml
-1
 (grey bars) for 30 min, comparing with the non-induced condition (white bars). β-galactosidase activities are 
expressed in Miller Units (MU) (Miller, 1972) and results are shown as the mean plus standard deviation of three 
biological replicates. A log scale is applied for reasons of clarity. 
Similar results were obtained for truncated psdA promoter fragments after nisin induction (grey bars) 
(Fig. 4.2C). Compared to the WT psdA promoter fragment (starting at position -126), no decrease of 
promoter activity was observed for truncations with 5’-positions starting from - 110 to -100. The 
promoter activities were significantly reduced for fragments chopping at position -99 to -96, while a 
truncation at position -95 completely lost its activity after nisin induction.  
Our data confirms that the 7-4-7 nt binding motif TGTGACGaaaaTGTCACA of PbceA and the 
TGTGACAgcatTGTAAGA binding motif of PpsdA are indeed necessary binding sites (main binding 
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site) for BceR and PsdR. Position -104 relative to bceA start codon and position -96 relative to psdA 
start codon determine the minimal 5’-end of active RR-dependent promoter fragments. Next, we 
addressed the question if there are other binding sites derived from these binding motifs on the 
promoter that are also sufficient for RR-dependent promoter activation. 
A secondary binding site on bceA and psdA promoters 
Sequence analysis of PbceA and PpsdA did not identify a typical -35 region (TTGACA) 17 nt upstream of 
the -10 region as normally recognized by σA (Jarmer et al., 2001). However, a 7 nt conserved half 
binding site located 13/14 nt downstream of the main binding site (MBS) and 38 nt upstream of the -
10 region was predicted for both the bceA and the psdA promoter regions (Dintner et al., 2011). This 
obsession implies the existence of a secondary binding site (SBS) instead of a typical -35 on bceA-like 
promoters. Based on this prediction, we annotated a putative 7-4-7 nt secondary binding site and a 
linker region (L) between the main and the secondary binding sites on both bceA and psdA promoters 
(Fig. 4.2A) and experimentally investigated the function of the predicted promoter motifs by mutating 
each of them into a random sequence (randomization). The GC/AT content of the linker region was 
kept during the randomization. These mutants were cloned into pAC6 generating transcriptional lacZ 
reporter fusions (Table 4.2) and integrated into the chromosome of B. subtilis WT 168 at the amyE 
locus (Table 4.1). The promoter activity was determined as described above. 
Both the WT bceA promoter (Fig. 4.2D) and the psdA promoter (Fig. 4.2E) showed strong induction 
with the corresponding inducers: bacitracin (black bars) or nisin (grey bars), compared to the non-
induced samples (white bars). The weak induction of PpsdA by bacitracin (Fig. 4.2E) was due to the 
known cross-phosphorylation of PsdR by BceS (Rietkötter et al., 2008) (Fig. 4.1 dotted arrow). 
Mutating the main binding site (MBS) into a random sequence led to a complete loss of activity for 
both promoters. The same effect was obtained when randomizing the sequence of the predicted 
secondary binding site (Fig. 4.2D and 4.2E). However, activities of both bceA and psdA promoters 
only showed a slight decrease by randomly mutating the corresponding linker region (L) between the 
two binding sites but keeping the same GC/AT content.  
The data demonstrates that on both PbceA and PpsdA, there is a secondary binding site located 
downstream of the main binding site with a 13/14 nt linker region in between them. This secondary 
binding site seemingly replaced the -35 promoter element, and it is as indispensable as the main 
binding site for RR-dependent promoter activity. Additional assays done by randomizing either the 
first or the second half of each secondary binding site were in consistency with the results obtained 
from the completely randomized secondary binding sites (data not shown), further demonstrating that 
each half binding site has the same importance for PbceA and PpsdA activity. 
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Major specificity determinants are located in the region containing the linker and the secondary 
binding site 
So far, we have identified an extended regulatory region in PbceA and PpsA, consisting of two binding 
sites and a linker region in between. Since there is no cross-regulation at the RR/promoter interface, 
either between BceR-PpsdA or PsdR-PbceA (Rietkötter et al., 2008), further we wanted to analyse the 
specificity determinants within bceA/psdA promoters. Towards that aim, a series of chimeric 
promoters derived from PbceA and PpsdA were constructed (Table 4.2) and fused with lacZ. Chimeric 
promoters BP1-4 are derived from PbceA (black) with gradually substituting PpsdA (grey) at the 3’-
terminal end (Fig. 4.3A). Chimeric promoters PB1-4 are derived from PpsdA (grey) with increasing of 
3’-fragments from PbceA (black) (Fig. 4.3B). Again, these constructs were integrated into the amyE 
locus of the B. subtilis WT 168 (Table 4.1). To specifically eliminate any cross-talk between the Bce 
and Psd systems, these chimeric promoters, WT PbceA and WT PpsdA fragments as references, were 
transformed into the ∆bceRS strain (TMB1460) and the ∆psdRS strain (TMB1462) (Table 4.1). 
Compared to the WT strain, the ∆bceRS and the ∆psdRS strains remove the effect of cross-
phosphorylation and hence provide a clearer view of RR/promoter specificity. 
PbceA showed the same high activity in the ∆psdRS mutant (Fig. 4.3D) as in WT strain (Fig. 4.3C) after 
bacitracin induction, but no activity after nisin induction in either the WT (Fig. 4.3C) or the ∆bceRS 
background (Fig. 4.3E). PpsdA was also highly induced by nisin in both the WT strain (Fig. 4.3C) and 
the ∆bceRS mutant (Fig. 4.3E). Importantly, the moderate induction of PpsdA by bacitracin in WT 
background (Fig. 4.3C) was not detected in ∆psdRS mutant (Fig. 4.3D) due to the elimination of cross-
phosphorylation between BceS and PsdR. These results are in agreement with previous studies that 
there is no cross-regulation at the RR/promoter level.  
Chimeric promoters BP1 and BP2 showed high activity after induction with bacitracin in both the WT 
strain (Fig. 4.3C) and the ∆psdRS strain (Fig. 4.3D), but no activity upon nisin induction in either the 
WT strain (Fig. 4.3C) or the ∆bceRS strain (Fig. 4.3E). Hence, BP2 could be recognized by BceR, but 
not by PsdR. These results indicate that specificity determinants are located within the region 
upstream of and including the secondary binding site. The chimeric promoter BP3, could not be 
induced either by bacitracin in the ∆psdRS background (Fig. 4.3D) or by nisin in the ∆bceRS 
background (Fig. 4.3E). However, it showed moderate activity in the WT background (Fig. 4.3C) after 
induction with bacitracin. Surprisingly, BP4, possessing the whole region downstream of the main 
binding site of PpsdA, was not only moderately induced by bacitracin in the ∆psdRS background (Fig. 
4.3D) but also by nisin in the ∆bceRS background (Fig. 4.3E), indicating a change of specificity from 
PbceA to PpsdA. These results of BP2 and BP4 demonstrate that major specificity determinants of PpsdA 
are located in the region containing the linker and the secondary binding site. 
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Figure 4.3. Functional studies of series of chimeric promoters. Schematic of series of chimeric promoters (A) 
BP1-4, bceA promoter fragments (black) with gradual substitutions of 3’ region by increased corresponding parts 
of psdA promoter (grey), and (B) PB1-4 vice versa are compared with WT PbceA and PpsdA. The MBS and the SBS 
from PbceA and PpsdA are filled the same as in Fig. 4.1. Grey dashed lines indicate the concrete fusion boundaries 
of each chimera. (C to H) Activities of chimeric promoters compared with WT promoters in different genetic 
backgrounds of B. subtilis. Transcriptional lacZ fusions of WT promoters (PbceA and PpsdA) as well as different 
sets of chimeras (BP1-4 and PB1-4) were integrated at amyE locus in B. subtilis WT (W168), ∆psdRS strain 
(TMB1462) and ∆bceRS strain (TMB1460). Promoter activities were measured as described in Fig. 4.2. 
Activities are shown as follows: (C) BP1-4 in WT, (D) BP1-4 in ∆psdRS strain, (E) BP1-4 ∆bceRS strain, (F) 
PB1-4 in WT, (G) PB1-4 in ∆bceRS strain and (H) PB1-4 in ∆psdRS strain. Black bars and grey bars represent 
for samples induced with bacitracin and nisin, while white bars stand for non-induced controls.  
Chapter IV - Wiring specificity of Bce-like systems 
46 
 
Chimeric promoters PB1 and PB2 showed a decreased activity after induction with nisin in both the 
WT background (Fig. 4.3F) and the ∆bceRS mutant (Fig. 4.3G) relative to PpsdA, and no bacitracin 
induction in the ∆psdRS mutant (Fig. 4.3H), indicating no change of specificity. These results 
corroborate that the region downstream of the secondary binding site on PbceA is not relevant for the 
RR/promoter specificity. Interestingly, PB3 showed a significantly decreased activity in the ∆bceRS 
mutant with nisin induction (Fig. 4.3G) and a hugely increased activity in the ∆psdRS mutant with 
bacitracin induction (Fig. 4.3H). It therefore behaved differently from the corresponding BP3 
construct that had no activity in either. Construct PB4 was not inducible by nisin in the ∆bceRS strain 
(Fig. 4.3G), but instead showed high induction by bacitracin in the ∆psdRS strain (Fig. 4.3H). The 
promoter activities of PB3 and PB4 in the WT strain (Fig. 4.3F) were in accordance with those 
observed in both mutant backgrounds. This data indicates that the change of specificity from PpsdA to 
PbceA started at PB3 with the secondary binding site being switched into PbceA, and obtained a further 
promotion in construct PB4 by an additional substitution of the linker region.  
Taken together, the analysis of chimeric promoter constructs demonstrates that the region containing 
the linker and the secondary binding site of PbceA/PpsdA includes major specificity determinants for 
BceR/PsdR recognition. 
Rewiring specificity from PbceA to PpsdA and dissecting the role of specificity determinants on PpsdA 
The analysis of chimeric promoter constructs showed that on the psdA promoter the region 
downstream of the main binding site contained the major specificity determinants for PsdR binding. 
This region contains two motifs: the linker and the secondary binding site. To further elaborate the 
functionality of the main binding site, the linker region and the secondary binding site on psdA 
promoter for PsdR recognition, additional chimeric promoters were constructed with different 
combinations of these three motifs on PbceA replaced by the corresponding region of PpsdA (Fig. 4.4A) to 
rewire specificity from PbceA to PpsdA. Promoter activities were measured as described above in the WT 
strain (Fig. 4.4C), the ∆psdRS strain (Fig. 4.4D) and the ∆bceRS strain (Fig. 4.4E). 
Compared to PbceA, replacing only the main binding site (M), the linker (L) or both (M+L) of PbceA with 
the corresponding region of PpsdA showed decreased promoter activity in the WT strain (Fig. 4.4C) as 
well as in the ∆psdRS mutant (Fig. 4.4D) after induction with bacitracin. In contrast, no increasing of 
the promoter activity was observed in either the WT strain (Fig. 4.4C) or the ∆bceRS mutant (Fig. 
4.4E) after induction by nisin. This data indicates that the main binding site, the linker or both of PpsdA 
are not enough to determine specificity. Changing the secondary binding site (S) on PbceA into PpsdA led 
to a decrease of promoter activity in the WT strain (Fig. 4.4C) as well as in the ∆psdRS mutant (Fig. 
4.4D) after induction with bacitracin, and a slight but detectable increase of promoter activity in the 
∆bceRS mutant (Fig. 4.4E) after induction with nisin. This data indicates that exchanging only the 
secondary binding site alone already conferred a change of promoter specificity from PbceA to PpsdA.  
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Figure 4.4. Unravelling the roles of different promoter elements in RR-promoter specificity. (A and B) 
Schematic of chimeric promoters derived from PbceA and PpsdA with specific regions switched into the 
corresponding part of PpsdA and PbceA, respectively, compared with two WT promoters. Names on the left side of 
each chimeric promoter stand for the exchanging region: M, main binding site; L, linker; S, secondary binding 
site. MBS and SBS from PbceA and PpsdA are filled the same as in Fig. 4.1. Activities of WT and chimeric 
promoters in different genetic backgrounds of B. subtilis are shown as follows: (C) PbceA derived chimeras in WT, 
(D) PbceA derived chimeras in ∆psdRS strain, (E) PbceA derived chimeras in ∆bceRS strain, (F) PpsdA derived 
chimeras in WT, (G) PpsdA derived chimeras in ∆bceRS strain and (H) PpsdA derived chimeras in ∆psdRS strain. 
Black bars and grey bars represent for samples induced with bacitracin and nisin, while white bars stand for non-
induced controls.  
Compared to only the secondary binding site switch (S), exchanging both the main binding site and 
the secondary binding site simultaneously (M+S) resulted in a severe decrease of the promoter activity 
in the ∆psdRS mutant after induction with bacitracin (Fig. 4.4D), while an increase of the promoter 
activity in the ∆bceRS mutant after induction with nisin (Fig. 4.4E). This indicates that based on the 
primary specificity determinant — the secondary binding site — the main binding site assists it to 
achieve a higher promoter activity with the cognate RR, PsdR, and a lower promoter activity with the 
non-cognate RR, BceR. Substitution of the linker together with the secondary binding site (L+S) 
resulted in a higher promoter activity compared to only exchanging the secondary binding site (S) in 
both the ∆psdRS mutant after bacitracin induction (Fig. 4.4D) and the ∆bceRS mutant after nisin 
induction (Fig. 4.4E). This data suggests that the linker region (L) can enhance promoter activity with 
both cognate PsdR and non-cognate BceR.  
Taken together, these results indicate that the secondary binding site on PpsdA mainly determines PsdR-
PpsdA specificity, even though the intensity of induction with secondary binding site substitution alone 
is not very strong. The linker cannot determine specificity by itself but can increase promoter activity 
with both BceR and PsdR, which explains the change of specificity that was detected for construct 
BP4 including the linker and the secondary binding site but not for construct BP3 with only the 
secondary binding site. Despite the fact that the main binding site is absolutely crucial for 
RR/promoter interaction, the main binding site of PpsdA alone cannot determine specificity. Instead, it 
supports the secondary binding site in strengthening specificity. Not surprisingly, switching all three 
elements together (M+L+S) resulted in the highest change of specificity in the ∆bceRS mutant after 
induction with nisin (Fig. 4.4E), demonstrating that all three parts together contribute to the specificity. 
Rewiring specificity from PpsdA to PbceA and dissecting the role of specificity determinants on PbceA 
In order to support the results obtained above, a similar approach was performed towards rewiring the 
specificity from PpsdA to PbceA. In contrast to the results obtained for the series of PB chimeras (change 
of specificity from PpsdA to PbceA started with PB3), the change of specificity from PbceA to PpsdA started 
later with construct BP4. This may indicate a subtle difference in the BceR-PbceA specificity 
determination compared to PsdR-PpsdA. To answer this question, chimeric promoters with different 
combinations of the main binding site, the linker region and the secondary binding site of PpsdA being 
replaced by the corresponding regions of PbceA were constructed (Fig. 4.4B) (Table 4.2) and the 
Chapter IV - Wiring specificity of Bce-like systems 
49 
 
promoter activities of the corresponding B. subtilis reporter strains (Table 4.1) were determined as 
described above. 
Replacing the secondary binding site (S) of PpsdA with the corresponding region from PbceA resulted in a 
dramatic drop of promoter activity in the ∆bceRS mutant after induction with nisin (Fig. 4.4G), and a 
huge increase of promoter activity in the ∆psdRS mutant after induction with bacitracin (Fig. 4.4H). 
Switching the main binding site (M) of PpsdA to PbceA also led to a decrease of promoter activity in the 
∆bceRS mutant after nisin induction (Fig. 4.4G) and an increase of promoter activity in the ∆psdRS 
mutant after bacitracin induction (Fig. 4.4H), but the effect was much weaker than that of the 
secondary binding site substitution. Replacing the linker (L) of PpsdA by the linker of PbceA resulted in 
decreased promoter activity in the ∆bceRS mutant after nisin induction (Fig. 4.4G) but no change of 
promoter activity in the ∆psdRS mutant after bacitracin induction (Fig. 4.4H). Together, these results 
illustrate that for PbceA, the secondary binding site is the main determinant of BceR-PbceA specificity, 
while the main binding site also contributes to a small extent. A combined exchange of the main 
binding site together with the secondary binding site (M+S) resulted in a further enhancement of 
promoter activity in the ∆psdRS mutant after bacitracin induction (Fig. 4.4H) and a complete loss of 
promoter activity after nisin induction in the ∆bceRS mutant (Fig. 4.4G). This data further suggests 
that the main binding site and the secondary binding site work together to determine BceR-PbceA 
specificity.  
Compared to only the secondary binding site switch (S), changing the linker and the secondary 
binding site together (L+S) of PpsdA into the corresponding region of PbceA decreased the promoter 
activity in both the ∆bceRS mutant after nisin induction (Fig. 4.4G) and the ∆psdRS mutant after 
bacitracin induction (Fig. 4.4H). This result is in consistency with the analysis of series PB chimeras 
that construct PB4 including the linker and the secondary binding site had lower promoter activity 
compared with construct PB3 including only the secondary binding site. Our data indicates that the 
linker region of PbceA can decrease the promoter activity with both the cognate BceR and the non-
cognate PsdR.  
Taken together, we demonstrated that determining the specificity for PbceA seems to slightly differ from 
PpsdA. Both the secondary binding site and the main binding site of PbceA have stronger effect to BceR-
PbceA specificity than these of PpsdA. Furthermore, the linker region of PbceA decreases promoter activity 
with both RRs, which is different from the linker region of PpsdA that increases the promoter activity 
with both RRs. Both promoters have in common, that the secondary binding sites mainly determine 
RR-promoter specificity, and the main binding sites strengthen the specificity by increasing the 
interactions with the cognate RR while simultaneously reducing the interactions with the non-cognate 
RR. 
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In vitro, BceR has a higher binding affinity for its native PbceA than for PpsdA 
Promoter activity assays demonstrated that PpsdA had no activity upon bacitracin induction in the 
∆psdRS mutant (Fig. 4.3D), which indicates that there is no cross-regulation between BceR and PpsdA in 
vivo. Next, we wanted to investigate if the binding of BceR is also specific to its native promoter PbceA 
in vitro. BceR carrying an N-terminal His10-tag with the expected molecular mass around 27 KDa was 
produced and purified from the cytoplasmic fraction of E. coli C43 (DE3) containing plasmid pCF120 
(Table 4.2), which was in consistent with its observed migration in SDS-PAGE. EMSAs were 
performed with this BceR and two bceA-like promoters PbceA and PpsdA. 300 bp promoter DNA 
fragments of PbceA or PpsdA containing the main binding site, the linker region and the secondary 
binding site were amplified and labeled at the 5’-end with 6FAM by PCR. 6FAM labeled PsigW (the 
target promoter of an ECF sigma factor in B. subtilis) was used as a negative control.  
Results of band shift assays with BceR and PbceA are shown in Figure 4.5A. Increasing concentrations 
of phosphorylated BceR (BceR-P) were incubated with 30 fmol of 6FAM-PbceA (from lane 2 to lane 5), 
demonstrating a concentration-dependent binding of BceR-P to PbceA. The first shift was observed at 
1.0 µM BceR-P representing the initial binding event of BceR-P to PbceA. An additional shift occurred 
at slightly higher BceR-P concentrations presumably represents a second binding event. In contrast, 
unphosphorylated BceR performed much weaker binding (data not shown), which demonstrated that 
RR-phosphorylation is necessary and seems to promote DNA binding by increasing BceR affinity to 
PbceA.  
 
 
 
 
 
 
 
 
 
Figure 4.5. In vitro binding of BceR-P to bceA-like promoters. Increasing concentrations of phosphorylated 
10×His-BceR were incubated with 30 fmol of different 6FAM-labeled promoter DNA fragments as follows: (A) 
PbceA from -122 to +82, (B) PpsdA from -126 to +30, (C) PbceA SBS
R
 (secondary binding site inactivated), (D) PbceA 
MBS
R
 (main binding site inactivated), and (E) PsigW as a negative control. Schematics of bceA-like promoters and 
corresponding mutants are shown in the lower left corner of each gel. The concentrations of phosphorylated 
BceR are indicated above the gel by [BceR-P] in μM. 900 fmol of unlabelled competitor (comp.) DNA 
fragments encoding PbceA, PpsdA and PsigW were added to gel (A) and (B) in lane 6, 7 and 8, respectively. 
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EMSAs were also performed between BceR-P and PpsdA (Fig. 4.5B). Two successive shifts of PpsdA 
band in lane 3 and lane 4 compared to free PpsdA DNA fragment (lane 1) demonstrated that BceR-P can 
also bind successively to the non-cognate but highly related PpsdA in vitro. In contrast, no shift was 
observed for the PsigW DNA fragment (Fig. 4.5E), confirming the overall specificity of the assay: 
BceR-P cannot bind to promoter fragments that do not harbor the binding motifs of a PbceA-like 
promoter.  
To further illustrate the specificity and affinities of BceR-P binding to PbceA and PpsdA, 900 fmol of 
unlabeled promoter fragments were used as competitor DNA (Fig. 4.5A/4.5B lane 6-8). Co-incubation 
of BceR-P with 30 fmol 6FAM-PbceA and 900 fmol unlabeled PbceA fragment (Fig. 4.5A lane 6) 
completely abolished the retardation of the labeled PbceA fragment due to the competitive binding of 
BceR-P to an excess of unlabeled PbceA. However, the shift of 6FAM-PbceA band was not influenced by 
adding a 30-fold amount of unlabeled PpsdA (Fig. 4.5A lane 7) or PsigW (Fig. 4.5A lane 8), 
demonstrating a much higher affinity of BceR-P for its cognate target promoter. In contrast, the 
retardation of the 6FAM-PpsdA DNA fragment was abolished by either addition of an extra 30-fold 
unlabeled PbceA (Fig. 4.5B lane 6) or unlabeled PpsdA (Fig. 4.5B lane 7) fragments but not by PsigW (Fig. 
4.5B lane 8).  These results clearly demonstrate that BceR-P has a higher binding affinity for PbceA and 
preferentially binds to its native promoter compared to PpsdA in vitro. 
Taken together, our results strongly suggest that phosphorylated BceR undergoes two successive 
binding reactions with both PbceA and PpsdA in vitro. However, the binding affinity for its cognate target 
promoter PbceA is much higher than for PpsdA that determines the in vivo specific transcription initiation. 
Unfortunately, any affects to purify PsdR failed, thereby preventing the performance of similar in vitro 
studies on PsdR-PpsdA/PbceA interactions. 
Cooperative binding of BceR to two binding sites on PbceA  
The in vivo promoter activity assays demonstrated that both binding sites on PbceA are indispensable for 
BceR-PbceA interaction (Fig. 4.2D). Moreover, EMSA on complete promoter fragment strongly 
suggests BceR has two successive binding events at PbceA in vitro (Fig. 4.5A). To discriminate between 
the individual binding reactions, we next performed EMSAs with BceR-P on 6FAM labeled bceA 
promoter DNA-fragments carrying random mutation of either the main binding site or the secondary 
binding site.  
Incubation of BceR-P with labeled PbceA SBS
R
 (PbceA containing a randomized and hence inactive 
secondary binding site) obtained only a single shift at a BceR-P concentration of 1.0 µM (Fig. 4.5C), a 
concentration comparable to the threshold concentration as the intact PbceA fragment (Fig. 4.5A lane 3). 
Increasing the BceR-P concentration did not lead to any additional shift. Hence, PbceA containing only 
the main binding site merely allows the first binding event that is the binding of BceR-P to the main 
binding site. The identical BceR-P concentrations required for shifting either the WT or the SBS
R
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fragments indicates that binding of BceR-P to the main binding site is independent from the secondary 
binding site. 
Incubation of BceR-P with labeled PbceA MBS
R
 (PbceA containing a randomized and hence inactive 
main binding site) basically failed to retard the DNA-fragment within the same concentration range 
(Fig. 4.5D). Hence, a non-functional main binding site prevents both binding events of BceR-P to 
PbceA. This result indicates that the second binding event, which requires the secondary binding site, 
depends on and occurs after BceR-P binding to the main binding site.  
Together, these results demonstrate that the two binding sites contribute in a successive manner to the 
BceR-PbceA interaction and imply a cooperative binding model of BceR to the two binding sites of 
PbceA. BceR first binds to the main binding site independently, which then supports the subsequent 
binding to the secondary binding site. In order to challenge this hypothesis we finally analyzed the 
binding affinities of BceR-P on PbceA/PpsdA by surface plasmon resonance (SPR) spectroscopy. 
Determination of binding kinetics of BceR-promoter interaction unravels the mechanism that 
determines BceR promoter specificity 
To quantify the binding kinetics of the BceR-promoter interaction we used SPR analysis. As first step 
we captured a biotin-labeled DNA-fragment comprising the PbceA region to a sensor chip previously 
immobilized with streptavidin. Then, increasing concentrations of His10-BceR and His10-BceR 
previously phosphorylated using phosphoramidate (BceR-P) were injected over the chip surface. It can 
be clearly seen that non-phosphorylated BceR does not interact with the PbceA promoter (Fig. 4.6A), 
whereas BceR-P showed clear binding (Fig. 4.6B). Since BceR has two binding sites on the DNA-
fragment used for SPR, we used the OneToTwo evaluation algorithm. The binding kinetics underlying 
this sensorgram could be determined revealing that these two binding events mainly differ in their 
association rates (ka1=7.46x10
4
 M*s; ka2=1.58x10
6
 M*s) rather than the dissociation rates 
(kd1=5.57x10
-4
/s; kd2=8.05x10
-4
/s) resulting in two binding events that differ in their overall affinity 
(KD1=7.47 nM; KD2=0.51 nM). As next step, we determined the binding kinetics between BceR-P and 
PbceA when the main binding site (MBS
R
) or the secondary binding site (SBS
R
) was destroyed, 
respectively. It can be clearly seen that inactivation of the main binding site completely prevented 
DNA-binding of BceR-P (Fig. 4.6C). However, when only the secondary binding site was destroyed, a 
clear DNA-binding of BceR could be observed (Fig. 4.6D). In contrast to the sensorgram when both 
binding sites are intact (Fig. 4.6B), the sensorgram here follows a real 1:1 binding kinetic that we 
quantified with an association rate of ka=6.59 x 10
5
 M*s and a dissociation rate kd=9.5x10
-4
/s making 
an overall binding affinity of KD=1.4 nM. Furthermore, we observed that the overall response units 
were reduced approximately 1/3 compared to the sensorgram representing the BceR-P/PbceA, which 
probably represents the portion of BceR-P binding to the secondary binding site. Our data clearly 
shows that the main binding site of PbceA region is essential for binding of the RR to the DNA. The RR 
obviously cannot bind the secondary binding site when the main binding site was not previously 
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occupied. Comparing the binding kinetics of BceR-P to the intact PbceA and the secondary binding site 
mutant, it can be assumed that the secondary binding site increases the overall affinity of the RR to the 
promoter region, and therefore is important for triggering gene expression.  
 
 
 
 
 
Figure 4.6. Surface plasmon resonance spectroscopy of BceR-P binding within the PbceA and PpsdA region. 
(A) BceR binding to PbceA, (B) BceR-P binding to PbceA, (C) BceR-P binding to PbceA MBS
R
 (main binding site 
inactivated), (D) BceR-P binding to PbceA SBS
R
 (second binding site inactivated), and (E) BceR-P binding to 
PpsdA. 0.2 nM (red line), 0.5 nM (brown line), 1 nM (dark blue line), 2.5 nM (magenta line), 5 nM (green line), 
7.5 nM (lime green line), and 10 nM (blue line), respectively, of each of purified BceR or BceR-P was passed 
over the chip. The figures represent each one characteristic of three independently performed experiments. 
In addition, we wanted to compare the binding of BceR-P to PbceA with PpsdA. Therefore, we captured 
DNA comprising the PpsdA promoter onto the chip, and then injected increasing concentrations of 
BceR-P. We observed that the sensorgram representing the interaction of BceR-P to PpsdA did not 
represent a typical 1:1 interaction due to the non-linear decrease of the dissociation curve (Fig. 4.6E). 
Compared to the PbceA promoter, the interaction of Bce-R to PpsdA was weaker. Our data clearly shows 
that the binding mechanism of BceR-P to PpsdA is comparable to that of BceR-P to PbceA, albeit the 
overall affinities of the two binding sites are lower. 
Discussion 
In this report, we have comprehensively investigated the mechanism that dictates Bce-like RR 
specifically regulating the transcription of its target bceAB-like operon by genetic and biochemical 
approaches. We found out determinants on the promoter of two bceAB-like operons — PbceA and PpsdA 
— for BceR and PsdR specific binding, respectively. Furthermore, we successfully rewired the 
transcriptional regulation between these two systems by exchanging these specificity determinants.  
Three extremely important findings were obtained in the process of understanding the specificity 
determining mechanism. First, we for the first time demonstrated that on PbceA/PpsdA there are two Bce-
like RR binding sites: an upstream main binding site and a downstream secondary binding site joined 
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together by a flexible linker region (Fig. 4.2D and 4.2E). Second, the secondary binding sites on both 
PbceA and PpsdA primarily dictate RR-promoter specificity. However, the secondary binding site by itself 
is not enough to fully dictate specificity. Together with the high affinity main binding site and the 
linker region, they are able to completely mediate RR-promoter specificity (Fig. 4.4). Third, we were 
able to demonstrate that BceR has two-step binding event on PbceA. By separating the binding, we 
demonstrated that BceR can bind to the main binding site independently with high affinity, which 
assists and stabilizes the binding to the low affinity secondary binding site (Fig. 4.5 and 4.6).  
Taken together, our findings strongly suggest that BceR has a hierarchical and cooperative binding 
model to these two binding sites on PbceA. A BceR dimer first binds tightly to the main binding site 
with low specificity, which favors and stabilizes the binding of a second BceR dimer to the secondary 
binding site specifically. The linker regions of PbceA and PpsdA with different AT/GC contents may play 
a role in maintaining different distances and/or angles of the two binding sites, and hence adjust the 
promoter activity. The overall binding affinity of BceR to its cognate promoter PbceA, as a combined 
effect of all three promoter motifs – the main binding site, the linker, and the secondary binding site, is 
much higher than to the non-cognate promoter, which is an intrinsic ability to discriminate the cognate 
promoter from the pool of similar non-cognate ones in a bacterial cell. RR determines the specific 
transcription initiation, most likely by direct interaction with the RNA polymerase so that recruits the 
polymerase to the promoter. The cooperative binding mechanism has already been confirmed by PhoB 
binding to the target pstS promoter containing double pho boxes (Blanco et al., 2012). EMSAs showed 
that two PhoB
E
 dimers bind to two consecutive pho boxes in a hierarchical and cooperative manner, 
which is at low concentration PhoB
E
 dimer first binds to the high-affinity pho box 1 and with 
increasing concentration the first binding assists the subsequent dimer bind to the downstream low-
affinity pho box 2.  
RR-promoter specificity is mainly determined by molecular recognition on the interaction surfaces 
between amino acids on the RR and bases on the promoter (Rohs et al., 2010). Most of studies about 
RR-promoter specificity focused on searching for amino acids on the DNA binding domain of RRs 
that can specifically recognize their cognate promoters. Structures of PhoB and OmpR C-terminal 
DNA binding domain indicated that these amino acids are located on the C-terminal helix α3 
(interaction with the DNA major groove) and the loop of the C-terminal hairpin (interaction with the 
DNA minor groove) (Martínez-Hackert & Stock, 1997, Blanco et al., 2002, Rhee et al., 2008). A 
previous study showed that a single amino acid, which is Glu215 on the α3 helix of Mycobacterium 
tuberculosis PhoP, is an important residue that significantly contributes to specific DNA binding site 
recognition. By mutating Glu215 into Ala, PhoP lost the ability to discriminate the specific binding 
site from the nonspecific DNA with sequence comparable compositions (Das et al., 2010). Similar 
studies about RRs FNR and CRP in E. coli further showed that exchanging Arg180 and Gly184 on the 
recognition-helix of CRP into Val and Ser of FNP was able to convert the binding specificity (Bell et 
al., 1989, Spiro et al., 1990). These two amino acids can specifically recognize bases (G at position 5 
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and C at position 8) on CRP binding site, and discriminate bases T and A on FNR binding site. Instead 
of searching for amino acids on the DNA binding domain of the RR, our study focused on the target 
promoters of Bce-like RRs and demonstrated that promoter specificity is determined by three 
promoter motifs together. The mechanism is different from previous studies that two bases on one 
binding site can determine RR-promoter specificity. This is probably due to that the DNA recognition 
motifs, the α3 helix and the loop of the C-terminal hairpin, are highly similar between BceR and PsdR. 
With only one promoter motif, it is hard to maintain the specificity and the high activity 
simultaneously. To solve this problem, B. subtilis developed a complicated regulatory region on the 
target promoter of the Bce-like RR, which contains a main binding site determines the binding affinity, 
a secondary binding site determines the binding specificity and a linker region ensures the structure of 
the promoter that contribute differently to maintain the RR-promoter specificity.  
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Experimental procedures 
Bacterial strains and growth conditions 
All strains used in this study are listed in Table 4.1. E. coli DH5α and XL1-blue were used for cloning. All B. 
subtilis strains used in this study are derivatives of the laboratory WT strain 168. E. coli and B. subtilis were 
grown routinely in Luria-Bertani (LB) medium at 37°C with aeration. B. subtilis was transformed by natural 
competence as previously described (Harwood & Cutting, 1990). Ampicillin (100 µg ml
-1
) was used for 
selection of all plasmids in E. coli. Chloramphenicol (5 µg ml
-1
), spectinomycin (100 µg ml
-1
), and erythromycin 
(1 µg ml
-1
) plus lincomycin (25 µg ml
-1
) for macrolide-lincosamide-streptogramin B (mls) resistance were used 
for the selection of B. subtilis mutants. Bacitracin was supplied as the Zn
2+
-salt. Growth was measured as optical 
density at 600 nm wavelength (OD600). Solid media contained 1.5 % (w/v) agar. 
Construction of plasmids and genetic techniques 
All plasmid constructs in this study are listed in Table 4.2. The corresponding primer sequences are provided in 
the supplemental material (Table S4.1). Different promoter fragments derived from PbceA and PpsdA were fused to 
lacZ and cloned into the vector pAC6 (Stülke et al., 1997) with EcoRI/BamHI sites. The details of promoter 
constructs are given in Table 4.2. For construction of the BceR-production plasmid in E. coli, bceR was 
amplified with primers TM2007/2008 and cloned into vector pET16b with XhoI and BamHI obtaining pCF120, 
resulting in an N-terminal His10-tag fusion. Constructs for unmarked gene deletion in B. subtilis were cloned into 
the vector pMAD (Arnaud et al., 2004). For each operon to be deleted, 800-1000 bp fragments located 
immediately before the start codon of the first gene (“up” fragment) and after the stop codon of the last gene 
(“down” fragment) were amplified. The primers were designed to create a 17-20 bp overlap between the PCR-
products (Table 4.2), facilitating fusion of the fragments by PCR overlap extension and subsequent cloning into 
pMAD. Gene deletions were performed as previously described (Arnaud et al., 2004). All constructs were 
checked by sequencing, and all B. subtilis strains created were verified by colony PCR using appropriate primers.  
β-galactosidase assays 
Assays on promoter activities were performed as described previously (Mascher et al., 2004). In brief, cells were 
inoculated from fresh overnight cultures and grown in LB medium at 37°C with aeration until they reached an 
OD600 between 0.4 and 0.5. The cultures were split into 2 mL aliquots and challenged with 30 µg ml
-1
 bacitracin 
or 2 µg ml
-1
 nisin with one aliquot left untreated (non-induced control). After incubation for an additional 30 min 
at 37°C with aeration, the cultures were harvested and the cell pellets were frozen at -20°C. The β-galactosidase 
activities were determined as described, with normalization to cell density (Miller, 1972). 
Expression and purification of His-tagged BceR  
To produce BceR carrying an N-terminal His10-tag, E. coli C43 (DE3) cells harboring plasmid pCF120 were 
grown at 25 °C with agitation until they reached an OD600 of about 0.4. 0.5 mM of IPTG was added to the 
culture and incubation was continued at 18 °C with agitation overnight. Cells were harvested by centrifugation at 
4,400 × g for 10 min. The cell pellet was washed with buffer A (20 mM KPi [pH7.5], 100 mM NaCl) and stored 
at -20 °C until use.  
To purify His10-tagged BceR, cells were resuspended in buffer B (50 mM KPi [pH 7.5], 500 mM NaCl, 5 mM β-
ME, 10 mM imidazole and 10 % (w/v) glycerol) supplemented with 0.1 mM phenylmethylsulfonyl fluoride 
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(PMSF) plus 2 mg DNaseI and disrupted by three passages through a French pressure cell (Thermo Fisher) at 
20,000 PSI. Unbroken cells were removed by centrifugation at 17,000 × g for 20 min and the cell-free 
supernatant was filtered through a 0.45 µm syringe filter before loading onto a 1 ml Ni
2+
-NTA resin column 
(Qiagen) pre-equilibrated with 5 column volumes (CVs) of buffer B. Loading was followed by washing with 5 
CVs of buffer B and then with 5 CVs of buffer B containing 100 mM imidazole. BceR was eluted with buffer B 
supplemented with 250 mM imidazole. Fractions containing BceR were pooled and dialyzed in buffer C (50 mM 
Tris-HCl [pH 7.5], 150 mM NaCl, 10 mM MgSO4, 5 mM β-ME, 5 mM imidazole and 10 % (w/v) glycerol) 
using dialysis membrane (neo Lab) at room temperature for 1 h. Protein concentration was determined with 
Roti®-Nanoquant (Carl Roth), and the protein were stored at 4 °C. 
Electrophoretic Mobility Shift Assays (EMSA) 
For electrophoretic mobility shift assays, different DNA fragments (around 300bp) generated by PCR using 
primers TM3146 (5’ terminal 6FAM labeled) and TM3137 were purified by gel extraction. Unlabeled DNA 
fragments were generated by PCR using primers TM3136/TM3137 and purified by HiYield® Gel/PCR DNA 
Extraction Kit (SLG®). N-terminal His10-BceR samples in the non-phosphorylated state and after 
phosphorylation by 50 mM phosphoramidate (PA) at room temperature for 2 h were centrifuged down by 16,060 
× g at 4 °C for 10 min to remove the aggregated protein. Protein concentrations of the supernatants were 
determined with Roti®-Nanoquant (Carl Roth) and the proteins were stored on ice. Binding reactions were set 
by incubating 6FAM-labelled DNA-fragments with different concentrations of His10-BceR at room temperature 
for 20 min. The reaction mixture included 30 fmol labeled target DNA and 0, 0.5, 1.0, 1.5, 2.0 µM protein with 
binding buffer (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgSO4, 1 mM DTT, 5 µg ml
-1
 salmon sperm 
DNA and 4 % (w/v) glycerol) in a total volume of 5.5 µl. Unlabeled competitor DNA was added to the system to 
a final concentration of 900 fmol. Samples were loaded on a 6% native polyacrylamide gel and electrophoresis 
was performed by 300 Volt for 15 min in TBE buffer. Gels were detected by PhosphorImager (Typhoon Trio™, 
GE Healthcare). 
Surface Plasmon Resonance (SPR) spectroscopy 
SPR assays were performed in a Biacore T200 using carboxymethyl dextran sensor chips pre-coated with 
streptavidin (Xantec SAD500-L, XanTec Bioanalytics GmbH, Düsseldorf, Germany). All experiments were 
carried out at a constant temperature of 25°C and using HBS-EP buffer [10 mM HEPES pH 7.4; 150 mM NaCl; 
3 mM EDTA; 0.005 % (v/v) detergent P20] as running buffer. Before immobilizing the DNA fragments, the 
chips were equilibrated by three injections using 1 M NaCl/50 mM NaOH at a flow rate of 10 µl min
-1
. Then, 10 
nM of the respective double-stranded biotinylated DNA fragment was injected using a contact time of 420 sec 
and a flow rate of 10 µl min
-1
. As a final wash step, 1 M NaCl/50 mM NaOH/50% (v/v) isopropanol was 
injected. Approximately 100-200 RU of each respective DNA fragment were captured onto the respective flow 
cell. All interaction kinetics of BceR or BceR-P with the respective DNA fragment were performed in HBS-EP 
buffer at 25°C at a flow rate of 30 µl min
-1
. The proteins were diluted in HBS-EP buffer and passed over all flow 
cells in different concentrations (0.1 nM-10 nM) using a contact time of 180 sec followed by a 300 sec 
dissociation time before the next cycle started. After each cycle the surface was regenerated by injection of 2.5 
M NaCl for 30 sec at 60 µl min
-1
 flow rate followed by a second regeneration step by injection of 0.5% (w/v) 
SDS for 30 sec at 60 µl min
-1
. All experiments were performed at 25°C. Sensorgrams were recorded using the 
Biacore T200 Control software 1.0 and analyzed with the Biacore T200 Evaluation software 1.0. OneToTwo 
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evaluation of the sensorgrams was performed with TraceDrawer software 1.5 (Ridgeview Instruments AB, 
Uppsala, Sweden). The surface of flow cell 1 was not immobilized with DNA and used to obtain blank 
sensorgrams for subtraction of bulk refractive index background. The referenced sensorgrams were normalized 
to a baseline of 0. Peaks in the sensorgrams at the beginning and the end of the injection emerged from the 
runtime difference between the flow cells of each chip. 
Calibration-free concentration analysis (CFCA) was performed using a 5 µM solution of purified BceR-P 
(calculated from Lowry-based protein determination), which was stepwise diluted 1:2, 1:5, 1:10, and 1:20. Each 
protein dilution was two-time injected, one at 5 µl min
-1
 as well as 100 µl min
-1
 flow rate. On the active flow cell 
PpsdA-DNA was used for BceR-P-binding. CFCA basically relies on mass transport, which is a diffusion 
phenomenon that describes the movement of molecules between the solution and the surface. The CFCA 
therefore relies on the measurement of the observed binding rate during sample injection under partially or 
complete mass transport limited conditions. Overall, the initial binding rate (dR/dt) is measured at two different 
flow rates dependent on the diffusion constant of the protein. The diffusion coefficient of BceR-P was calculated 
using the Biacore diffusion constant calculator and converter webtool 
(https://www.biacore.com/lifesciences/Application_Support/online_support/Diffusion_Coefficient_Calculator/in
dex.html), whereby a globular shape of the protein was assumed. The diffusion coefficient of BceR-P was 
determined as D=1.031x10
-10
 m
2
/s. The initial rates of those dilutions that differed in a factor of at least 1.5 were 
considered for the calculation of the „active“ concentration, which was determined as 5x10-8M (1% of the total 
protein concentration) for BceR-P. The „active“ protein concentration was then used for calculation of the 
binding kinetic constants. 
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Tables 
Table 4.1. Bacterial strains used in this study. 
Strain Genotype or characteristic(s)
a 
Reference or source  
E. coli strains   
DH5α recA1 endA1 gyrA96 thi-1 hsdR17 (rK
-
 mK
+
) relA1 glnV44 
Φ80’ ∆lacZ ∆M15 ∆(lacZYA-argF)U169 
(Grant et al., 1990) 
XL1-Blue endA1 gyrA96 (nal
R
) thi-1 recA1 relA1 lac supE44 [F’ 
proAB
+
 lacI
q
 Δ(lacZ)M15] hsdR17(rK
-
 mK
+
) 
Stratagene 
 
C43 (DE3) F
–
 ompT gal dcm hsdSB (rB
-
 mB
-
)(DE3) (Miroux & Walker, 1996) 
B. subtilis strains   
W168 Wild type, trpC2 Laboratory stock 
TMB279 W168 amyE::pER603; cm
r
 (Rietkötter et al., 2008) 
TMB299 W168 amyE::pER605; cm
r
 (Rietkötter et al., 2008) 
TMB412 W168 amyE::pCF601; cm
r
 This study 
TMB607 W168 amyE::pJS605; cm
r
 This study 
TMB805 W168 amyE::pAS601; cm
r
 This study 
TMB806 W168 amyE::pAS602; cm
r
 This study 
TMB960 W168 amyE::pAS603; cm
r
 This study 
TMB961 W168 amyE::pAS604; cm
r
 This study 
TMB962 W168 amyE::pAS605; cm
r
 This study 
TMB963 W168 amyE::pAS606; cm
r
 This study 
TMB964 W168 amyE::pAS607; cm
r
 This study 
TMB965 W168 amyE::pAS608; cm
r
 This study 
TMB966 W168 amyE::pAS609; cm
r
 This study 
TMB967 W168 amyE::pAS610; cm
r
 This study 
TMB1047 W168 amyE::pAS613; cm
r
 This study 
TMB1048 W168 amyE::pAS614; cm
r
 This study 
TMB1049 W168 amyE::pAS615; cm
r
 This study 
TMB1050 W168 amyE::pAS616; cm
r
 This study 
TMB1051 W168 amyE::pAS617; cm
r
 This study 
TMB1052 W168 amyE::pAS618; cm
r
 This study 
TMB1053 W168 amyE::pAS619; cm
r
 This study 
TMB1054 W168 amyE::pAS620; cm
r
 This study 
TMB1460 W168 with unmarked deletions of the bceRS loci This study 
TMB1462 W168 with unmarked deletions of the psdRS loci This study 
TMB2244 W168 amyE::pMG600; cm
r
 This study 
TMB2245 W168 amyE::pMG601; cm
r
 This study 
TMB2247 W168 amyE::pMG603; cm
r
 This study 
TMB2248 W168 amyE::pMG604; cm
r
 This study 
TMB2249 W168 amyE::pMG605; cm
r
 This study 
TMB2250 W168 amyE::pMG606; cm
r
 This study 
TMB2252 W168 amyE::pMG608; cm
r
 This study 
TMB2253 W168 amyE::pMG609; cm
r
 This study 
TMB2303 TMB1462 amyE::pER603; cm
r
 This study 
TMB2304 TMB1462 amyE::pCF601; cm
r
 This study 
TMB2307 TMB1460 amyE::pER603; cm
r
 This study 
TMB2308 TMB1460 amyE::pCF601; cm
r
 This study 
TMB2382 TMB1460 amyE::pMG600; cm
r
 This study 
TMB2383 TMB1460 amyE::pMG601; cm
r
 This study 
TMB2385 TMB1460 amyE::pMG603; cm
r
 This study 
TMB2386 TMB1460 amyE::pMG604; cm
r
 This study 
TMB2387 TMB1462 amyE::pMG600; cm
r
 This study 
TMB2388 TMB1462 amyE::pMG601; cm
r
 This study 
TMB2390 TMB1462 amyE::pMG603; cm
r
 This study 
TMB2391 TMB1462 amyE::pMG604; cm
r
 This study 
TMB2392 TMB1460 amyE::pMG605; cm
r
 This study 
TMB2393 TMB1460 amyE::pMG606; cm
r
 This study 
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TMB2395 TMB1460 amyE::pMG608; cm
r
 This study 
TMB2396 TMB1460 amyE::pMG609; cm
r
 This study 
TMB2397 TMB1462 amyE::pMG606; cm
r
 This study 
TMB2399 TMB1462 amyE::pMG608; cm
r
 This study 
TMB2400 TMB1462 amyE::pMG609; cm
r
 This study 
TMB2455 W168 amyE::pMG612; cm
r
 This study 
TMB2456 W168 amyE::pMG613; cm
r
 This study 
TMB2457 W168 amyE::pMG614; cm
r
 This study 
TMB2460 W168 amyE::pMG617; cm
r
 This study 
TMB2461 W168 amyE::pMG618; cm
r
 This study 
TMB2462 W168 amyE::pMG619; cm
r
 This study 
TMB2463 TMB1462 amyE::pMG614; cm
r
 This study 
TMB2464 TMB1460 amyE::pMG614; cm
r
 This study 
TMB2465 TMB1462 amyE::pMG613; cm
r
 This study 
TMB2466 TMB1460 amyE::pMG613; cm
r
 This study 
TMB2467 TMB1462 amyE::pMG619; cm
r
 This study 
TMB2468 TMB1460 amyE::pMG619; cm
r
 This study 
TMB2469 TMB1462 amyE::pMG618; cm
r
 This study 
TMB2470 TMB1460 amyE::pMG618; cm
r
 This study 
TMB2475 TMB1462 amyE::pMG605; cm
r
 This study 
TMB2505 W168 amyE::pCF608; cm
r
 This study 
TMB2506 W168 amyE::pCF609; cm
r
 This study 
TMB2507 W168 amyE::pCF610; cm
r
 This study 
TMB2508 W168 amyE::pCF611; cm
r
 This study 
TMB2509 W168 amyE::pMG621; cm
r
 This study 
TMB2510 TMB1460 amyE::pMG621; cm
r
 This study 
TMB2511 TMB1462 amyE::pMG621; cm
r
 This study 
TMB2512 W168 amyE::pMG622; cm
r
 This study 
TMB2513 TMB1460 amyE::pMG622; cm
r
 This study 
TMB2514 TMB1462 amyE::pMG622; cm
r
 This study 
TMB2515 W168 amyE::pCF612; cm
r
 This study 
TMB2516 TMB1460 amyE::pCF612; cm
r
 This study 
TMB2517 TMB1462 amyE::pCF612; cm
r
 This study 
TMB2518 W168 amyE::pCF613; cm
r
 This study 
TMB2519 TMB1460 amyE::pCF613; cm
r
 This study 
TMB2520 TMB1462 amyE::pCF613; cm
r
 This study 
TMB2536 W168 amyE::pCF614; cm
r
 This study 
TMB2537 TMB1460 amyE::pCF614; cm
r
 This study 
TMB2538 TMB1462 amyE::pCF614; cm
r
 This study 
TMB2539 W168 amyE::pCF615; cm
r
 This study 
TMB2540 TMB1460 amyE::pCF615; cm
r
 This study 
  TMB2541 TMB1462 amyE::pCF615; cm
r
 This study 
  TMB2631 W168 amyE::pCF616 This study 
  TMB2632 TMB1460 amyE::pCF616 This study 
  TMB2633 TMB1462 amyE::pCF616 This study 
  TMB2637 W168 amyE::pCF618 This study 
  TMB2638 TMB1460 amyE::pCF618 This study 
  TMB2639 TMB1462 amyE::pCF618 This study 
TMB2640 W168 amyE::pCF619; cm
r
 This study 
TMB2641 TMB1460 amyE::pCF619; cm
r
 This study 
TMB2642 TMB1462 amyE::pCF619; cm
r
 This study 
TMB2643 W168 amyE::pCF620; cm
r
 This study 
TMB2644 TMB1460 amyE::pCF620; cm
r
 This study 
TMB2645 TMB1462 amyE::pCF620; cm
r
 This study 
a 
Resistant cassettes: cm, chloramphenicol; r, resistant. 
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Table 4.2. Vectors and plasmids used in this study. 
Plasimd Genotype or characteristic(s)
 
Primers used for cloning Reference or source  
Vectors    
pAC6 Vector for transcriptional promoter fusions to 
lacZ in B. subtilis, integrates in amyE; cm
r
 
 (Stülke et al., 1997) 
pET16b Vector for IPTG-inducible gene expression; 
carries a N-terminal His10-tag sequence; amp
r
 
 Novagen 
pMAD Vector for construction of unmarked deletions 
in B. subtilis, temperature sensitive replicon; 
mls
r
 
 (Arnaud et al., 2004) 
Plasmids    
pAS601 pAC6 PpsdA (-99 to +30) -lacZ 1591/0600 This study 
pAS602 pAC6 PpsdA (-97 to +30) -lacZ 1592/0600 This study 
pAS603 pAC6 PpsdA (-104 to +30) -lacZ 1688/0600 This study 
pAS604 pAC6 PpsdA (-103 to +30) -lacZ 1687/0600 This study 
pAS605 pAC6 PpsdA (-102 to +30) -lacZ 1686/0600 This study 
pAS606 pAC6 PpsdA (-101 to +30) -lacZ 1685/0600 This study 
pAS607 pAC6 PpsdA (-100 to +30) -lacZ 1684/0600 This study 
pAS608 pAC6 PpsdA (-98 to +30) -lacZ 1683/0600 This study 
pAS609 pAC6 PpsdA (-96 to +30) -lacZ 1682/0600 This study 
pAS610 pAC6 PpsdA (-95 to +30) -lacZ 1681/0600 This study 
pAS613 pAC6 PbceA (-110 to +82) -lacZ 1869/0555 This study 
pAS614 pAC6 PbceA (-109 to +82) -lacZ 1870/0555 This study 
pAS615 pAC6 PbceA (-108 to +82) -lacZ 1871/0555 This study 
pAS616 pAC6 PbceA (-107 to +82) -lacZ 1872/0555 This study 
pAS617 pAC6 PbceA (-106 to +82) -lacZ 1873/0555 This study 
pAS618 pAC6 PbceA (-105 to +82) -lacZ 1874/0555 This study 
pAS619 pAC6 PbceA (-104 to +82) -lacZ 1875/0555 This study 
pAS620 pAC6 PbceA (-103 to +82) -lacZ 1876/0555 This study 
pCF101 pMAD ∆bceRS 2351/2352 2353/2354 This study 
pCF103 pMAD ∆psdRS 2357/2358 2359/2360 This study 
pCF120 pET16b bceR  2007/2008 This study 
pCF601 pAC6 PpsdA (-126 to +30 )-lacZ 0674/0600 This study 
pCF608 pAC6 PbceA (-122 to +82) main binding site 
mutation-lacZ  
2262/3563 3564/0555 This study 
pCF609 pAC6 PbceA (-122 to +82) second binding site 
mutation-lacZ 
0554/3565 3566/0555 This study 
pCF610 pAC6 PpsdA (-126 to +30) main binding site 
mutation-lacZ   
2262/3567 3568/0600 This study 
pCF611 pAC6 PpsdA (-126 to +30) second binding site 
mutation-lacZ 
0674/3569 3570/0600 This study 
pCF612 pAC6 PpsdA (-126 to +30) second binding site 
switched into the corresponding region of 
PbceA -lacZ 
0674/3553 3554/0600 This study 
pCF613 pAC6 PpsdA (-126 to +30) linker and second 
binding site switched into the corresponding 
region of PbceA -lacZ 
0674/3557 3558/0600 This study 
pCF614 pAC6 PbceA (-122 to +82) main binding site, 
linker and second binding site switched into 
the corresponding region of PpsdA -lacZ 
3692/0555 This study 
pCF615 pAC6 PpsdA (-126 to +30) main binding site, 
linker and second binding site switched into 
the corresponding region of PbceA -lacZ 
3693/0600  This study 
pCF616 pAC6 PbceA (-122 to +82) main binding site 
and second binding site switched into the 
corresponding region of PpsdA -lacZ 
3719/0555 This study 
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pCF618 pAC6 PbceA (-122 to +82) main binding site 
and linker switched into the corresponding 
region of PpsdA -lacZ 
3721/0555 This study 
pCF619 pAC6 PpsdA (-126 to +30) main binding site 
and second binding site switched into the 
corresponding region of PbceA -lacZ 
3720/0600  This study 
pCF620 pAC6 PpsdA (-126 to +30) main binding site 
and linker switched into the corresponding 
region of PbceA -lacZ 
3722/0600  This study 
pER603 pAC6 PbceA (-122 to +82) -lacZ 0554/0555 (Rietkötter et al., 
2008) 
pER605 pAC6 PpsdA (-110 to +30 )-lacZ 0599/0600 (Rietkötter et al., 
2008) 
pMG600 pAC6 PbceA (-122 to -46) - PpsdA (-36 to +30) 
(BP1) -lacZ   
1689/3240 3241/0600 This study 
pMG601 pAC6 PbceA (-122 to -56) - PpsdA (-46 to +30) 
(BP2) -lacZ   
1689/3242 3243/0600 This study 
pMG603 pAC6 PbceA (-122 to -76) - PpsdA (-66 to +30) 
(BP3) -lacZ   
1689/3246 3247/0600 This study 
pMG604 pAC6 PbceA (-122 to -88) - PpsdA (-79 to +30) 
(BP4) -lacZ   
1689/3248 3249/0600 This study 
pMG605 pAC6 PpsdA (-126 to -37) - PbceA (-45 to +82) 
(PB1) -lacZ   
0674/3230 3231/0555 This study 
pMG606 pAC6 PpsdA (-126 to -47) - PbceA (-55 to +82) 
(PB2) -lacZ   
0674/3232 3233/0555 This study 
pMG608 pAC6 PpsdA (-126 to -67) - PbceA (-75 to +82) 
(PB3) -lacZ   
0674/3236 3237/0555 This study 
pMG609 pAC6 PpsdA (-126 to -80) - PbceA (-87 to +82) 
(PB4) -lacZ   
0674/3238 3239/0555 This study 
pMG612 pAC6 PbceA (-122 to + 82) linker mutation -
lacZ  
0146/3351 3395/0010  This study 
pMG613 pAC6 PbceA (-122 to + 82) linker switched into 
the corresponding part of PpsdA -lacZ 
0146/3401 3400/0010  This study 
pMG614 pAC6 PbceA (-122 to + 82) main binding site 
switched into the corresponding region of 
PpsdA -lacZ 
0146/3419 3354/0010  This study 
pMG617 pAC6 PpsdA (-126 to + 30) linker mutation -
lacZ   
0146/3353 3352/0600  This study 
pMG618 pAC6 PpsdA (-126 to + 30) linker switched into 
the corresponding region of PbceA -lacZ  
0146/3403 3402/0600  This study 
pMG619 pAC6 PpsdA (-126 to + 30) main binding site 
switched into the corresponding region of 
PbceA -lacZ  
0146/3357 3356/0600  This study 
pMG621 pAC6 PbceA (-122 to + 82) second binding site 
switched into the corresponding region of 
PpsdA -lacZ 
2262/3551 3552/0555 This study 
pMG622 pAC6 PbceA (-122 to + 82) linker and the 
second binding site switched into the 
corresponding region of PpsdA -lacZ 
2262/3555 3556/0555 This study 
pJS605 pAC6 PbceA (-111 to +82) -lacZ  1307/0555 This study 
Amp, ampicillin; cm, chloramphenicol; mls, macrolide-lincosamide-streptogramin B group antibiotics; r, 
resistant. 
Supplemental Table 4.1. Primers used in this study. 
Primer 
name 
Sequence (5'-3')
a
 Use 
TM0010 CTTCGCTATTACGCCAGCTGG lacZ check rev 
TM0146 GTCTGCTTTCTTCATTAGAATCAATCC cat check rev 
TM0554 GATCGAATTCGAACATGTCATAAGCGTGTGACG PbceA (-122) fwd 
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TM0555 GATCGGATCCTATCGATGCCCTTCAGCACTTCC PbceA rev 
TM0599 AGTCGAATTCCACCCTCGTGAATGTGACAGC PpsdA (-110) fwd 
TM0600 AGTCGGATCCCGATAGGTTCGTTGTTTGCAACACG PpsdA rev 
TM0674 AGTCGAATTCTCGTGTTTTCAAGTGACACC PpsdA (-126) fwd 
TM1307 GATCGAATTCAAGCGTGTGACGAAAATGTCACAT PbceA (-111) fwd 
TM1591 AGTCGAATTCATGTGACAGCATTGTAAGATTGG PpsdA (-99) fwd 
TM1592 AGTCGAATTCGTGACAGCATTGTAAGATTGG PpsdA (-97) fwd 
TM1681 AGTCGAATTCACGACAGCATTGTAAGATTGG PpsdA (-95) fwd 
TM1682 AGTCGAATTCATGACAGCATTGTAAGATTGG PpsdA (-96) fwd 
TM1683 AGTCGAATTCTGTGACAGCATTGTAAGATTGG PpsdA (-98) fwd 
TM1684 AGTCGAATTCTAATGTGACAGCATTGTAAG PpsdA (-100) fwd 
TM1685 AGTCGAATTCGAATGTGACAGCATTGTAAG PpsdA (-101) fwd 
TM1686 AGTCGAATTCTGAATGTGACAGCATTGTAAG PpsdA (-102) fwd 
TM1687 AGTCGAATTCAGTGAATGTGACAGCATTGTAAG PpsdA (-103) fwd 
TM1688 AGTCGAATTCCGTGAATGTGACAGCATTGTAAG PpsdA (-104) fwd 
TM1689 CCGATGATAAGCTGTCAAAC pAC6 bandshifts 
TM1869 ATGCGAATTCAGCGTGTGACGAAAATG PbceA (-110) fwd 
TM1870 ATGCGAATTCGCGTGTGACGAAAATGTC PbceA (-109) fwd 
TM1871 ATGCGAATTCACGTGTGACGAAAATGTC PbceA (-108) fwd 
TM1872 ATGCGAATTCAAGTGTGACGAAAATGTC PbceA (-107) fwd 
TM1873 ATGCGAATTCAAATGTGACGAAAATGTC PbceA (-106) fwd 
TM1874 ATGCGAATTCGTGACGAAAATGTCAC PbceA (-105) fwd 
TM1875 ATGCGAATTCATGACGAAAATGTCAC PbceA (-104) fwd 
TM1876 ATGCGAATTCAAGACGAAAATGTCAC PbceA (-103) fwd 
TM2007 ATCGCTCGAGTTGTTTAAACTTTTGCTGATTG bceR fwd 
TM2008 ATCGGGATCCTTAATCATAGAACTTGTCCTC bceR rev 
TM2262 GAGCGTAGCGAAAAATCC pAH328 checkfwd 
TM2351 AATTTGGATCCGAGGAAGCAAAAGGAAATC bceRS deletion up fwd 
TM2352 CTTGATTTCATGAAACAGCG bceRS deletion up rev 
TM2353 ctgtttcatgaaatcaag ATATTGATGTTGAGTCGGAG bceRS deletion down fwd 
TM2354 AATTCCATGGTTCAAATTTCGCAGGATGAG bceRS deletion down rev 
TM2357 AATTTGGATCCCTACGATCTAAATGGTTTCC psdRS deletion up fwd 
TM2358 ATTTTTGAAGATGACCGCCC psdRS deletion  up rev 
TM2359 cggtcatcttcaaaaat CACTGTGATGACCATCGTG psdRS deletion down fwd 
TM2360 AATTCCATGGACCGAAACGGCAAACACAC psdRS deletion down rev 
TM3230 GTCAGCATCCTCCCATCGAAC PB1 up rev 
TM3231 cgatgggaggatgctgac TTCCTTTTTATAATGAGATTATCC PB1 down fwd 
TM3232 TCCCATCGAACTTTCTTGCAATTC PB2 up rev 
TM3233 caagaaagttcgatggga AAGCCCGGCATTCCTTTTTATAATG PB2 down fwd 
TM3236 TTCCGCTCCCCAATCTTACAATG PB3 up rev 
TM3237 taagattggggagcggaa TTGTTCGCCGTATCGAAGG PB3 down fwd 
TM3238 ATCTTACAATGCTGTCACATTC PB4 up rev 
TM3239 gtgacagcattgtaagat GCTTTTCTTTTTTGTTCGCCG PB4 down fwd 
TM3240 TGCCGGGCTTTTCCTTCGATAC BP1 up rev 
TM3241 cgaaggaaaagcccggcaTTCCTTTTTATAATAAAGAAAAAGG BP1 down fwd 
TM3242 TTCCTTCGATACGGCGAAC BP2 up rev 
TM3243 ttcgccgtatcgaaggaaGGATGCTGACTTCCTTTTTATAATAAAG BP2 down fwd 
TM3246 AAAAGAAAAGCATGTGACATTTTC BP3 up rev 
TM3247 gtcacatgcttttcttttTTGCAAGAAAGTTCGATGGGAGG BP3 down fwd 
TM3248 ATGTGACATTTTCGTCACACGC BP4 up rev 
TM3249 gtgacgaaaatgtcacatTGGGGAGCGGAATTGCAAGAAAG BP4 down fwd 
TM3351 cgaacaaatttgtataGCATGTGACATTTTCGTC PbceA L-M up rev 
TM3352 cgcacggcaattgcaAGAAAGTTCGATGGGAGG PpsdA L-M down fwd 
TM3353 tgcaattgccgtgcgCAATCTTACAATGCTGTCAC PpsdA L-M up rev 
TM3354 gacagcattgtaagaTGCTTTTCTTTTTTGTTCGCC PbceA M-S down fwd 
TM3356 gacgaaaatgtcacaTTGGGGAGCGGAATTGCAAG PpsdA M-S down fwd 
TM3357 tgtgacattttcgtcACATTCACGAGGGTGTCACTTG PpsdA M-S up rev 
TM3395 tatacaaatttgttcgCCGTATCGAAGGAAAAGC PbceA L-M down fwd 
TM3400 ggcgaacaatccgctcccGCATGTGACATTTTCGTCAC PbceA L-S down fwd 
TM3401 gggagcggattgttcgccGTATCGAAGG PbceA L-S up rev 
TM3402 cttgcaataaaagaaaaCAATCTTACAATGCTGTCAC PpsdA L-S down fwd 
Chapter IV - Wiring specificity of Bce-like systems 
64 
 
TM3403 ttttcttttattgcaagAAAGTTCGATGGG PpsdA L-S up rev 
TM3419 tcttacaatgctgtcACACGCTTATGACATGTTCG PbceA M-S up rev 
TM3551 ccatcgaactttcttgCAAAAAAGAAAAGCATGTGACATTTTC PbceA S-S up rev 
TM3552 caagaaagttcgatGGAAAAGCCCGGCATTCC PbceA S-S down fwd 
TM3553 ccttcgatacggcgaaCAATTCCGCTCCCCAATC PpsdA S-S up rev 
TM3554 ttcgccgtatcgaaGGGAGGATGCTGACTTCC PpsdA S-S down fwd 
TM3555 actttcttgcaattccgctccccaATGTGACATTTTCGTCACACG PbceA S+L-S up rev 
TM3556 ggaattgcaagaaagttcgatGGAAAAGCCCGGCATTCC PbceA S+L-S down fwd 
TM3557 tacggcgaacaaaaaagaaaagcATCTTACAATGCTGTCACATTC PpsdA S+L-S up rev 
TM3558 ttttttgttcgccgtatcgaaGGGAGGATGCTGACTTCC PpsdA S+L-S down fwd 
TM3563 gcgttaagtcaccgctaaCGCTTATGACATGTTCGAATTCG PbceA M-M up rev 
TM3564 ttagcggtgacttaacgcTGCTTTTCTTTTTTGTTCGCCG PbceA M-M down fwd 
TM3565 cagctagcagtcagtcagAAAAAGAAAAGCATGTGACATTTTC PbceA S-M up rev 
TM3566 ctgactgactgctagctgAAAAGCCCGGCATTCCTTTT PbceA S-M down fwd 
TM3567 tacttcggtcaccgctaaTTCACGAGGGTGTCACTTG PpsdA M-M up rev 
TM3568 ttagcggtgaccgaagtaTTGGGGAGCGGAATTGCAAG PpsdA M-M down fwd 
TM3569 gtcagtcgtcagtcagtcATTCCGCTCCCCAATCTTAC PpsdA S-M up rev 
TM3570 gactgactgacgactgacGAGGATGCTGACTTCCTTTT PpsdA S-M down fwd 
TM3665 
GTCATAAGCGTGTGACGAAAATGTCACATGCTTTTCTTTTT
TGTTCGCCGTATCGAAGGAAAAGCCCGGCATTCCT 
PbceA WT fwd (for SPR) 
TM3666 
AGGAATGCCGGGCTTTTCCTTCGATACGGCGAACAAAAAA
GAAAAGCATGTGACATTTTCGTCACACGCTTATGAC 
Biotin-PbceA WT rev (for SPR) 
TM3667 
CCCTCGTGAATGTGACAGCATTGTAAGATTGGGGAGCGGA
ATTGCAAGAAAGTTCGATGGGAGGATGCTGACTTCCT 
PpsdA WT fwd (for SPR) 
TM3668 
AGGAAGTCAGCATCCTCCCATCGAACTTTCTTGCAATTCC
GCTCCCCAATCTTACAATGCTGTCACATTCACGAGGG 
Biotin-PpsdA WT rev (for SPR) 
TM3669 
GTCATAAGCGTTAGCGGTGACTTAACGCTGCTTTTCTTTTT
TGTTCGCCGTATCGAAGGAAAAGCCCGGCATTCCT 
PbceA M-M fwd (for SPR) 
TM3670 
AGGAATGCCGGGCTTTTCCTTCGATACGGCGAACAAAAAA
GAAAAGCAGCGTTAAGTCACCGCTAACGCTTATGAC 
Biotin-PbceA M-M rev (for SPR) 
TM3671 
CCCTCGTGAATTAGCGGTGACCGAAGTATTGGGGAGCGGA
ATTGCAAGAAAGTTCGATGGGAGGATGCTGACTTCCT 
PpsdA M-M fwd (for SPR) 
TM3672 
AGGAAGTCAGCATCCTCCCATCGAACTTTCTTGCAATTCC
GCTCCCCAATACTTCGGTCACCGCTAATTCACGAGGG 
Biotin-PpsdA M-M rev (for SPR) 
TM3673 
GTCATAAGCGTGTGACGAAAATGTCACATGCTTTTCTTTTT
CTGACTGACTGCTAGCTGAAAAGCCCGGCATTCCT 
PbceA S-M fwd (for SPR) 
TM3674 
AGGAATGCCGGGCTTTTCAGCTAGCAGTCAGTCAGAAAAA
GAAAAGCATGTGACATTTTCGTCACACGCTTATGAC 
Biotin-PbceA S-M rev (for SPR) 
TM3675 
CCCTCGTGAATGTGACAGCATTGTAAGATTGGGGAGCGGA
ATGACTGACTGACGACTGACGAGGATGCTGACTTCCT 
PpsdA S-M fwd (for SPR) 
TM3676 
AGGAAGTCAGCATCCTCGTCAGTCGTCAGTCAGTCATTCC
GCTCCCCAATCTTACAATGCTGTCACATTCACGAGGG 
Biotin-PpsdA S-M rev (for SPR) 
TM3677 
TCACGAATTACCATCTACACCCTGCCAAAAATTTGATAAA
CTTATTTTATAAAAAAATTGAAACCTTTTGAAACGAA 
PsigW WT fwd (for SPR) 
TM3678 
TTCGTTTCAAAAGGTTTCAATTTTTTTATAAAATAAGTTTA
TCAAATTTTTGGCAGGGTGTAGATGGTAATTCGTGA 
Biotin-PsigW WT rev (for SPR) 
TM3692 
GATCGAATTCGAACATGTCATAAGCGTGTGACAGCATTGT
AAGATTGGGGAGCGGAATTGC 
PbceA M+L+S-S fwd 
TM3693 
AGTCGAATTCTCGTGTTTTCAAGTGACACCCTCGTGAATGT
GACGAAAATGTCACATGCTTTTCTTTTTTGTTCGC 
PpsdA M+L+S-S fwd 
TM3719 
GATCGAATTCGAACATGTCATAAGCGTGTGACAGCATTGT
AAGATGCTTTTCTTTTTTGCAAG 
PbceA M+S-S fwd 
TM3720 
AGTCGAATTCTCGTGTTTTCAAGTGACACCCTCGTGAATGT
GACGAAAATGTCACATTGGGGAGCGGAATTG 
PpsdA M+S-S fwd 
TM3721 
GATCGAATTCGAACATGTCATAAGCGTGTGACAGCATTGT
AAGATTG 
PbceA M+L-S fwd 
TM3722 
AGTCGAATTCTCGTGTTTTCAAGTGACACCCTCGTGAATGT
GACGAAAATGTCACATG 
PpsdA M+L-S fwd 
a
 Restriction sites are underlined; overlaps to other primers for PCR fusions are shown by lower case letters.  
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Specificity Determinant and Rewiring Signal Transduction of BceRS-like 
two-component systems in Bacillus subtilis 
Summary  
Two-component signal transduction systems are comprised of a membrane-anchored histidine kinase 
that senses the input stimulus and a cognate response regulator, which binds to specific promoter 
regions to trigger a cellular response. In Bacillus subtilis, there are three Bce-like two-component 
systems: BceRS, PsdRS and YxdJK, which — together with their cognate ABC transporters — 
mediate peptide antibiotic resistance. These three Bce-like two-component systems share significant 
sequence similarity and were predicted to have considerable cross-talk. However, in vivo, these three 
systems are insulated very well with only low level of cross-regulation between BceS and PsdR. In 
this chapter, we focused on the Bce and the Psd systems and investigated the specificity determinants 
in BceR and PsdR that ensure the insulation of these two paralogous pathways at the level of 
interaction with their histidine kinases. First, we verified that the specificity determinants are located 
on the Bce-like response regulator receiver domain. Next chimeric response regulator analysis 
demonstrated that the α1 helix, which is speculated to contain one of the interaction surfaces with the 
histidine kinase, is not enough to determine specificity. Exchanging this region alone between BceR 
and PsdR had no influence on specificity. Surprisingly, we found that the β2-α2 region, which is 
located away from the interaction surfaces with the histidine kinase, can influence the specificity with 
the histidine kinase. However, replacing this region alone in PsdR by the corresponding region from 
BceR was not sufficient to confer a complete change of specificity. By substituting both regions 
together, i.e. α1-β2-α2, we successfully rewired signal transduction from BceS to PsdR. These results 
demonstrated that the α1-β2-α2 region dictates the specificity of Bce-like two-component systems in 
B. subtilis.  
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Introduction  
Two-component signal transduction systems (TCSs) are one of the prevalent ways used by bacteria to 
respond to environmental changes. They are involved in regulating a wide array of physiological 
processes, including chemotaxis, utilization of various nutrients, virulence, quorum sensing, and 
antimicrobial peptide (AMP) resistance (Wadhams & Armitage, 2004, Paterson et al., 2006, Williams 
et al., 2007, Gooderham & Hancock, 2009). A typical TCS is comprised of a membrane-anchored 
histidine kinase (HK) that detects the signal input and a cytoplasmic response regulator (RR) that 
mediates the cellular response (Stock et al., 2000). The HK normally harbors a variable periplasmic 
sensor (Input) domain and a conserved cytoplasmic autokinase domain linked by a linker region (Fig. 
5.1). In addition, most HKs harbor a HAMP domain or a PAS domain at the N-terminal of the 
cytoplasmic domain, which is critical for signal transmission from the periplasmic sensor domain to 
the cytoplasmic region. The highly conserved HK cytoplasmic region consists of a long α-hairpin 
dimerization and histidine phosphotransfer (DHp) domain and a globular catalytic and ATP binding 
(CA) domain (Mascher, 2006, Krell et al., 2010, Jung et al., 2012). In the RR, a conserved receiver 
domain that typically adopts a (βα)5 topology is connected by a flexible linker to a variable output 
domain that frequently has a DNA binding function (Bourret, 2010, Galperin, 2010) (Fig. 5.1).   
Signal transduction within TCSs is mediated by three phosphotransfer reactions. Activation of the HK 
leads to autophosphorylation of a conserved His residue located in the α1 helix of the DHp domain. 
This is followed by transferring the phosphoryl group to a conserved Asp residue located in the β3 
strand of the cognate RR receiver domain. Direct protein-protein interaction between the HK DHp 
domain and the RR receiver domain is involved in this step (West & Stock, 2001, Gao & Stock, 2009). 
Finally, the dephosphorylation of the RR switches off the signal transduction of the system (Parkinson, 
1993).   
Most bacteria encode dozens, sometimes hundreds of TCSs (Capra & Laub, 2012). In the genome of B. 
subtilis, 36 HKs and 34 RRs were found among the open reading frames including three paralogous 
Bce-like TCSs that regulate resistance against AMPs (Fabret et al., 1999). The three Bce-like HKs are 
intramembrane-sensing histidine kinases, which have short extracellular loops and cannot detect 
AMPs by themselves (Mascher, 2006, Mascher, 2014). Instead, they get the signal from Bce-like ABC 
transporters, which harbor functions of both AMP perception and resistance, and subsequently pass 
the signal to their cognate RRs. Bce-like RRs belong to the OmpR subfamily and possess a winged 
helix-turn-helix (wHTH) DNA-binding output domain (Fabret et al., 1999, Galperin, 2006). The 
activated RRs in turn bind to the promoter regions of their cognate ABC transporters and upregulate 
the transcription to ensure AMP resistance (Ohki et al., 2003, Bernard et al., 2007, Rietkötter et al., 
2008). The Bce-like TCS together with the ABC transporter form an AMP sensing and detoxification 
module. In B. subtilis, the BceRS-BceAB system and the PsdRS-PsdAB system can sense and respond 
mainly to bacitracin and nisin, respectively (Gebhard & Mascher, 2011, Staroń et al., 2011). The third 
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Bce system, YxdJK-YxdLM, is poorly understood and has been found to be induced only by the 
human neutrophil peptide LL-37 (Joseph et al., 2004, Pietiäinen et al., 2005). 
The three Bce-like TCSs of B. subtilis share significant sequence and structural similarity. This 
indicates the potential of considerable cross-talk between them, which has already been predicted by 
direct coupling analysis based on the co-evolution of inter-protein contact residues (Szurmant & Hoch, 
2010, Procaccini et al., 2011). Such unwanted cross-talk can be deleterious. Therefore avoiding cross-
talk and maintaining high fidelity of signal transmission within TCSs is necessary to guarantee 
bacterial cells respond specifically to each stimulus and produce the desired, beneficial response. A 
previous study demonstrated that instead of the predicted high level of cross-talk between these three 
paralogous Bce-like TCSs in B. subtilis, there is only some minor degree of cross-regulation in vivo 
between BceS and PsdR at high concentrations of bacitracin (Rietkötter et al., 2008) (Fig. 5.1). This 
raises two questions: (1) how do bacteria coordinate the activity of so many highly related signaling 
systems while maintaining the signal transduction specificity and preventing unwanted cross-talk? (2) 
How does the HK discriminate between its cognate RR and the non-cognate ones in the pool of 
numerous RRs? 
 
 
 
 
 
 
Figure 5.1. Schematic overview of two Bce-like two-component signal transduction systems in B. subtilis. 
Bce and Psd TCSs including their target promoters, PbceA and PpsdA, are colored with black and grey, respectively. 
The major stimulus of each system is given on the left side. The phosphoryl group (P) is transferred from the 
conserved histidine residue (H) on the HK to the conserved aspartate residue (D) on the RR. Solid arrows 
indicate the signal transduction pathway within one system, while cross-regulation between BceS and PsdR is 
pointed out by dashed arrow. HK, histidine kinase; RR, response regulator; Input, input domain of HK; DHp, 
dimerization and histidine phosphotransferase domain of HK; CA, catalytic and ATPase domain of HK; 
Receiver, receiver domain of RR; Output, output domain of RR. 
The predominant way to maintain intrasystem specificity and intersystem insulation is the molecular 
recognition between HK and RR (Podgornaia & Laub, 2013). During signal transmission of the TCS, 
specific interactions mediated by a few amino acids on the interaction surfaces of both proteins lead to 
a global and strong kinetic preference of the HK to its cognate RR. These amino acids are specificity 
determinants. The co-crystal structure of HK853-RR468 from Thermotoga maritima provides a clear 
view of the HK/RR interaction surfaces and implies the possible positions of those amino acids. The 
interaction surfaces involved in forming the HK853-RR468 pair are: the α1 helix and the β5-α5 loop 
of the RR468 receiver domain with the two α helices of the HK853 DHp domain; the β3-α3 loop of 
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the RR468 with the ATP lid and the β4-α4 loop of the HK853 CA domain; the RR468 β4-α4 loop with 
the DHp-CA interdomain linker of HK853(Casino et al., 2009) (see Fig. 1.5). 
In this chapter, we focused on the two Bce-like TCSs BceRS and PsdRS of B. subtilis to explore the 
regions on Bce-like RRs that are specifically recognized by the cognate HK and excluded by the non-
cognate HK. We demonstrated that Bce-like RRs containing an extended specificity determinant 
compared to the other studied OmpR subfamily members, which suggests a novel mechanism of 
protein-protein interactions for Bce-type TCSs.  
Results  
The receiver domain of Bce-like RRs dictates specific interaction with the cognate HK 
Signal transmission from HK to RR is mediated by direct interactions between the HK cytoplasmic 
domain and the RR receiver domain (West & Stock, 2001). Here, we first wanted to verify that the 
BceR receiver domain is indeed responsible for specific interaction with the cognate BceS instead of 
the non-cognate PsdS. To address this question, a chimeric RR, BP1, was constructed with the 
receiver domain from BceR fused to the linker and output domain of PsdR. BP1 as well as wild-type 
BceR and PsdR (Fig. 5.2) were cloned into vector pBS2E under the control of a constitutive promoter, 
PbceR (Table 5.2). To test the signaling between BceS and the RR-constructs, the plasmids were 
transformed into B. subtilis reporter strain (TMB 1975 or TMB 1976) lacking all Bce-like TCS 
components but BceS (Table 5.1). To test the signaling between PsdS and the RR-constructs, the 
plasmids were transformed into B. subtilis reporter strain (TMB 2051 or TMB 2052) harboring PsdS 
(Table 5.1). In the B. subtilis reporter strain, PbceA-lux, with the target promoter of BceR fused to the 
bacterial promoterless luciferase operon luxABCDE, was the reporter construct for RRs that contained 
the BceR output domain, while a PpsdA-lux reporter construct was used for RRs that contained the PsdR 
output domain. Signaling via BceS was induced by addition of bacitracin and signaling via PsdS was 
induced by addition of nisin (Fig. 5.1). 
The strain harboring BceS, BceR and target promoter reporter PbceA-lux showed only basal expression 
of the promoter in the absence of bacitracin (ca. 1×10
3
 RLU/OD), which was induced 50-fold (ca. 
5×10
4
 RLU/OD) within 150 min after addition of 2 µg ml
-1
 bacitracin (Fig. 5.2A). BceR was not able 
to induce the expression of the reporter construct PbceA-lux in the strain containing PsdS in the presence 
of 8 µg ml
-1
 nisn (Fig. 5.2B). PsdR, on the other hand, was not able to induce the expression of the 
reporter construct PpsdA-lux in the strain possessing BceS in presence of bacitracin (Fig. 5.2E), but 
strongly upregulated the expression of PpsdA-lux in presence of nisin in the strain containing PsdS (Fig. 
5.2F). The chimeric RR BP1, with its receiver domain from BceR and the flexible linker as well as the 
output domain from PsdR, showed strong upregulation of PpsdA activity (50-fold over the uninduced 
control) in the reporter strain containing BceS in the presence of bacitracin (Fig. 5.2C), but no 
induction of expression of the reporter construct PpsdA-lux in the strain harboring PsdS after addition of 
nisin (Fig. 5.2D). 
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Figure 5.2. Rewiring the specificity of Bce-like two-component systems in B. subtilis. Signal transduction 
between different HK and RR pairs was monitored in vivo as the induction of PbceA-luxABCDE or PpsdA-
luxABCDE transcriptional fusions for 150 min after addition of antibiotics (black square), and compared to the 
uninduced controls (grey square). Antibiotics, bacitracin for BceS activation (top row) and nisin for PsdS 
activation (bottom row), were added to exponential growing cultures at time point 0 min, and luminescence 
(relative luminescence units, RLU) and cell growth (optical density at 600 nm, OD600) were measured in 5-min 
intervals. Luminescence was normalized to cell density and is expressed as RLU/OD. Schematics of HKs are 
illustrated on the left side of the graphs with the same shading as in Fig. 5.1. Schematics of RR constructs are 
illustrated under the graphs. Wild-type BceR and PsdR are colored the same as in Fig. 5.1; BP1 has the receiver 
domain from BceR (black) and linker as well as output domain from PsdR (grey). The combinations of different 
HKs and RRs are indicated on top of each graph. 
Taken together, our data verified that the signal is transduced from Bce-like HKs to Bce-like RRs via 
only the receiver domain of the RR, while is responsible for specific interactions with the cognate 
Bce-like HK upon induction with one corresponding signal AMPs. This result demonstrates that the 
HK/RR specificity determinants are located in this region. In the next step, we wanted to narrow down 
the region containing these specificity determinants.  
The β1-α1-β2-α2 region of the Bce-like RR receiver domain contains the specificity determinants 
Typically, the receiver domain of RRs, including BceR and PsdR, has a modular secondary structure 
with alternating β-strands and α-helices: β1-α1-β2-α2-β3-α3-β4-α4-β5-α5 (Fig. 5.3A). In order to 
dissect the role of each β-α repeat in HK-RR specificity determination, a series of chimeric RRs with 
N-terminal four β-α repeats (BP2), three β-α repeats (BP3), two β-α repeats (BP4) as well as only one 
β-α repeat (BP5) of the PsdR receiver domain substituted by the corresponding regions of BceR were 
constructed (Fig. 5.4). These chimeric RRs were cloned into pBS2E under the control of a constitutive 
promoter, PbceR (Table 5.2). Plasmids carrying these chimeras were introduced into B. subtilis reporter 
strain TMB1976 (PpsdA-lux reporter strain where of all Bce-like TCS components only the BceS was 
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present) to monitor the signal transmission from BceS, and TMB2052 (PpsdA-lux reporter strain 
harboring PsdS) to monitor the signal transmission from PsdS (Table 5.1), based on the PpsdA-lux 
output.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Sequence and structure analysis of two-component systems. (A) Sequence alignment of 
BceS/PsdS DHp domains (top) and BceR/PsdR receiver domains (bottom). Residues shaded in black and grey 
are identical and similar amino acids, respectively, between these two proteins. Residues shaded in red and 
pointed by red arrows are conserved in all HKs or RRs. Residues shaded in blue are predicted to be responsible 
for direct contact with the cognate partners (Procaccini et al., 2011). The predicted secondary structures of HKs 
and RRs are shown below their respective alignments. (B) The co-crystal structure of the HK 853 and the RR 
468 from T. maritime (the figure is from (Capra et al., 2010)). Coevolved residues in HK853 are colored in 
orange and in RR468 are colored in red. The side chains of the conserved phosphoacceptors, His and Asp 
residues, are shown as magenta sticks. The HK853/RR468 complex is shown in the center with each individual 
molecule rotated 90° and shown separately.  
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Wild-type PsdR, which can only accept the signal from PsdS but not from BceS, was used as a 
negative control (Fig. 5.4A and 5.4B), while wild-type BceR, which can accept the signal from BceS 
but not from PsdS served as a positive control (Fig. 5.4K and 5.4L). BP2 and BP3, with the N-terminal 
four and three β-α repeats of the PsdR receiver domain, respectively, swapped for the corresponding 
region of BceR, showed no induction of PpsdA with either BceS or PsdS in the presence of bacitracin or 
nisin (Fig. 5.4C to 5.4F), indicating that BP2 and BP3 were dysfunctional. In contrast, chimera BP4, 
with only two β-α repeats (β1-α1-β2-α2) of the PsdR receiver domain replaced by the corresponding 
region of BceR, showed a strong upregulation of promoter activity in the presence of bacitracin, which 
was dependent on BceS (Fig. 5.4G). This chimera displayed extremely low level of promoter 
induction, 3-fold over the uninduced control, after addition of nisin in the presence of PsdS (Fig. 5.4H). 
These results showed a change of specificity from PsdR to BceR. BP5, with the β1-α1 region on PsdR 
receiver domain changed into BceR, was unable to induce expression of the promoter either in the 
presence of BceS or PsdS (Fig. 5.4I and 5.4J).  
These results demonstrated that the signal transduction could successfully be redirected between 
BceRS and PsdRS sytems by swapping the β1-α1-β2-α2 region on the RR receiver domain. Although 
most of the chimeric RRs failed to accept a signal from either BceS or PsdS, the results from BP4 
demonstrated that the β1-α1-β2-α2 region on the BceR receiver domain contains the motifs that 
determine specific interaction with the cognate BceS. The co-crystal structure of the TCS HK853-
RR468 indicates that the α1 helix on the RR receiver domain directly interacts with the HK DHp 
domain (Casino et al., 2009, Capra et al., 2010) (Fig. 5.3B). We therefore next wanted to analyze the 
function of the α1 helix for Bce-like HK and RR specificity. 
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Figure 5.4. Signal transduction between HKs and series of chimeric RRs. Signal transduction between 
different HK and RR pairs was monitored in vivo as the induction of PbceA-luxABCDE or PpsdA-luxABCDE 
transcriptional fusions within 150 min in the presence of antibiotics (black square): bacitracin for BceS 
activation and nisin for PsdS activation, and compared with the uninduced controls (grey square) as described in 
Fig. 5.2. Schematics of HKs are illustrated on top of the graphs with the same shading as in Fig. 5.1. Schematics 
of RR constructs are illustrated on the left side of the graphs. BceS/BceR and PsdS/PsdR are with the same 
shading as in Fig. 5.1. From chimera BP2 to BP5, the part of the receiver domain from BceR is colored with 
black and the region from PsdR is colored with grey. The combinations of different HKs and RRs are indicated 
on top of each graph. 
The α1 helix together with the β2-α2 region of the Bce-like RR receiver domain dictates 
specificity for the cognate Bce-like HK 
Based on the direct coupling analysis, five amino acids in the α1 helix and one residue on the β5-α5 
loop of BceR/PsdR receiver domain were predicted to dictate specific interactions with eight amino 
acids of the BceS/PsdS DHp domains in B. subtilis (Procaccini et al., 2011) (Fig. 5.3A). To 
experimentally verify the function of the α1 helix and the β5-α5 loop in specificity determination, we 
first constructed a chimera, BPα1, with the whole α1 helix of PsdR substituted by the corresponding 
region of BceR (Fig. 5.5). This chimera was dysfunctional, since it was unable to induce the 
expression of the promoter construct with either an active BceS or PsdS (Fig. 5.5C and 5.5D). To 
investigate if the α1 helix is the specificity determinant, another chimera, PBα1, was constructed with 
the α1 helix on BceR receiver domain replaced by the α1 helix of PsdR (Fig. 5.5). This chimera RR 
strongly upregulated the activity of PbceA in a BceS-dependent manner in the presence of bacitracin 
(Fig. 5.5E), and no induction of the promoter was observed with an active PsdS in the presence of 
nisin (Fig. 5.5F). Hence, PBα1 displayed a behavior similar to that of wild-type BceR. This result 
indicates that switching the α1 helix alone could not rewire the signal transduction specificity of Bce-
like TCSs.  
Next, we wanted to analyze if the β5-α5 loop is involved in determining specificity, that is, the α1 
helix together with the β5-α5 loop should be able to determine the specificity between BceS/BceR and 
PsdS/PsdR. PBα1+loop (β5-α5), with both the α1 helix and the β5-α5 loop on BceR receiver domain 
replaced by corresponding regions of PsdR, was constructed and the signaling was checked from BceS 
and PsdS, respectively. Surprisingly, PBα1+loop (β5-α5) was able to highly induce the expression of the 
promoter construct with an active BceS (Fig. 5.5G), but had no induction of the promoter construct 
with an active PsdS (Fig. 5.5H). PBα1+loop (β5-α5), therefore, behaved similarly as wild-type BceR. These 
results demonstrate that the regions containing specificity determining amino acids predicted by direct 
coupling analysis are not sufficient to dictate the specificity of Bce-like TCSs in B. subtilis. This 
provoked a sense for additional specificity determinant that would allow rewiring the signal 
transduction between the Bce and Psd TCSs. 
Sequence alignments showed that amino acids on the β2-α2 region (RR receiver domain) vary 
considerably between BceR and PsdR (Fig. 5.3A). To further analyze a pontential function of tthis 
region in specificity determination, we constructed chimera BPβ2-α2 with this region on PsdR switched 
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into the corresponding region of BceR (Fig. 5.5). This chimera showed a low level of induction (10-
fold over the uninduced control) with BceS (Fig. 5.5I), and a high level of induction with PsdS (50-
fold over the uninduced control) (Fig. 5.5J). These results indicated that chimera BPβ2-α2, which is 
PsdR carrying the β2-α2 region of BceR, accepted a weak signal from BceS. However, the signaling 
from PsdS to BPβ2-α2 was not diminished and was still as strong as to wild-type PsdR. This data reveal 
that the β2-α2 region can influence the specificity of the Bce-like TCSs but is by itself not able to fully 
determine signaling specificity between the HK and the RR. 
Next, we tested the effect of exchanging the α1 helix and the β2-α2 region together on specificity. 
Towards that goal, we further constructed chimera BPα1-β2-α2 (PsdR with the α1-β2-α2 region 
substituted by the corresponding region of BceR) and analyzed the signaling with either BceS or PsdS. 
PpsdA was strongly induced in the strain harboring BceS and BPα1-β2-α2 after addition of bacitracin (40-
fold over the uninduced control) (Fig. 5.5K), but almost not induced after addition of nisin in the strain 
harboring PsdS and BPα1-β2-α2 (3-fold over the uninduced control) (Fig. 5.5L). These results 
demonstrate that PsdR with the whole α1-β2-α2 region substituted by the corresponding region of 
BceR changed the specificity of signal transduction from PsdS to BceS. This data therefore indicates 
that the α1 helix together with the β2-α2 region of the Bce-like RRs receiver domain is necessary to 
determine the specific interaction with the cognate HK, since exchanging this region is sufficient to 
rewire the signal transduction for Bce-like TCSs. 
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Figure 5.5. Dissection the specificity determinants on the RR receiver domain. Signal transduction between 
different HK and RR pairs was monitored in vivo as the induction of PbceA-luxABCDE or PpsdA-luxABCDE 
transcriptional fusions within 150 min in the presence of antibiotics (black square): bacitracin for BceS 
activation and nisin for PsdS activation, and compared with the uninduced controls (grey square) as described in 
Fig. 5.2. Schematics of HKs are illustrated on top of the graphs with the same shading as in Fig. 5.1. Schematics 
of RR constructs are illustrated on the left side of the graphs. BP chimera represents the corresponding secondary 
element (α1, β2-α2, or α1-β2-α2) from PsdR (grey) is replaced by BceR (black), and PB chimera represents the 
corresponding secondary element (α1 or α1+loop (β5-α5)) from BceR (black) is replaced by PsdR (grey). The 
combinations of different HKs and RRs are indicated on top of each graph. 
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Discussion  
The genome of B. subtilis encodes three paralogous Bce-like TCSs, which share significant sequence 
similarity and were predicted to have considerable cross-talk (Procaccini et al., 2011). In contrast to 
the prediction, experiments clearly demonstrated that they are insulated quite well with only minor 
level of cross-regulation between BceS and PsdR in vivo (Rietkötter et al., 2008). The specificity of 
TCSs is extremely important for bacteria to ensure the desired responses to specific stimuli, and is 
mainly maintained by molecular recognition of interactions between HKs and cognate RRs. A number 
of studies were recently performed to understand the determinant of specificity between HKs and RRs 
(Skerker et al., 2008, Siryaporn et al., 2010, Capra et al., 2012). The co-crystal structure of HK853-
RR468 from T. maritima showed that the α1 helix and the β5-α5 loop of the RR468 receiver domain 
interact directly with two α helices of HK853 DHp domain, implying that specificity is most likely 
determined by specific interactions on this surface (Casino et al., 2009) (Fig. 5.3B). Further analysis of 
RRs (OmpR, RstA and CpxR) from the OmpR subfamily confirmed the importance of this interaction 
surface in specificity determination (Capra et al., 2010). EnvZ/OmpR, CpxA/CpxR and RstB/RstA are 
three well-insulated TCSs in E. coli. Substitution of three residues predicted for specificity on the α1 
helix of OmpR with the corresponding residues from RstA weaken the phosphotransfer from EnvZ to 
the substituted OmpR derivative, but no visible phosphotransfer was observed between RstB and the 
substituted OmpR derivative. Based on this three-amino acid substitution, subsequent substitution of 
three more amino acids on the OmpR β5-α5 loop by the corresponding residues of RstA diminished 
the phosphotransfer from EnvZ to OmpR and established the phosphotransfer from RstB to OmpR. 
Similarly, the study between EnvZ-OmpR and CpxA-CpxR systems proved that the α1 helix and the 
β5-α5 loop of OmpR/RstA/CpxR receiver domain are specificity determinants (Capra et al., 2010).  
However, the mechanism of specificity determination between these three paralogou Bce-like TCSs in 
B. subtilis was still poorly understood. In this chapter, we investigated determinants on Bce-like RRs 
that dictate specific interactions with their cognate HKs to maintain the signal transduction fidelity 
between Bce-like TCSs. In accordance with the other studied OmpR subfamily members (Howell et 
al., 2003), we verified that the specificity determinants are located on the receiver domain of Bce-like 
RRs. Previous studies of other OmpR subfamily members indicated that normally the α1 helix and the 
β5-α5 loop of the RR receiver domain are responsible for specific interactions with the cognate HK 
(Podgornaia et al., 2013). In contrast to studies of OmpR, swapping the α1 helix and the β5-α5 loop on 
the receiver domain of BceR into the corresponding regions of PsdR failed to rewire the signaling 
specificity. This chimera still behaved like wild-type BceR, which accepted the signal from BceS, but 
not from PsdS (Fig. 5.5G and 5.5H). The fact that determinants predicted by direct-coupling analysis 
(Procaccini et al., 2011) are not sufficient to determine specificity explaining the discrepancy between 
in silico modeling and in vivo facts regarding the predicted cross-talk between the BceRS and the 
PsdRS systems. 
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Our results demonstrated that to solve the problem of the insufficient discrimination of the α1 helix 
and the β5-α5 loop on Bce-like RRs, B. subtilis developed an extended determinant — the β2-α2 
region — working together with the α1 helix to guarantee the specificity of these three paralogous 
Bce-like TCSs. By exchanging both the α1 helix and β2-α2 region together of PsdR receiver domain 
into the corresponding regions of BceR, we successfully redirected the signal transmission from BceS 
to the substituted PsdR derivative (Fig. 5.5K and 5.5L). Our results revealed that B. subtilis evolved a 
double-insurance mechanism by using two indispensable specificity determinants to ensure the 
insulation of these three Bce-like TCSs to mediate the desired and beneficial responses to specific 
AMPs.  
All chimeras, including exchanging of the complete receiver domain, showed slower dynamics of 
target promoter induction. Comparison of the data in Figure 5.2C and Figure 5.5K strongly suggests 
that the α1 helix together with the β2-α2 is indeed both necessary and sufficient to determine the 
specificity in molecular interactions with the cognate HK and hence the specificity in the 
phosphotransfer reaction. 
In the co-crystal structure of HK853-RR468, the β2-α2 region of the RR receiver domain is not 
located on the interaction surfaces with the cognate HK. Bce-like TCSs are usually functionally 
related with ABC transporters, and a previous study suggested a positive interaction between the 
BceAB (ABC transporter) and BceR (RR) in vivo in the presence of BceS (Dintner et al., 2014). This 
extended specificity determining region possibly forms specific interaction with the ABC transporter.  
However this hypothesis still needs to be proved by further experiments. 
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Experimental procedures 
Bacterial strains and growth conditions 
All strains used in this study are listed in Table 5.1. E. coli DH5α and XL1-blue were used for cloning. E. coli 
and B. subtilis were routinely grown in Luria-Bertani (LB) medium at 37°C with agitation (200 rpm). B. subtilis 
was transformed by natural competence as previously described (Harwood & Cutting, 1990). Selective media 
contained ampicillin (100 µg ml
-1
 for E. coli), chloramphenicol (35 µg ml
-1 
for E. coli, 5 µg ml
-1 
for B. subtilis), 
kanamycin (10 µg ml
-1
 for B. subtilis), erythromycin 1 µg ml
-1
 with lincomycin 25 µg ml
-1
 (for macrolide-
lincosamide-streptogramin B (MLS) resistance in B. subtilis) or spectinomycin (100 µg ml
-1
 for B. subtilis). 
Bacitracin was supplied as the Zn
2+
-salt. 0.2% (w/v) xylose was added to media for the production of BceS. 
Solid media contained 1.5 % (w/v) agar. Growth was measured as optical density at 600 nm wavelength (OD600). 
Construction of plasmids and genetic techniques 
All plasmid constructs are listed in Table 5.2; all primer sequences used for this study are listed in Table 5.3. The 
constructs for the wild-type and chimeric RRs in B. subtilis were cloned according to the BioBrick standard 
(Knight, 2003). To facilitate constitutive expression in B. subtilis, a BioBrick of the bceRS operon promoter, 
PbceR, of B. subtilis was amplified and cloned into the EcoRI and SpeI sites of vector pSB1A3, creating pCF144. 
The BioBricks of BceR and PsdR containing an optimal Shine-Dalgarno sequence for B. subtilis were similarly 
cloned into pSB1A3 via EcoRI and SpeI, creating plasmids pCFSB101 and pCFSB103. The Biobricks of the 
chimeric RRs were constructed based on BceR and PsdR Biobricks. Further assembly of PbceR BioBrick, RR 
BioBrick together with a C terminal triple FLAG tag Biobrick into vector pBSBS2E created plasmids listed in 
Table 5.2.  
These plasmids were transformed into B. subtilis reporter strains TMB1975 (W168 ∆bceRS ∆psdRS ∆yxdJK-
yxeLMy-xeA PbceA-lux Pxyl-bceS) or TMB1976 (W168 ∆bceRS ∆psdRS ∆yxdJK-yxeLM-yxeA PpsdA-lux Pxyl-bceS) 
to check the signal from BceS, and TMB2051 (W168 ΔbceR psdR::kan PbceA-lux) or TMB2052 (W168 ΔbceR 
psdR::kan PpsdA-lux) to check the signal transduction from PsdS (Table 5.1). The production of BceS is under the 
control of a xylose-inducible (Pxyl) promoter and the production of PsdS is under the control of its native 
operon.All constructs were checked for PCR-fidelity by sequencing, and all created strains were verified by PCR 
using appropriate primers.  
Luciferase assays  
Luciferase activities of B. subtilis strains were assayed using a Synergy
TM
2 multi-mode microplate reader from 
BioTek
®
 controlled by the software Gen5
TM
. LB medium was inoculated 1:500 from overnight cultures, and 
each strain was grown in 100 µl volumes in a 96-well plate. Cultures were incubated at 37°C with shaking 
(intensity: medium), and the OD600 was monitored every 10 min. At an OD600 of 0.02 (4-5 doublings since 
inoculation; corresponding to OD600 = 0.1 in cuvettes of 1 cm light-path length), either bacitracin was added to a 
final concentration of 2 µg ml
-1
, or nisin to a final concentration of 8 µg ml
-1
; in all cases one well was left 
untreated. Cultures were further incubated for 2.5 h, and the OD600 and luminescence (endpoint-reads; 1 s 
integration time; sensitivity: 200) were monitored every 5 min. OD600 values were corrected using wells 
containing 100 µl LB medium as blanks. Raw luminescence output (relative luminescence units, RLU) was 
normalized to cell density by dividing each data-point by its corresponding corrected OD600 value (RLU/OD).  
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Tables 
Table 5.1. Bacterial strains used in this study. 
Strain Genotype or characteristic(s)
 
Reference or source  
E. coli strains   
DH5α recA1 endA1 gyrA96 thi-1 hsdR17(rK
-
mK
+
) relA1 glnV44 
Φ80’ ∆lacZ ∆M15 ∆(lacZYA-argF)U169 
(Grant et al., 1990) 
XL1-Blue endA1 gyrA96(nal
R
) thi-1 recA1 relA1 lac supE44 
[F’proAB+ lacIq Δ(lacZ)M15] hsdR17(rK
-
 mK
+
) 
Stratagene 
 
B. subtilis strains   
TMB1975 W168 ∆bceRS psdRS yxdJK-yxeLM-yxeA PbceA-lux 
thrC::pAS718 (bceS) 
This study 
TMB1976 W168 ∆bceRS psdRS yxdJK-yxeLM-yxeA PpsdA-lux 
thrC::pAS718 (bceS) 
This study 
TMB2026 TMB2051 lacA::pCF2E11 This study 
TMB2029 TMB1975 lacA::pCF2E11 This study 
TMB2030 TMB1976 lacA::pCF2E12 This study 
TMB2051 W168 ΔbceR psdR::kan sacA::pSDlux101 (PbceA-lux) This study 
TMB2052 W168 ΔbceR psdR::kan sacA::pSDlux102 (PpsdA-lux) This study 
TMB2065 TMB2052 lacA::pCF2E12 This study 
TMB2072 TMB2052 lacA::pCF2E25 This study 
TMB2073 TMB2052 lacA::pCF2E26 This study 
TMB2074 TMB2052 lacA::pCF2E27 This study 
TMB2075 TMB2052 lacA::pCF2E28 This study 
TMB2076 TMB2051 lacA::pCF2E29 This study 
TMB2085 TMB1976 lacA::pCF2E25 This study 
TMB2086 TMB1976 lacA::pCF2E26 This study 
TMB2087 TMB1976 lacA::pCF2E27 This study 
TMB2088 TMB1976 lacA::pCF2E28 This study 
TMB2089 TMB1975 lacA::pCF2E29 This study 
TMB2139 TMB1976 lacA::pCF2E31 This study 
TMB2140 TMB1976 lacA::pCF2E32 This study 
TMB2141 TMB1976 lacA::pCF2E33 This study 
TMB2142 TMB1976 lacA::pCF2E34 This study 
TMB2144 TMB2052 lacA::pCF2E31 This study 
TMB2145 TMB2052 lacA::pCF2E32 This study 
TMB2146 TMB2052 lacA::pCF2E33 This study 
TMB2147 TMB2052 lacA::pCF2E34 This study 
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Table 5.2. Vectors and plasmids used in this study. 
Plasmid Genotype or characteristic(s)
a Primers used for 
cloning 
Reference or source  
Vectors    
pSB1A3 
Replicative E. coli vector for 
cloning,amp
R
, rfp in BioBrick MCS 
 (Vick et al., 2011) 
pBS2E 
pAX01-derivative vector for 
cloning, rfp in BioBrick MCS; 
amp
R
, mls
R
, integrates in lacA in B. 
subtilis 
 (Radeck et al., 2013) 
Plasmids    
pCF144 pSB1A3 PbceR Biobrick 2610/2611 This study 
pCF2E11 pBS2E PbceR-bceR-3xFLAG  This study 
pCF2E12 pBS2E PbceR-BP1-3xFLAG 2610/2797 2798/2730 This study 
pCF2E25 pBS2E PbceR-BP2-3xFLAG 2610/2828 2829/2730 This study 
pCF2E26 pBS2E PbceR-BP3-3xFLAG 2610/2830 2831/2730 This study 
pCF2E27 pBS2E PbceR-BP4-3xFLAG 2610/2832 2833/2730 This study 
pCF2E28 pBS2E PbceR-BP5-3xFLAG 2610/2834 2794/2730 This study 
pCF2E29 pBS2E PbceR-PBα1-3x FLAG 2610/2767 2768/2673 This study 
pCF2E31 pBS2E PbceR-psdR-3xFLAG  This study 
pCF2E32 pBS2E PbceR-BPα1-3xFLAG 2610/2793 2794/2730 This study 
pCF2E33 pBS2E PbceR-BPβ2-α2-3xFLAG 2610/3132 2768/2730 This study 
pCF2E34 pBS2E PbceR-BPα1-β2-α2-3xFLAG 2610/27933133/2730 This study 
pCFSB101 pSB1A3 bceR Biobrick 2579/2673 This study 
pCFSB103 pSB1A3 psdR Biobrick 2729/2730 This study 
pSB1C3-3xFlag-tag pSB1C3 3xFlag Biobrick  Laboratory stock 
a
Amp, ampicillin; mls, macrolide-lincosamide-streptogramin B group antibiotics; r, resistant.  
Chapter V – The specificity determinant of Bce-like HKs/RRs  
84 
 
Table 5.3. Primers used in this study. 
Primer name Sequence (5'-3')
a
 Use 
TM2579 
GATCGAATTCGCGGCCGCTTCTAGAAAGGAGGTGGCCGGCATG
AGTCGATTGTTTAAACTTTTG 
bceR prefix 
TM2610 
AATTGAATTCGCGGCCGCTTCTAGAGTTCCGATGATTCTTGCG
GCC 
PbceR prefix 
TM2611 AATTACTAGTACAAGTGTATAGCAAAACGCC PbceR suffix 
TM2673 AAATTACTAGTAATTACCGGTATCATAGAACTTGTCCTCTTC bceR suffix 
TM2729 
AAATTGAATTCGCGGCCGCTTCTAGAAAGGAGGTGGCCGGCGT
GTATCGGATTTTGCTTG 
psdR prefix 
TM2730 AAATTACTAGTATTAACCGGTACATTCCGCTTCATCCTTC psdR suffix 
TM2767 gaagatgaccgcccagcaaagaagcaatccgTTCATCATCTTCAATCAGC PBα1 up rev 
TM2768 tttgctgggcggtcatcttcaaaaatacggaTATGATGTATACGGCATTC BPβ2-α2 down fwd 
TM2793 ttaaacgatccttgatttcatgaaacagcgaCTCATCATCTTCCACAAGC BPα1 up rev 
TM2794 
tgaaatcaaggatcgtttaacgggatggtccTATGAAGTGAAAATTGCTGAACAG
C 
BPα1 down fwd 
TM2797 GAACATCGCTTGGATTTTCG BP1 up rev 
TM2798 cgaaaatccaagcgatgttcCGCCGCACATATGGTGAATATTC BP1 down fwd 
TM2828 TGCCCCGAGCTGCATGGAC BP2 up rev 
TM2829 tccatgcagctcggggcaGATGATTATATCACAAAGCCG BP2 down fwd 
TM2830 AACATTTGACCGGGAGCGG BP3 up rev 
TM2831 cgctcccggtcaaatgttCCGATTATCTTTATATCGGC BP3 down fwd 
TM2832 ATTAACCGCCGCAAATTCCTG BP4 up rev 
TM2833 gaatttgcggcggttaatCCTGATCTTGTGCTGCTTG BP4 down fwd 
TM2834 GGACCATCCCGTTAAACGATC BP5 up rev 
TM3132 TCCGTATTTTTGAAGATGACCG BPβ2-α2 up rev 
TM3133 TCGCTGTTTCATGAAATCAAGG BPα1-β2-α2 down fwd 
a
Restriction sites are underlined; overlaps to other primers for PCR fusions are shown by lower case letters.  
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6. Concluding discussion  
Resistance against antimicrobial peptides (AMPs) largely determines bacterial survival in competitive 
habitats. Among the resistance mechanisms developed by bacteria, the most efficient ways often 
involve ATP-binding cassette (ABC) transporters. A special type of BceAB-like ABC transporters, is 
exclusively contained within and widespread among Firmicutes bacteria (Gebhard, 2012). It 
frequently pairs with an adjacent BceRS-like two-component system (TCS), forming the Bce-type 
specific AMP sensing and detoxification module (Dintner et al., 2011). Although a number of Bce-
type systems have been studied in Bacillus subtilis and Staphylococcus aureus (reviewed in (Gebhard 
& Mascher, 2011)), many questions remain unanswered. The aim of this thesis was to obtain a deep 
insight into the regulatory network of Bce-type systems in two Firmicutes bacteria: Enterococcus 
faecalis and B. subtilis.  
The technical challenges of molecular studies in E. faecalis impedes the understanding of Bce-type 
AMP sensing and detoxification system. Therefore, we exploited B. subtilis as a heterologous host to 
study the E. faecalis systems (Chapter II). By combining the homologous study in E. faecalis with 
the heterologous study in the B. subtilis platform, we successfully identified and characterized the 
Bce-type AMP sensing and resistance network of E. faecalis, which provides useful insight for clinical 
research (Chapter III). B. subtilis has three paralogous but well insulated Bce-like systems. Focusing 
on the Bce and Psd systems, we investigated the molecular mechanisms using by B. subtilis to 
maintain the intrasystem signal transduction and intersystem insulation at the response regulator 
(RR)/promoter level (Chapter IV) and the histidine kinase (HK)/RR level (Chapter V). At both 
interfaces, novel specificity determinants could be identified and characterized. 
6.1. Bacillus subtilis as a heterologous host: advantages and considerations 
Understanding AMP resistance mechanisms of pathogenic bacteria is important for antibiotic 
development. However, for many species, such studies are impeded by the difficulty of genetic 
manipulation as well as pathogenicity. Because of the easy genetic manipulation and the well-
understood genetic background, the Gram-negative bacterium Escherichia coli has been used as a 
heterologous host for in vivo analysis of the VanRS TCSs in both type A and B vancomycin resistant 
enterococci (Silva et al., 1998). However, the differences in cell wall composition between Gram-
positive and Gram-negative bacteria suggest that E. coli is probably not a suitable host for 
heterologous studies of enterococci cell wall active AMP resistance systems. B. subtilis, on the other 
hand, the best-characterized member of Gram-positive bacteria with well understood AMP resistance 
systems (reviewed in (Jordan et al., 2008)), might be a more suitable candidate for such heterologous 
studies of E. faecalis AMP resistance mechanisms. It provides numerous established genetic tools, a 
comparable GC content (43.5%) with E. faecalis (37.5%), similar transcription machinery, and the 
most important ― a comparable cell envelope. 
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The objective of Chapter II was to exploit B. subtilis as a platform for heterologous study of AMP 
resistance mechanisms of E. faecalis. Two kinds of AMP resistance systems from E. faecalis, the 
BcrR one-component system and the VanSB-VanRB two-component system, were transferred into B. 
subtilis and their functionality was demonstrated. The three native Bce-like AMP sensing and 
resistance systems in B. subtilis were deleted to minimize the interference with the heterologously 
introduced systems. We were also able to demonstrate that the one-component system BcrR from E. 
faecalis is fully functional in B. subtilis in both gene regulation and bacitracin resistance. In a previous 
study, the VanSB-VanRB TCS system from E. faecalis, which can sense vancomycin and regulate the 
resistance operon, showed a constitutive expression of the target promoter PvanYB in B. subtilis 
(Bisicchia et al., 2011). In contrast to this result, by adjusting the expression level of the TCS using a 
xylose inducible promoter, Pxyl, we demonstrated that the target promoter PvanYB of the VanSB-VanRB 
TCS is induced in a vancomycin-dependent manner and the system is functionally produced in B. 
subtilis. With this B. subtilis platform, we were also able to functionally characterize a complex Bce-
type system of E. faecalis with two ABC transporters and a regulatory TCS for bacitracin sensing and 
resistance. These results are presented in Chapter III and will be discussed in the next section. 
Based on these results, we confirmed that B. subtilis is clearly a suitable heterologous host for 
studying cell wall-targeting antibiotic resistance systems of E. faecalis. Attentions must be paid to the 
genetic background of the host to minimize the interference of the intrinsic resistance system to the 
introduced system. The expression level of the introduced system may influence its function, which 
means optimization is required and important for functional analysis. In addition to functional 
characterization of AMP resistance systems, the high degree of competence of B. subtilis can also be 
used for preliminary high-throughput screening of random mutations and synthetic DNA libraries for 
deep understanding of the signal transduction mechanism of E. faecalis. Promising results can be 
validated in a more targeted fashion further in E. faecalis. B. subtilis is of course also a suitable host 
for heterologous studying of cell wall-targeting AMP resistance systems of the other Firmicutes 
bacteria. 
6.2. The Bce-type modules are arranged differently within Bacillus subtilis and 
Enterococcus faecalis 
The BceAB-like ABC transporters have been shown to be widely distributed in Firmicutes bacteria for 
AMP sensing and resistance (Dintner et al., 2011). Three such ABC transporters, BceAB, PsdAB and 
YxdLM, were identified and characterized in B. subtilis by previous studies reviewed in (Gebhard & 
Mascher, 2011) (Fig. 6.1 B. subtilis). Each of these BceAB-like ABC transporters is functionally 
related with a cognate BceRS-like TCS, and together they form a signal transduction circuit. Taking 
the best understood BceRS-BceAB system as an example: the signaling starts when the ABC 
transporter BceAB detects the AMP and activates the cognate HK BceS by direct protein-protein 
interaction; the subsequent signal transmission within the TCS BceRS will upregulate the transcription 
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of the ABC transporter operon for further resistance (Ohki et al., 2003, Coumes-Florens et al., 2011, 
Dintner et al., 2014).  
The majority of BceAB-like ABC transporters, such as the above-mentioned three ABC transporters in 
B. subtilis, are usually regulated by BceRS-like TCSs encoded in the genomic neighborhood of the 
ABC transporters (Dintner et al., 2011). However, there are still a number of such ABC transporters 
lacking neighboring TCSs. In the genome of E. faecalis, two putative BceAB-like transporters and one 
BceRS-like TCS were identified in previous study, but neither of these ABC transporters was located 
next to the TCS (Dintner et al., 2011). To identify the relationship between these two BceAB-like 
ABC transporters and the only one BceRS-like TCS, functional analysis was done with these three 
gene loci in both E. faecalis and the heterologous host B. subtilis in Chapter III. We showed that 
these three gene loci are all required for full bacitracin resistance: (1) one ABC transporter, EF2050-
2049, that was strongly upregulated in response to bacitracin can mediate bacitracin resistance; (2) the 
other ABC transporter, EF2752-2751, that was slightly induced by bacitracin is responsible for 
bacitracin perception; and (3) the expression of these two ABC transporter operons was differentially 
regulated by the TCS EF0927-0926, and the expression of the TCS was induced by an as-yet-
unidentified regulator that is not directly part of the resistance network. We were able to build the 
bacitracin sensing and resistance network in E. faecalis (Fig. 6.1 E. faecalis), which starts when the 
transporter EF2752-2751 detects the presence of bacitracin and subsequently transfers the signal to the 
TCS EF0926-0927. Signaling within the TCS leads to a highly increased production of the transporter 
EF2050-2049 to mediate resistance against bacitracin, and a slightly increased production of the 
transporter EF2752-2751 to detect bacitracin. However, the mechanism of differentiating the level of 
regulation is not known and more investigation is needed to address this question.  
Compared to the signaling transduction circuit of B. subtilis for AMP sensing and resistance (Fig. 6.1 
B. subtilis), we demonstrated that products of these three gene loci of E. faecalis form another 
configuration for the AMP sensing and resistance module (Fig. 6.1 E. faecalis). The Bce-type ABC 
transporters and TCSs are arranged differently in B. subtilis and in E. faecalis. The combined 
functions of the ABC transporter BceAB with both bacitracin sensing and resistance in B. subtilis is 
separated into two in E. faecalis, i.e. one ABC transporter, EF2752-2751, is only responsible for 
bacitracin sensing and an additional one, EF2050-2049, is required for bacitracin resistance. The gene 
regulation is also split and differentiated in E. faecalis: the TCS is able to strongly upregulate the 
transcription of the resistance ABC transporter EF2050-2049 operon and slightly upregulate the 
transcription of the sensor ABC transporter EF2752-2751 operon. The expression of the BceRS TCS 
operon of B. subtilis is under the control of a constitutive promoter, while the expression of the 
EF0927-0926 TCS operon of E. faecalis it is induced by an as-yet-unidentified regulator, which is not 
directly part of the resistance network.  
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Figure 6.1. Schematic of signaling network of Bce-type AMP sensing and detoxification systems in B. 
subtilis, E. facalis and S. aureus. Coloring is chosen to reflect the assignment of each module to its 
phylogenetic group (yellow, group II; red, group III; blue, group IV; green, group VII; grey and black, no group 
assigned) (Dintner et al., 2011). Names of genes and proteins of each system are given next to their schematics. 
Main substrates of each system are shown on top of the ABC transporter, with black curved downward arrow 
representing the perception and grey curved upward arrow representing the detoxification. Signal transfer 
between transporters and TCSs is indicated in the membrane bilayer. Phosphotransfer between HKs and RRs, 
transcriptional activation, and production of ABC transporters are shown by solid arrows. The minor level of 
cross-regulation between BceS and PsdR is shown by a dashed arrow. The induction of EF0926-EF0927 operon 
by an unknown regulator in E. faecalis is showen by a dotted arrow. The differences in the strength of induction 
are reflected by thickness of lines. This figure was originally based in parts on (Gebhard & Mascher, 2011, 
Gebhard et al., 2014), with modifications. 
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Our results of the E. faecalis Bce-type network are similar to the previously described BraDE-BraRS-
VraDE network of S. aureus (Fig. 6.1 S. aureus). In S. aureus, the production of two Bce-type ABC 
transporters, VraDE and BraDE, is controlled by one Bce-type TCS BraRS. The BraDE ABC 
transporter can sense AMPs (bacitracin and nisin) and activate the TCS BraRS, which will further 
induce the expression of both ABC transporter operons braDE and vraDE for AMP detection and 
resistance, respectively (Li et al., 2007, Hiron et al., 2011). In addition to this system, the division of 
labor between two ABC transporters — one is only for AMP sensing while the other one is only for 
AMP resistance — was also observed in other Firmicutes bacteria, such as the ABC12-TCS12-orphan 
ABC transporter system in Lactobacillus casei for sensing and resistance against AMPs (Revilla-
Guarinos et al., 2013). 
The existence of these two types of arrangement for AMP sensing and resistance network in 
Firmicutes bacteria raises the question: why do bacteria sometimes split functions of the ABC 
transporter and sometimes not? One explanation is that splitting the functions (AMP perception and 
resistance) of the ABC transporter may endow bacteria the possibility of mediating nonspecific 
responses, i.e. TCSs from other systems can cross-regulate the resistance ABC transporter operon. 
While combining the functions is beneficial for bacteria to maintain the specificity of the signal 
transduction pathway, i.e. the expression of the ABC transporter can only be regulated by its cognate 
TCS. It may also be that the separation of the AMP sensing and resistance functions and 
differentiation of the expression level keep the proper energy distribution between two ABC 
transporters. However, these hypotheses still need to be proved by experimental evidence.  
6.3. Specificity determination of Bce-like TCSs in Bacillus subtilis 
Cross-talk is defined as the communication between two distinct systems, which is often detrimental 
and must be kept to a minimum for generating desired responses to specific stimuli. However, there 
are examples of beneficial cross-talk under some conditions, such as mediating multiple responses to a 
single input, called cross-regulation (Laub & Goulian, 2007). Although minor level of cross-regulation 
between the HK BceS and the RR PsdR was observed in vivo under high concentrations of bacitracin 
in B. subtilis, the remaining parts of three paralogous Bce-type AMP sensing and detoxification 
systems are very well insulated from each other (Rietkötter et al., 2008) (Fig. 6.1 B. subtilis). These 
three systems most likely evolved by duplication for a common ancestor followed by sequence 
divergence so that each of them can detect specific signal input and mediate corresponding output. In 
this evolutionary process, mutations that occurred on the specific interaction surfaces of one protein 
need to be compensated by corresponding mutations on its partner to maintain a functional interaction 
and simultaneously to avoid cross-talk (Szurmant & Hoch, 2010). This indicates that the predominant 
mechanism to ensure specificity is molecular recognition — the intrinsic ability of a protein to 
distinguish its cognate partner from the non-cognate ones with a relatively high preference. To 
guarantee the fidelity of the whole system, specificity needs to be maintained at every step of the 
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signal transduction pathway. In this thesis, we tried to gain a deeper understanding of mechanisms that 
dictate intrasystem fidelity and intersystem insulation of the two Bce-type systems (BceRS-BceAB 
and PsdRS-PsdAB) in B. subtilis, on both the HK/RR and the RR/promoter interaction level. 
6.3.1. The mechanism of maintaining specificity at the RR and target promoter level 
On PbceA and PpsdA, no typical -35 element was found in the appropriate location upstream of the -10 
element, indicating that the σ unit of the RNA polymerase cannot bind properly to the promoter by 
itself for further transcription initiation. However, this problem can be solved when the σ unit interacts 
with RRs, which bind to the up element of the promoter, to compensate its weak binding (Lee et al., 
2012). DNA binding domain structures of both PhoB and OmpR from OmpR subfamily demonstrated 
that the α2-α3 loop is essential for direct interaction with the σ subunit of the RNA polymerase 
(Martínez-Hackert & Stock, 1997, Blanco et al., 2002). BceR and PsdR, which belong to the same 
subfamily, are assumed to assist the transcription initiation of RNA polymerase in a similar way.  
Specific transcription initiation by the RR is important for maintaining the insulation of the signaling 
system. The similarity of Bce-like RRs DNA-binding domain and their binding sites on target 
promoters increases the potential of cross-talk on the transcription initiation level. However, we could 
show that Bce-type RRs in B. subtilis are extremely specific in inducing the transcription of their 
cognate ABC transporters. Although the binding of BceR to the cognate PbceA and the non-cognate 
PpsdA were both observed in vitro, BceR can only induce the transcription of bceAB and not of psdAB 
in vivo (Chapter IV). To understand the mechanism of specific regulation, further EMSAs and SPR 
assays were performed in Chapter IV and indicated that the in vitro cross-talk and in vivo insulation 
are due to the great difference in binding affinities, i.e. BceR has a much higher affinity to its cognate 
promoter PbceA than to the non-cognate promoter PpsdA. Although it can bind to PpsdA in vitro, the 
binding affinity is still not high enough to recruit the RNA polymerase to the promoter for in vivo 
transcription initiation. 
The affinity preference is the ability of the RR to distinguish the cognate promoter from non-cognate 
ones. Our data strongly suggests that B. subtilis evolved an intelligent mechanism to maintain this 
ability, which is a hierarchical and cooperative binding model (Fig. 6.2). Instead of only the one 
binding site reported by previous studies (Ohki et al., 2003, de Been et al., 2008), we demonstrated for 
the first time the necessary of two binding sites in the regulatory region of the Bce-type RR target 
promoters. By performing EMSAs and SPR assays of BceR with PbceA mutants carrying either the 
main binding site random mutation or the secondary binding site random mutation, we further 
demonstrated that BceR has a high affinity and shows independent binding to the upstream main 
binding site. It has a low affinity to the downstream secondary binding site and cannot bind to it alone. 
Our data suggests that a BceR dimer first binds to the high affinity main binding site. This first 
binding event then assists the subsequent binding of another dimer to the downstream low affinity 
secondary binding site. Furthermore, we were able to show that exchanging the secondary binding site 
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resulted in a much stronger influence on promoter specificity than the main binding site by in vivo 
promoter activity assays. The hierarchical and cooperative binding model that enables BceR to have 
distinct binding affinities to its cognate promoter PbceA from the non-cognate PpsdA is based on: (1) the 
main binding sites of these two promoters differ only in three bases, and provide a high affinity, low 
specificity docking site; (2) the secondary binding sites of these two promoters harbors five different 
bases, and represent a low affinity, but high specificity interaction site; and (3) the combination of the 
main binding site and the secondary binding site results in the relatively higher affinity of BceR to its 
cognate promoter PbceA compared to the non-cognate PpsdA (Chapter IV).  
 
 
 
 
 
 
 
 
Figure 6.2. The model of specific transcriptional activation of bceAB operon by BceR and RNA 
polymerase. Firstly, BceR dimer (black) not PsdR dimer (gray) binds to the main binding site (MBS) on PbceA. 
Secondly, the binding of the first dimer helps another dimer bind to the secondary binding site (SBS) upstream 
of the -10 element on PbceA. Finally, the binding of the second BceR dimer to PbceA can assist the binding of σ
A
 
subunit of the holo RNA polymerase (RNAP) to the promoter region by direct protein-protein interaction and 
hence recruits the RNA polymerase for further transcription. The structure of the DNA is altered by the linker 
region between two binding sites.   
The linker regions of these two promoters showed characteristically distinct GC/AT contents — PbceA 
has high AT content, while PpsdA has high GC content. In Chapter IV we showed that mutating the 
linker region into a random sequence but still keeping the GC/AT content of each promoter slightly 
affected the promoter activity. However, exchanging linker regions between these two promoters, 
which means changing the GC/AT content, obtained more influence on the promoter activity. AT-rich 
sequence is known to cause the bending of DNA (Koo et al., 1986). One possibility is that the AT-rich 
linker region on PbceA confers a structural difference from PpsdA by bending the promoter between two 
binding sites to fit the binding of two BceR dimers.  
The high specificity of the secondary binding site is presumably determined mainly by its first half site, 
because the first half sites of PbceA and PpsdA differ in four out of seven bases, while the second half 
sites show only one. The sequence identity of the second half site and its location at the position of -35 
suggest that it can probably be bound by both BceR and the σA subunit of the RNA polymerase. We 
showed that a PbceA mutant with the secondary binding site replaced by the main binding site (main 
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binding site-linker-main binding site) lost the promoter activity (data not shown), which further 
indicates the importance of the second half for σA subunit binding and transcription initiation. This 
mechanism was already demonstrated for the transcription initiation by PhoB and σ70  binding together 
to the pho box (Blanco et al., 2011). 
This hierarchical and cooperative binding model has already been shown to be widely spread among 
the OmpR RR subfamily. For example, PhoB can bind cooperatively on two binding sites of the pstS 
promoter with different binding affinities (Blanco et al., 2012). PompF has three OmpR binding sites 
with gradually reduced affinity from upstream to downstream, and the binding of OmpR to the first 
site is important for subsequent binding to the lower affinity downstream sites (Harlocker et al., 1995). 
The cooperative binding model is also demonstrated using by RRs from other families. A recent study 
of the RR YpdB by SPR analysis also showed a two-step cooperative binding mechanism to its target 
PyhjX (Behr et al., unpublished). The binding of YpdB to the upstream site A initiates a subsequent 
binding of YpdB to the downstream site B. Similar as BceR binding to PbceA, binding of YpdB to PyhjX 
was completely abolished when the site A was inactivated, but YpdB was still able to bind properly to 
the downstream binding site B in the presence of an inactivated site A. The evolution of such complex 
regulatory systems is related, to some extent, to the regulatory function of RRs. PhoB and OmpR have 
been demonstrated to regulate dozens of operons in E. coli in the presence of certain stimuli. However, 
some operons need to be highly upregulated while others require only moderate or subtle regulation. 
Control of the desired expression level of these operons can be achieved through assembly of different 
numbers of binding sites with sequence divergence. For B. subtilis, a similar mechanism is used to 
maintain the signal transduction specificity and the regulatory insulation between three paralogous 
Bce-like systems. By evolving the cooperation of a high affinity but low specificity main binding site 
and a high specificity but low affinity secondary binding site, B. subtilis is able to ensure the Bce-like 
RR a relatively higher preference to its cognate promoter to the non-cognate ones, hence maintains the 
signaling fidelity of these three paralogoue Bce-like systems on the transcription level.  
6.3.2. The mechanism of maintaining specificity at the HK and the RR interaction level 
Bce-type RRs of B. subtilis belong to the OmpR RR subfamily (Fabret et al., 1999). Previous studies 
of one family member, PhoP (RR of the PhoPR TCS), showed that substitution of three amino acids 
(Ser13, Leu17, and Tyr20) on the α1 helix together with one amino acid (Pro107) on the β5-α5 loop of 
PhoP receiver domain with corresponding amino acids from WalR (RR of the WalRK TCS) was 
sufficient to rewire the phosphotransfer between these two TCSs (Fig. 6.3A). The PhoP mutant could 
be phosphorylated by the non-cognate HK WalK and no longer by the cognate PhoR (Jende et al., 
2010). Similarly, replacing three amino acids (Arg15, Leu16, and Arg22) of the α1 helix and three 
amino acids (Pro106, Phe107, and Asn108) of the β5-α5 loop of the OmpR receiver domain (RR from 
the EvnZ/OmpR TCS) with corresponding amino acids of RstA (RR of the RstAB TCS) was able to 
redirect the phosphotransfer specificity from RstB to OmpR and eliminate the phosphotransfer from 
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the cognate EnvZ to OmpR (Capra et al., 2010) (Fig. 6.3A). These results indicated that the α1 helix 
and the β5-α5 loop of the RR receiver domain contain the specificity determinants and can dictate 
specific interactions with the cognate HK. This is in agreement with the co-crystal structure of 
HK853-RR468. In this structure the α1 helix and the β5-α5 loop on the RR receiver domain form 
interaction surfaces with the HK DHp domain (Casino et al., 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. (A) Sequence alignment of the specificity determinants on RRs. Names of RRs and the sequence 
of specificity determinants are shown. Residues highlighted in cyan on OmpR, RstA, PhoP, and WalR are 
demonstrated by experiments, while on BceR and PsdR are predicted by direct-coupling analysis that are 
responsible for dictating specificity with their cognate HKs (Capra et al., 2010, Jende et al., 2010, Procaccini et 
al., 2011). Residues highlighted in yellow on BceR and PsdR are the extended specificity determinants. 
Secondary structure elements are given above the RR sequences. (B) Signaling analysis between BceS/ PB6×
amino acids and PsdS/ PB6×amino acids. Signal transduction between HK and RR was monitored in vivo as the 
induction of PbceA-luxABCDE transcriptional fusions within 150 min in the presence of antibiotics (black square): 
bacitracin for BceS activation and nisin for PsdS activation, and compared with the non-induced controls (grey 
square). Schematics of BceR and PsdR are illustrated on top and schematic of chimeric RR is illustrated on the 
left side of the graphs with the same shading as in Chapter V. On PB6×amino acids, six amino acids (highlighted in 
cyan in Fig. 6.3 (A)) on the receiver domain from PsdR is colored with grey and the region from BceR is colored 
with black.  
BceR and PsdR also belong to the OmpR subfamily, and they may share similar mechanism as the 
other family members to determine specific interactions with their cognate HKs. However, chimera 
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PB6×amino acids, BceR with five amino acids on the α1 helix and one amino acid on the β5-α5 loop 
exchanged into corresponding residues of PsdR did not show any change of specificity (Fig. 6.3A and 
6.3B). Our data indicates that the α1 helix and the β5-α5 loop of the RR receiver domain are not able 
to determine the specificity of Bce-like TCSs in B. subtilis. This is in good agreement with the 
prediction done by direct-coupling analysis that BceRS and PsdRS systems have the potential of 
considerable cross-talk (Procaccini et al., 2011).  
However, a previous study demonstrated that BceRS and PsdRS only have minor level of cross-
regulation between BceS and PsdR at some concentrations of bacitracin (Rietkötter et al., 2008), 
which indicates that Bce-like TCSs probably evolved different mechanism to maintain the signaling 
specificity. We further explored this hypothesis in Chapter V by making chimeric RRs between BceR 
and PsdR on different regions of the receiver domain. We demonstrated that the α1-β2-α2 region on 
the Bce-like RR receiver domain is the specificity determinant. BceS, instead of PsdS, strongly 
activated PsdR if this region is substituted by the corresponding part of BceR. We showed that the α1 
helix of Bce-like RRs is not enough to determine specificity, but it is necessary and indispensable. We 
demonstrated that to compensate the lacking of specificity of the α1 helix, B. subtilis developed an 
extended determinant with high sequence diversity ― the β2-α2 region. This region can partially 
determine the specificity but together with the α1 helix can fully dictate the specificity of Bce-type 
TCSs. Compared to the other studied TCSs, B. subtilis uses a different mechanism to maintain the 
insulation of Bce-like TCSs (Fig. 6.3A).  
Two additional interaction surfaces are also observed in the co-crystal structure of HK853-RR468 
(Casino et al., 2009) (Fig. 1.5). One is the interaction between the β3-α3 loop of RR468 receiver 
domain and the ATP lid together with the β4-α4 loop of the HK853 CA domain. The other is the 
interaction between RR468 β4-α4 loop and the DHp-CA interdomain linker of HK853. However, the 
extended β2-α2 region on the RR receiver domain for Bce-type TCSs specificity is not located on any 
of these interaction surfaces. The Bce-type TCSs are often functionally related to their ABC 
transporters. A bold assumption is proposed that the additional region — β2-α2 — is possibly 
responsible for specific interaction with the cognate ABC transporter instead of with the HK. 
Supporting this idea, positive interaction between BceR (RR) and BceAB (ABC transporter) was 
observed in the presence of BceS (HK) by bacterial two-hybrid assay (BACTH) (Dintner et al., 2014). 
However this hypothesis still needs to be proved by further experiments. Taken together, our studies in 
Chapter V suggest that B. subtilis evolved an extended determinant (the α1 helix and the β2-α2 region) 
to maintain the specificity of three paralogous Bce-like TCSs, which is different from the other studied 
OmpR subfamily members (the α1 helix and the β5-α5 loop). Our results provide a clear view of the 
location of specific interacting amino acids between HK and RR and a nice starting point for further 
studying the mechanism.   
Chapter VI - Concluding discussion 
98 
 
6.4. Open questions and further research 
In this thesis, we demonstrated that B. subtilis is a suitable platform for heterologous studies of the 
AMP resistance mechanisms of E. faecalis. Based on this platform, we identified and characterized a 
Bce-type AMP sensing and resistance network of E. faecalis. Furthermore, we investigated the 
specificity determining mechanisms of two Bce-type systems in B. subtilis. Nevertheless, there are still 
several unsolved questions about the Bce-type AMP sensing and detoxification pathways.  
6.4.1. Amino acids located on the α1-β2-α2 region for the specificity of Bce-like TCSs  
By performing chimeric RR analysis, we were able to demonstrate the determinant ― the α1-β2-α2 
region ― on the RR receiver domain that dictates the specificity of Bce-like TCSs. The α1 helix is 
comprised of 13 amino acids, and 5 of them are predicted by direct-coupling analysis that can interact 
specifically with corresponding amino acids on the cognate HK. However, no information is available 
about which amino acids on the β2-α2 region are responsible for specificity. To answer this question, 
more chimeras should be made by exchanging these 5 amino acids on the α1 helix together with 
different amino acids on the β2-α2 region between BceR and PsdR to construct a chimeric RR library. 
The screening can be done by high-throughput promoter-reporter assays on the plate and promising 
candidates will be checked further by both in vivo and in vitro experiments. 
6.4.2.  Is there direct interaction between BceAB and BceR? 
Investigation of the specificity determinant between Bce-type TCSs showed an extended α1-β2-α2 
region on the RR receiver domain different from the α1 helix and the β5-α5 loop of the other OmpR 
subfamily members. According to the co-crystal structure of HK853-RR468, the α1 helix is on the 
HK/RR interaction surface but not the β2-α2 region. The functional relation between Bce-type TCSs 
and Bce-type ABC transporters implies that this β2-α2 region possibly can form an interaction surface 
with the ABC transporter (Fig. 6.3A). BACTH assays suggested a positive interaction between BceR 
and BceAB in the presence of BceS (Dintner et al., 2014). This is in good agreement with the previous 
study about the GraXSR-VraFG system in S. aureus that these proteins were shown to form a 
interaction complex by BACTH assay (Meehl et al., 2007, Falord et al., 2012).  
Without BceS, however, no detectable interaction between BceR and BceAB was observed in the 
BACTH assay. It is also possible that BceS plays an important role in bringing BceR close to the 
cytoplasmic side of the membrane, so that BceR can interact with BceAB. The interaction between 
BceR and BceAB probably is not as strong as with BceS, therefore we failed to detect it in the absence 
of BceS. Formation of a four-protein complex, demanding that BceR match the specific interaction 
with both BceS (by the α1 helix of BceR) and BceAB (by the β2-α2 region of BceR), provides a 
double insurance to guarantee the signal transduction specificity of Bce-type systems. This hypothesis 
still needs to be proven by further experiments. 
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6.4.3. How does BceR initiate the transcription of the bceAB operon? 
We have already demonstrated that BceR binds to two binding sites on PbceA and upregulates 
transcription of the bceAB operon. The binding of a BceR dimer to the main binding site can assist 
another dimer binding to the low affinity secondary binding site. Does this assistance happen via direct 
interaction between two BceR dimers? If yes, on which region do they form the interaction surfaces? 
Another open question is whether the RNA polymerase is recruited to the promoter by direct 
interaction between the second BceR dimer and the σA subunit. Blanco and colleagues have already 
demonstrated that the α2-α3 loop on the PhoB DNA binding domain is essential for transcription 
activation by interacting with the σ4 subdomain of the σ70 subunit. The σ4 subdomain can then bind to 
the pho box at the -35 position together with the PhoB dimer, but at different sides, and recruit the 
RNA polymerase for transcription initiation (Blanco et al., 2002, Blanco et al., 2011). In B. subtilis, 
the second halves of the secondary binding sites replace the -35 elements and the sequences are almost 
identical between PbceA and PpsdA, which provides a potential low affinity binding region for the σ
A
 
subunit. Substitution of the whole secondary binding site by the main binding site resulted in the loss 
of promoter activity, which probably undermines the essential binding of the σA subunit to the 
promoter. We suggest that the transcription initiation starts with the first dimer binding to the upstream 
binding site, which assists and stabilizes the binding of the second dimer to the secondary binding site 
by direct dimer-dimer interaction. This is followed by interacting with the σA subunit and recruiting it 
to the promoter DNA, which enhance the binding of the σA subunit to the second half of the secondary 
binding site and the -10 region to start the transcription of the bceAB operon. Further experiments are 
required to verify the interaction between BceR dimers, BceR dimer and the σA subunit of the RNA 
polymerase. Furthermore, the binding of the σA subunit to the second half of the downstream 
secondary binding site also needs to be proven in this model.  
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